Unaudited Interim Consolidated Statements of Financial Position (Parenthetical) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Fixed Maturities, Available-for-sale, allowance for credit losses | $ 42,828 | $ 40,414 |
| Fixed Maturities, Available-for-sale, amortized cost | 40,807,986 | 36,980,933 |
| Fixed maturities, trading, amortized cost | 4,761,537 | 4,415,277 |
| Equity securities, at cost | 2,478,826 | 2,650,542 |
| Commercial mortgage and other loans, allowance for credit losses | 39,784 | 37,715 |
| Other invested assets, at fair value | 120,398 | 68,623 |
| Reinsurance recoverable and deposit receivables, embedded derivatives at fair value | $ 716,745 | $ 645,193 |
| Common Stock, Par or Stated Value Per Share | $ 10 | $ 10 |
| Common Stock, Shares Authorized | 1,000,000 | 1,000,000 |
| Common Stock, Shares, Issued | 250,000 | 250,000 |
| Common Stock, Shares, Outstanding | 250,000 | 250,000 |
| ASU 2016-13 | ||
| Short-term investments, allowance for credit losses | $ 57 | $ 49 |
Unaudited Interim Consolidated Statements of Equity - USD ($) $ in Thousands |
Total |
Common Stock |
Additional Paid-in Capital |
Retained Earnings / (Accumulated Deficit) |
Accumulated Other Comprehensive Income (Loss) |
Total Pruco Life Insurance Company Equity |
Noncontrolling Interests |
Total Equity |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Begining Balance at Dec. 31, 2023 | $ 2,500 | $ 5,052,602 | $ (551,471) | $ (30,961) | $ 4,472,670 | $ 30,194 | $ 4,502,864 | |||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||
| Contributions from noncontrolling interests | 25,310 | 25,310 | ||||||||||||||||
| Contributed (distributed) capital-parent/child asset transfers | 5,722 | 5,722 | 5,722 | |||||||||||||||
| Comprehensive income (loss): | ||||||||||||||||||
| Net Income (Loss) | $ (574,395) | [1] | (575,576) | [2] | (575,576) | [2] | 1,181 | [2] | (574,395) | [2] | ||||||||
| Other comprehensive income (loss), net of tax | (412,481) | (412,481) | [2] | (412,481) | [2] | 0 | [2] | (412,481) | [2] | |||||||||
| Total comprehensive income (loss) | (986,876) | (575,576) | (412,481) | (988,057) | 1,181 | (986,876) | ||||||||||||
| Ending Balance at Mar. 31, 2024 | [2] | 2,500 | 5,058,324 | (1,127,047) | (443,442) | 3,490,335 | 56,685 | 3,547,020 | ||||||||||
| Begining Balance at Dec. 31, 2024 | 4,701,980 | 2,500 | 4,923,299 | 272,519 | (601,877) | 4,596,441 | 105,539 | 4,701,980 | ||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||||||||
| Contributed capital | 220,000 | 220,000 | 220,000 | |||||||||||||||
| Contributions from noncontrolling interests | 52,350 | 52,350 | ||||||||||||||||
| Contributed (distributed) capital-parent/child asset transfers | 26,303 | 26,303 | 26,303 | |||||||||||||||
| Comprehensive income (loss): | ||||||||||||||||||
| Net Income (Loss) | 134,526 | 129,569 | 129,569 | 4,957 | 134,526 | |||||||||||||
| Other comprehensive income (loss), net of tax | 332,968 | 332,968 | 332,968 | 0 | 332,968 | |||||||||||||
| Total comprehensive income (loss) | 467,494 | 129,569 | 332,968 | 462,537 | 4,957 | 467,494 | ||||||||||||
| Ending Balance at Mar. 31, 2025 | $ 5,468,127 | $ 2,500 | $ 5,169,602 | $ 402,088 | $ (268,909) | $ 5,305,281 | $ 162,846 | $ 5,468,127 | ||||||||||
| ||||||||||||||||||
Unaudited Interim Consolidated Statements of Cash Flows - USD ($) $ in Thousands |
3 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||
| Net income (loss) | $ 134,526 | $ (574,395) | [1] | ||||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||||||
| Policy charges and fee income | [2] | (1,607) | 12,084 | ||||||
| Interest credited to policyholders’ account balances | 293,762 | 258,350 | [1] | ||||||
| Realized investment (gains) losses, net | 106,374 | 2,805 | [3] | ||||||
| Change in value of market risk benefits, net of related hedging (gains) losses | 326,071 | (103,996) | [3] | ||||||
| Change in: | |||||||||
| Future policy benefits and other insurance liabilities | 384,212 | 758,805 | |||||||
| Reinsurance related-balances | [2] | (248,674) | 496,373 | [1] | |||||
| Accrued investment income | [2] | (31,424) | (23,101) | ||||||
| Net payables to (receivables from) parent and affiliates | 119,595 | 53,794 | |||||||
| Deferred policy acquisition costs | [2] | (197,401) | (194,547) | [1] | |||||
| Income taxes | 20,891 | (68,453) | [1] | ||||||
| Derivatives, net | (714,931) | 125,100 | [1] | ||||||
| Other, net | [2] | (150,083) | (52,194) | [1] | |||||
| Cash flows from (used in) operating activities | 41,311 | 690,625 | |||||||
| Proceeds from the sale/maturity/prepayment of: | |||||||||
| Fixed maturities, available-for-sale | 1,418,413 | 534,863 | |||||||
| Fixed maturities, trading | 241,633 | 109,671 | |||||||
| Equity securities | 629,347 | 599,147 | |||||||
| Policy loans | 58,359 | 43,678 | |||||||
| Ceded policy loans | (33,853) | (152,846) | |||||||
| Short-term investments | 258,052 | 203,345 | |||||||
| Commercial mortgage and other loans | 77,769 | 138,763 | |||||||
| Other invested assets | 40,182 | 47,619 | |||||||
| Notes receivable from parent and affiliates | [2] | 120,268 | 0 | ||||||
| Payments for the purchase/origination of: | |||||||||
| Fixed maturities, available-for-sale | (5,060,663) | (2,738,376) | |||||||
| Fixed maturities, trading | (610,084) | (521,570) | |||||||
| Equity securities | (482,925) | (355,267) | |||||||
| Policy loans | (60,078) | (64,385) | |||||||
| Ceded policy loans | 24,835 | 26,675 | |||||||
| Short-term investments | (202,411) | (495,831) | |||||||
| Commercial mortgage and other loans | (340,870) | (309,826) | |||||||
| Other invested assets | (443,965) | (146,510) | |||||||
| Notes receivable from parent and affiliates | [2] | (160,235) | (120,777) | ||||||
| Derivatives, net | 40,418 | (17,634) | |||||||
| Other, net | 7,611 | 7,478 | |||||||
| Cash flows from (used in) investing activities | (4,478,197) | (3,211,783) | |||||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||
| Policyholders’ account deposits | 4,181,256 | 4,110,730 | |||||||
| Ceded policyholders’ account deposits | (592,077) | (301,733) | [1] | ||||||
| Policyholders’ account withdrawals | (1,048,147) | (978,866) | [1] | ||||||
| Ceded policyholders’ account withdrawals | 188,798 | 239,384 | |||||||
| Net change in securities sold under agreement to repurchase and cash collateral for loaned securities | 115,426 | (214,607) | |||||||
| Contributed capital | 220,000 | 0 | |||||||
| Contributed (distributed) capital - parent/child asset transfers | 0 | 7,481 | |||||||
| Net change in all other financing arrangements (maturities 90 days or less) | 0 | (1,296) | |||||||
| Drafts outstanding | 9,224 | (69,072) | |||||||
| Contributions from noncontrolling interests | [2] | 52,350 | 25,310 | ||||||
| Other, net | [2] | 86,696 | (78,207) | [1] | |||||
| Cash flows from (used in) financing activities | 3,213,526 | 2,739,124 | |||||||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (1,223,360) | 217,966 | |||||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 3,325,698 | 2,139,792 | |||||||
| CASH AND CASH EQUIVALENTS, END OF PERIOD | $ 2,102,338 | $ 2,357,758 | |||||||
| |||||||||
Unaudited Interim Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Non-cash activities | $ 0 | |
| Affiliated Entity | PURE and Prudential Insurance | ||
| Non-cash activities | $ 1,138 | |
Unaudited Interim Consolidated Statements of Operations and Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Income Statement [Abstract] | ||
| Gain (loss) from changes in estimates on deferred profit liability amortization | $ 650 | $ (330) |
Business and Basis of Presentation |
3 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Business and Basis of Presentation | BUSINESS AND BASIS OF PRESENTATION Pruco Life Insurance Company (“Pruco Life”) is a wholly-owned subsidiary of Prudential Insurance, which in turn is a direct wholly-owned subsidiary of Prudential Financial, Inc. (“Prudential Financial”). Pruco Life is a stock life insurance company organized in 1971 under the laws of the State of Arizona. It is licensed to sell life insurance and annuities in the District of Columbia, Guam and in all states except New York, and sells such products primarily through affiliated and unaffiliated distributors. Pruco Life has one wholly-owned insurance subsidiary, Pruco Life Insurance Company of New Jersey (“PLNJ”). PLNJ is a stock life insurance company organized in 1982 under the laws of the State of New Jersey. It is licensed to sell life insurance and annuities in New Jersey and New York only. Pruco Life and its subsidiaries are together referred to as the "Company", "we" or "our" and all financial information is shown on a consolidated basis. Basis of Presentation The Unaudited Interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). The Unaudited Interim Consolidated Financial Statements include the accounts of Pruco Life and entities over which the Company exercises control, including majority-owned subsidiaries. Intercompany balances and transactions have been eliminated. In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company's Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. Segment Information Although there are separate products within Pruco Life, the Company is organized as a single reportable segment and manages the business activities on a consolidated basis. The accounting policies are the same as those described in Note 2 included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. The Company analyzes operating performance using “Income (loss) from operations before income taxes and equity in earnings of operating joint venture”, as determined in accordance with U.S. GAAP. This is the measure of profit or loss used by the Company’s chief operating decision maker to evaluate performance and allocate resources. The measure of segment assets is reported as “Total Assets” on the Consolidated Statements of Financial Position. Segment revenue is reported as “Total Revenues” on the Consolidated Statements of Operations and Comprehensive Income (Loss). As the Company has one reportable segment, there are no intersegment revenues. The Company discloses all significant expense categories separately on the Consolidated Statements of Operations and Comprehensive Income (Loss). The Company’s chief operating decision maker is a group of Prudential Financial executives that include the chief financial officer, controller, treasurer, and business leaders, which include the Company’s chief executive officer and chief financial officer. Overall business decisions for the Company are made by this group of executives. Such business decisions include the allocation of capital, distribution/sale of products, and allocation/deployment of overall Prudential Financial resources. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The most significant estimates include those used in determining future policy benefits; policyholders' account balances and reinsurance related to the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products; market risk benefits ("MRBs"); the valuation of investments including derivatives, the measurement of allowance for credit losses, and the recognition of other-than-temporary impairments; reinsurance recoverables; any provision for income taxes and valuation of deferred tax assets; and accruals for contingent liabilities, including estimates for losses in connection with unresolved legal and regulatory matters. Reclassifications Certain amounts in prior periods have been reclassified to conform to the current period presentation. Revision to Prior Period Interim Financial Statements As previously disclosed in the Company’s Annual Report on Form 10-K for the year-ended December 31, 2024, during the fourth quarter of 2024, the Company identified multiple errors which impacted previously issued Consolidated Financial Statements, including for the three months ended March 31, 2024. Certain reinsurance recoverable balances associated with the coinsurance with funds withheld of fixed indexed annuities, certain deferred acquisition cost balances associated with indexed variable annuities, and certain other immaterial items were not properly accounted for. Prior period amounts have been revised in the Consolidated Financial Statements and related disclosures to correct these errors. In connection with this revision, the Company also corrected certain other immaterial adjustments within the Financing Section of the Unaudited Interim Consolidated Statements of Cash Flows for the three months ended March 31, 2024. Management evaluated these adjustments and concluded they were not material to any previously reported quarterly Consolidated Financial Statements. See Note 16 for a more detailed description of the revisions and for comparisons of amounts previously reported to the revised amounts.
|
Significant Accounting Policies and Pronouncements |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Significant Accounting Policies and Pronouncements | SIGNIFICANT ACCOUNTING POLICIES AND PRONOUNCEMENTS Recent Accounting Pronouncements Changes to U.S. GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of Accounting Standards Updates ("ASUs") to the FASB Accounting Standards Codification ("ASC"). The Company considers the applicability and impact of all ASUs. ASUs listed below include those that have been adopted during the current fiscal year and/or those that have been issued but not yet adopted as of March 31, 2025, and as of the date of this filing. ASUs not listed below were assessed and determined to be either not applicable or not material. ASUs issued but not yet adopted as of March 31, 2025
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | 3. INVESTMENTS Fixed Maturity Securities The following tables set forth the composition of fixed maturity securities (excluding investments classified as trading), as of the dates indicated:
(1)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans and education loans. (2)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.
(1)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans and education loans. (2)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. The following tables set forth the fair value and gross unrealized losses on available-for-sale fixed maturity securities without an allowance for credit losses aggregated by investment category and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of the dates indicated:
As of March 31, 2025 and December 31, 2024, the gross unrealized losses on fixed maturity, available-for-sale securities without an allowance of $1,849 million and $2,059 million, respectively, related to “1” highest quality or “2” high quality securities based on the National Association of Insurance Commissioners (“NAIC”) or equivalent rating and $81 million and $102 million, respectively, related to other than high or highest quality securities based on NAIC or equivalent rating. As of March 31, 2025, the $1,754 million of gross unrealized losses of twelve months or more were concentrated in the Company’s corporate securities within the finance, consumer non-cyclical and utility sectors. As of December 31, 2024, the $1,894 million of gross unrealized losses of twelve months or more were concentrated in the Company's corporate securities within the finance, consumer non-cyclical and utility sectors. In accordance with its policy described in Note 2 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, the Company concluded that an adjustment to earnings for credit losses related to these fixed maturity securities was not warranted at March 31, 2025. This conclusion was based on a detailed analysis of the underlying credit and cash flows for each security. Gross unrealized losses are primarily attributable to increases in interest rates, general credit spread widening and foreign currency exchange rate movements. As of March 31, 2025, the Company did not intend to sell these securities, and it was not more likely than not that the Company would be required to sell these securities before the anticipated recovery of the remaining amortized cost basis. The following table sets forth the amortized cost and fair value of fixed maturities by contractual maturities, as of the date indicated:
Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Asset-backed, commercial mortgage-backed and residential mortgage-backed securities are shown separately in the table above, as they do not have a single maturity date. The following table sets forth the sources of fixed maturity proceeds and related investment gains (losses), as well as losses on write-downs and the allowance for credit losses of fixed maturities, for the periods indicated:
(1)Excludes activity from non-cash related proceeds due to the timing of trade settlements of $150.7 million and $(8.7) million for the three months ended March 31, 2025 and 2024, respectively. (2)Amounts represent write-downs on credit adverse securities. The following tables set forth the balance of and changes in the allowance for credit losses for fixed maturity securities, as of and for the periods indicated:
For additional information regarding the Company’s methodology for developing its allowance and expected losses, see Note 2 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. For the three months ended March 31, 2025, the net increase in the allowance for credit losses on available-for-sale securities was primarily related to net additions within the consumer non-cyclical and technology sectors within corporate securities due to adverse projected cash flows, partially offset by net reductions within the capital goods and consumer non-cyclical sectors with corporate securities primarily due to security restructures. For the three months ended March 31, 2024, the net decrease in the allowance for credit losses on available-for-sale securities was primarily related to net reductions within the finance sector within corporate securities. The Company did not have any fixed maturity securities purchased with credit deterioration as of both March 31, 2025 and December 31, 2024. Fixed Maturities, Trading The net change in unrealized gains (losses) from fixed maturities, trading still held at period end, recorded within “Other income (loss),” was $87.8 million and $(81.3) million during the three months ended March 31, 2025 and 2024, respectively. Equity Securities The net change in unrealized gains (losses) from equity securities still held at period end, recorded within “Other income (loss),” was $(93.6) million and $(12.2) million during the three months ended March 31, 2025 and 2024, respectively. Commercial Mortgage and Other Loans The following table sets forth the composition of “Commercial mortgage and other loans”, as of the dates indicated:
As of March 31, 2025, the commercial mortgage and agricultural property loans were secured by properties geographically dispersed throughout the United States with the largest concentrations in California (24%), Florida (8%) and Texas (8%) and included loans secured by properties in Europe (9%), Mexico (1%) and Australia (1%). The following table sets forth the balance of and changes in the allowance for credit losses for commercial mortgage and other loans, as of and for the periods ended:
For additional information regarding the Company’s methodology for developing its allowance and expected losses, see Note 2 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. For the three months ended March 31, 2025, the net increase in the allowance for credit losses on commercial mortgage and other loans was primarily related to an increase in loan-specific allowances within the retail sector of commercial mortgage loans. For the three months ended March 31, 2024, the net increase in the allowance for credit losses on commercial mortgage and other loans was primarily related to an increase in loan-specific allowances within the office sector and in the general allowance due to net negative credit migration. The following tables set forth key credit quality indicators based upon the recorded investment gross of allowance for credit losses, as of the dates indicated:
For additional information regarding the Company’s commercial mortgage and other loans credit quality monitoring process, see Note 2 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. The Company may grant loan modifications in its commercial mortgage and other loan portfolios to borrowers experiencing financial difficulties. These loan modifications may be in the form of principal forgiveness, interest rate reduction, other-than-insignificant payment delay, term extension or some combination thereof. The amount, timing and extent of modifications granted and subsequent performance are considered in determining any allowance for credit losses. The following table sets forth the amortized cost basis of loan modifications made to borrowers experiencing financial difficulties during the periods indicated:
(1) Prior period amounts have been updated to conform to current period presentation. For the three months ended March 31, 2024, the modification added less than one year to the weighted average life in the commercial mortgage loan portfolio. The Company did not have any commitments to lend additional funds to borrowers experiencing financial difficulties on modified loans as of both March 31, 2025 and December 31, 2024. The following tables set forth an aging of past due commercial mortgage and other loans based upon the recorded investment gross of allowance for credit losses, as well as the amount of commercial mortgage and other loans on non-accrual status, as of the dates indicated:
(1)As of March 31, 2025, there were no loans in this category accruing interest. (2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
(1)As of December 31, 2024, there were no loans in this category accruing interest. (2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. Loans on non-accrual status recognized interest of less than $1 million and $0 million for the three months ended March 31, 2025 and 2024, respectively. Loans on non-accrual status that did not have a related allowance for credit losses were $5 million and $2 million as of March 31, 2025 and December 31, 2024, respectively. For both the three months ended March 31, 2025 and 2024, there were no commercial mortgage and other loans acquired, other than those through direct origination, and there were no commercial mortgage and other loans sold. The Company did not have any commercial mortgage and other loans purchased with credit deterioration as of both March 31, 2025 and December 31, 2024. Other Invested Assets The following table sets forth the composition of “Other invested assets,” as of the dates indicated:
(1)Includes tax advantaged investments and investments in separate account funds. Accrued Investment Income The following table sets forth the composition of “Accrued investment income,” as of the dates indicated:
There were no significant write-downs on accrued investment income for both the three months ended March 31, 2025 and 2024. Net Investment Income The following table sets forth “Net investment income” by investment type, for the periods indicated:
Realized Investment Gains (Losses), Net The following table sets forth “Realized investment gains (losses), net” by investment type, for the periods indicated:
(1)Includes fixed maturity securities classified as available-for-sale and excludes fixed maturity securities classified as trading. (2)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. (3)Includes changes in the value of reinsurance and funds withheld payables, primarily reflecting the impact of net investment income on withheld assets that are ceded to certain reinsurance counterparties. (4)Prior period amounts have been updated to conform to current period presentation. Net Unrealized Gains (Losses) on Investments within AOCI The following table sets forth net unrealized gains (losses) on investments, as of the dates indicated:
(1)For additional information regarding cash flow hedges, see Note 4. (2)Primarily includes net unrealized gains (losses) on certain joint ventures that are strategic in nature and are included in "Other assets." Repurchase Agreements and Securities Lending In the normal course of business, the Company sells securities under agreements to repurchase and enters into securities lending transactions. As of both March 31, 2025 and December 31, 2024, the Company had no repurchase agreements. The following table sets forth the composition of “Cash collateral for loaned securities,” which represents the liability to return cash collateral received for the following types of securities loaned, as of the dates indicated:
(1)The Company did not have any agreements with remaining contractual maturities greater than thirty days, as of the dates indicated.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments | DERIVATIVES AND HEDGING Types of Derivative Instruments and Derivative Strategies The Company utilizes various derivative instruments and strategies to manage its risk. Commonly used derivative instruments include, but are not necessarily limited to: •Interest rate contracts: futures, swaps, options, caps and floors •Equity contracts: futures, options and total return swaps •Foreign exchange contracts: futures, options, forwards and swaps •Credit contracts: single and index reference credit default swaps Other types of financial contracts that the Company accounts for as derivatives include: •Embedded derivatives and synthetic guaranteed investment contracts (“GICs”) For detailed information on these contracts and the related strategies, see Note 4 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. Primary Risks Managed by Derivatives The table below provides a summary of the gross notional amount and fair value of derivative contracts by the primary underlying risks, excluding embedded derivatives and associated reinsurance recoverables and deposit receivables. Many derivative instruments contain multiple underlying risks. The fair value amounts below represent the value of derivative contracts prior to taking into account the netting effects of master netting agreements and cash collateral.
(1)Excludes embedded derivatives which contain multiple underlying risks. The fair value of these embedded derivatives was a net liability of $11,017 million and $11,968 million as of March 31, 2025 and December 31, 2024, respectively, primarily included in "Policyholders' account balances". (2)Recorded in “Other invested assets” and “Payables to parent and affiliates” on the Unaudited Interim Consolidated Statements of Financial Position. Offsetting Assets and Liabilities The following table presents recognized derivative instruments (excluding embedded derivatives and associated reinsurance recoverable and deposit receivables), and repurchase and reverse repurchase agreements that are offset in the Unaudited Interim Consolidated Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Unaudited Interim Consolidated Statements of Financial Position.
(1)Amounts exclude the excess of collateral received/pledged from/to the counterparty. For information regarding the rights of offset associated with the derivative assets and liabilities in the table above see “Credit Risk” below and Note 14. For securities purchased under agreements to resell and securities sold under agreements to repurchase, the Company monitors the value of the securities and maintains collateral, as appropriate, to protect against credit exposure. Where the Company has entered into repurchase and resale agreements with the same counterparty, in the event of default, the Company would generally be permitted to exercise rights of offset. For additional information on the Company’s accounting policy for securities repurchase and resale agreements, see Note 2 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. Cash Flow Hedges The primary derivative instruments used by the Company in its cash flow hedge accounting relationships are currency swaps and interest rate swaps. These instruments are only designated for hedge accounting in instances where the appropriate criteria are met. The Company does not use futures, options, credit, or equity derivatives in any of its cash flow hedge accounting relationships. The following tables provide the financial statement classification and impact of derivatives used in qualifying and non-qualifying hedge relationships, excluding the offset of the hedged item in an effective hedge relationship.
(1) Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. Presented below is a rollforward of current period cash flow hedges in AOCI before taxes:
The changes in fair value of cash flow hedges are deferred in AOCI and are included in "Net unrealized investment gains (losses)" in the Unaudited Interim Consolidated Statements of Operations and Comprehensive Income (Loss); these amounts are then reclassified to earnings when the hedged item affects earnings. Using March 31, 2025 values, it is estimated that a pre-tax gain of $40 million is expected to be reclassified from AOCI to earnings during the subsequent twelve months ending March 31, 2026. The exposures the Company is hedging with these qualifying cash flow hedges include the variability of the payment or receipt of interest or foreign currency amounts on existing financial instruments. There were no material amounts reclassified from AOCI into earnings relating to instances in which the Company discontinued cash flow hedge accounting because the forecasted transaction did not occur by the anticipated date or within the additional time period permitted by the authoritative guidance for the accounting for derivatives and hedging. Credit Derivatives Credit Derivatives, where the Company has written credit protection on certain index references, have outstanding notional amounts of $881 million and $912 million as of March 31, 2025 and December 31, 2024, respectively. These credit derivatives are reported at fair value as an asset of $2 million and $10 million as of March 31, 2025 and December 31, 2024, respectively. As of March 31, 2025 the notional amount of these credit derivatives had the following NAIC ratings: $849 million in NAIC 3 and $32 million in NAIC 6. The Company has no exposure on purchased credit protection as of March 31, 2025 and December 31, 2024. Counterparty Credit Risk The Company is exposed to credit-related losses in the event of non-performance by counterparties to financial derivative transactions with a positive fair value. The Company manages credit risk by entering into derivative transactions with regulated derivatives exchanges for exchange traded derivatives and its affiliate, Prudential Global Funding LLC (“PGF”), related to its over-the-counter ("OTC") derivatives. PGF, in turn, manages its credit risk by: (i) entering into derivative transactions with highly rated major international financial institutions and other creditworthy counterparties governed by master netting agreements, as applicable; (ii) trading through central clearing and OTC parties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single-party credit exposures which are subject to periodic management review. Substantially all of the Company’s derivative agreements have zero thresholds which require daily full collateralization by the party in a liability position.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Assets and Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value of Assets and Liabilities | FAIR VALUE OF ASSETS AND LIABILITIES Fair Value Measurement - Fair value represents the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The authoritative fair value guidance establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows: Level 1 – Fair value is based on unadjusted quoted prices in active markets that are accessible to the Company for identical assets or liabilities. Level 2 – Fair value is based on significant inputs, other than quoted prices included in Level 1, that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability through corroboration with observable market data. Level 2 inputs include quoted prices in active markets for similar assets and liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, and other market observable inputs. Level 3 – Fair value is based on at least one significant unobservable input for the asset or liability. The assets and liabilities in this category may require significant judgment or estimation in determining the fair value. For a discussion of the Company's valuation methodologies for assets and liabilities measured at fair value and the fair value hierarchy, see Note 5 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. There have been no material changes in our valuation techniques during the period represented by these Unaudited Interim Consolidated Financial Statements. Assets and Liabilities by Hierarchy Level – The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated.
(1)“Netting” amounts represent cash collateral of $(9,412) million and $(8,311) million as of March 31, 2025 and December 31, 2024, respectively, and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting agreements. (2)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans and education loans. (3)Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at net asset value ("NAV") per share (or its equivalent) as a practical expedient. As of March 31, 2025 and December 31, 2024, the fair value of such investments was $40 million and $44 million, respectively. (4)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company's Unaudited Interim Consolidated Statements of Financial Position. (5)Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and a corporate owned life insurance fund. As of March 31, 2025 and December 31, 2024, the fair value of such investments was $6,805 million and $6,444 million, respectively. Quantitative Information Regarding Internally Priced Level 3 Assets and Liabilities – The tables below present quantitative information regarding significant internally-priced Level 3 assets and liabilities.
(1)Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table. (2)Directional impacts for MRB assets and liabilities are associated with the directional impacts of direct and assumed MRBs. (3)Includes assets classified as fixed maturities, available-for-sale and fixed maturities, trading. (4)Represents multiple of earnings before interest, taxes, depreciation and amortization ("EBITDA"), and are amounts used when the Company has determined that market participants would use such multiples when valuing the investments. (5)Market risk benefits primarily represent fair value for all living benefit guarantees including accumulation, withdrawal and income benefits. Since the valuation methodology for these assets and liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (6)Lapse rates for contracts with living benefit guarantees are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates for contracts with index-linked crediting guarantees may be adjusted at the contract level based on the applicability of any surrender charges, product type, and market related factors such as interest rates. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For any given contract, lapse rates vary throughout the period over which cash flows are projected for the purposes of valuing these balances. (7)The spread over the Secured Overnight Financing Rate (“SOFR”) swap curve represents the premium added to the proxy for the risk-free rate (SOFR) to reflect the Company’s estimates of rates that a market participant would use to value the living benefits in both the accumulation and payout phases and index-linked interest crediting guarantees as of March 31, 2025 and December 31, 2024, respectively. This spread includes an estimate of non-performance risk ("NPR"), which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements are insurance liabilities and are therefore senior to debt. Effective April 2023, the Company entered into an agreement with The Ohio National Life Insurance Company, now known as AuguStar Life Insurance Company ("AuguStar"), an affiliate of Constellation Insurance Holdings, Inc., to reinsure approximately $10 billion of account values of Prudential Defined Income ("PDI") traditional variable annuity contracts with guaranteed living benefits. See Note 11 for additional information regarding this transaction. As a result of this transaction, a ceded MRB asset balance was established to fair value the reinsurance reimbursements to the Company. The establishment of the fair value also required an estimate of NPR for AuguStar, which may differ from the Company's; however, the NPR spreads for AuguStar were developed using a methodology similar to that of the Company. (8)The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits. (9)The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of both March 31, 2025 and December 31, 2024, the minimum withdrawal rate assumption is 78% and the maximum withdrawal rate assumption may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%. (10)The range reflects the mortality rates for the vast majority of business with living benefits and other contracts, with policyholders ranging from 50 to 90 years old. While the majority of living benefits have a minimum age requirement, certain other contracts do not have an age restriction. This results in contractholders with mortality rates approaching 0% for certain benefits. Mortality rates may vary by product, age, and duration. A mortality improvement assumption is also incorporated into the overall mortality table. (11)Includes deposit assets related to reinsurance agreements using deposit method of accounting and modified coinsurance agreements, which include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain annuity products. (12)Policyholders’ account balances primarily represent general account liabilities for the index-linked interest credited on certain of the Company’s life and annuity products that are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (13)Option budget estimates the expected long-term cost of options used to hedge exposures associated with equity price and interest rate changes. The level of option budget determines future costs of the options, which impacts the growth in account value and the valuation of embedded derivatives. Interrelationships Between Unobservable Inputs – In addition to the sensitivities of fair value measurements to changes in each unobservable input in isolation, as reflected in the table above, interrelationships between these inputs may also exist, such that a change in one unobservable input may give rise to a change in another or multiple inputs. Examples of such interrelationships for significant internally-priced Level 3 assets and liabilities are as follows: Corporate Securities – The rate used to discount future cash flows reflects current risk-free rates plus credit and liquidity spread requirements that market participants would use to value an asset. The discount rate may be influenced by many factors, including market cycles, expectations of default, collateral, term, and asset complexity. Each of these factors can influence discount rates, either in isolation, or in response to other factors. During weaker economic cycles, as the expectations of default increase, credit spreads widen, which results in a decrease in fair value. Commercial Mortgage-backed Securities – Interrelationships may exist between the prepayment rate, the default rate and/or loss severity, depending on specific market conditions. In stronger economic cycles, prepayment rates are generally driven by underlying property appreciation and subsequent cash-out refinances, while default rates and loss severity may be lower. During weaker economic cycles, prepayment rates may decline, while default rates and loss severity increase. Generally, a change in the assumption used for the probability of default would be accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumption used for prepayment rates. The impact of these factors on average life and economics varies with the deal structure and tranche subordination. Market Risk Benefits – The Company expects efficient benefit utilization and withdrawal rates to generally be correlated with lapse rates. However, behavior is generally highly dependent on the facts and circumstances surrounding the individual contractholder, such as their liquidity needs or tax situation, which could drive lapse behavior independent of other contractholder behavior assumptions. To the extent more efficient contractholder behavior results in greater in-the-moneyness at the contract level, lapse rates may decline for those contracts. Similarly, to the extent that increases in equity volatility are correlated with overall declines in the capital markets, lapse rates may decline as contracts become more in-the-money. Changes in Level 3 Assets and Liabilities – The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods (excluding MRBs disclosed in Note 10). When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
(1)"Other" includes additional activity not allocated to the specific categories within the rollforward of Level 3 Assets and Liabilities. (2)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. (3)Includes U.S. corporate private, foreign corporate public, foreign corporate private, and foreign government bonds. (4)Includes asset-backed and commercial mortgage-backed securities. (5)Purchases/issuances and settlements for Policyholders' account balances and Reinsurance recoverables and deposit receivables are presented net in the rollforward. (6)Excludes MRB assets of $2,509 million and $2,537 million and MRB liabilities of $4,803 million and $4,388 million for the periods ended March 31, 2025 and 2024, respectively. See Note 10 for additional information. (7)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter. (8)Prior period amounts have been updated to conform to current period presentation. (9)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. Fair Value of Financial Instruments The tables below present the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value. The financial instruments presented below are reported at carrying value on the Company’s Unaudited Interim Consolidated Statements of Financial Position. In some cases, as described below, the carrying amount equals or approximates fair value.
(1) Carrying values presented herein differ from those in the Company’s Unaudited Interim Consolidated Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or are out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs, Deferred Reinsurance, and Deferred Sales Inducements |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Charges, Insurers [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Policy Acquisition Costs, Deferred Reinsurance, and Deferred Sales Inducements | DEFERRED POLICY ACQUISITION COSTS, DEFERRED REINSURANCE AND DEFERRED SALES INDUCEMENTS Deferred Policy Acquisition Costs ("DAC") The following tables show a rollforward for the lines of business that contain DAC balances, along with a reconciliation to the Company's total DAC balance:
(1)Other includes the impact of the Universal Life reinsurance transaction with Prudential Arizona Reinsurance Universal Company (“PAR U”) and PURE. See Note 11 for additional information. (2)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. Deferred Reinsurance Losses ("DRL") The following tables show a rollforward for the lines of business that contain DRL balances, along with a reconciliation to the Company's total DRL balance:
Deferred Reinsurance Gains ("DRG") The following tables show a rollforward for the lines of business that contain DRG balances, along with a reconciliation to the Company's total DRG balance:
(1)Includes the impact of the International reinsurance transaction with The Prudential Life Insurance Company, Ltd. ("Prudential of Japan"), including $14 million of DRG. See Note 11 for additional information.
(1)Other includes the impact of the Universal Life reinsurance transaction with PAR U, PURE and Prudential Insurance, including $1,207 million of DRG, partially offset by a $116 million write-off. See Note 11 for additional information. Deferred Sales Inducements ("DSI") The following table shows a rollforward of DSI balances for variable annuity products, which is the only line of business that contains a DSI balance, along with a reconciliation to the Company's total DSI balance:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Separate Accounts |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate Accounts | SEPARATE ACCOUNTS The Company issues variable annuity and variable life insurance contracts through its separate accounts for which investment income and investment gains and losses accrue directly to, and investment risk is borne by, the contractholder. Most variable annuity and variable life insurance contracts are offered with both separate and general account options. See Note 9 for additional information. The assets supporting the variable portion of variable annuity and variable life insurance contracts are carried at fair value and reported as “Separate account assets” with an equivalent amount reported as “Separate account liabilities”. The liabilities related to the net amount at risk are reflected within “Future policy benefits” or “Market risk benefit liabilities” (or “assets,” if applicable). Amounts assessed against the contractholders for mortality, administration, and other services are included within revenue in “Policy charges and fee income” and changes in liabilities for minimum guarantees are generally included in “Policyholders’ benefits” or “Change in value of market risk benefits, net of related hedging gains (losses)”. Separate Account Assets The aggregate fair value of assets, by major investment asset category, supporting separate accounts is as follows:
For the three months ended March 31, 2025 and year ended December 31, 2024, there were no transfers of assets, other than cash, from the general account to a separate account; therefore, no gains or losses were recorded. Separate Account Liabilities The balances of and changes in separate account liabilities as of and for the periods indicated are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability For Future Policy Benefits |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liability For Future Policy Benefits | LIABILITY FOR FUTURE POLICY BENEFITS Liability for Future Policy Benefits primarily consists of the following sub-components, which are discussed in greater detail below. •Benefit Reserves; •Deferred Profit Liability ("DPL"); and •Additional Insurance Reserves ("AIR") Benefit Reserves The balances of and changes in Benefit Reserves as of and for the periods indicated consist of the three tables presented below: Present Value of Expected Net Premiums rollforward, Present Value of Expected Future Policy Benefits rollforward, and Net Liability for Future Policy Benefits.
The following tables provide supplemental information related to the balances of and changes in Benefit Reserves included in the disaggregated tables above, on a gross (direct and assumed) basis, as of and for the periods indicated:
For additional information regarding observable market information and the techniques used to determine the interest rate assumptions seen above, see Note 2 to the Company's Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. For non-participating traditional and limited-payment products, if a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for the present value of expected future policy benefits and non-level claim settlement expenses, then the liability for future policy benefits is adjusted at that time, and thereafter such that all changes, both favorable and unfavorable, in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately as a gain or loss, respectively. For both the first three months of 2025 and 2024, there was an immaterial impact to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts. Deferred Profit Liability The balances of and changes in DPL as of and for the periods indicated are as follows:
AIR represents the additional liability for annuitization, death, or other insurance benefits, including guaranteed minimum death benefits ("GMDB") and guaranteed minimum income benefits ("GMIB") contract features, that are above and beyond the contractholder's account balance for certain long-duration life contracts. The following table shows a rollforward of AIR balances for variable and universal life products for the periods indicated, along with a reconciliation to the Company's total AIR balance:
(1) Represents the portion of gross assessments required to fund the future policy benefits.
Future Policy Benefits Reconciliation The following table presents the reconciliation of the ending balances from the above rollforwards, Benefit Reserves, DPL, and AIR, including other liabilities, gross of related reinsurance recoverables, to the total liability for Future Policy Benefits as reported on the Company's Unaudited Interim Consolidated Statements of Financial Position as of the periods indicated:
(1)Primarily represents balances for which disaggregated rollforward disclosures are not required, including unpaid claims and claims expenses, and incurred but not reported and in course of settlement claim liabilities. Revenue and Interest Expense The following tables present revenue and interest expense related to Benefit Reserves, DPL, and AIR, as well as related revenue and interest expense not presented in the above supplemental tables, in the Company's Consolidated Statement of Operations for the periods indicated:
(1)Represents gross premiums for benefit reserves; revenue for DPL and gross assessments for AIR.
Policyholders' Account Balances The balances of and changes in policyholders' account balances as of and for the periods ended are as follows:
(1) Primarily relates to changes in the value of embedded derivative instruments associated with the indexed options of certain products. (2) The net amount at risk calculation includes both general and separate account balances. (3) Represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. (4) Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. The Company issues variable life and universal life insurance contracts which may also include a “no-lapse guarantee” where the Company contractually guarantees to the contractholder a death benefit even when the account value drops to zero, as long as the “no-lapse guarantee” premium is paid. The net amount at risk is generally defined as the current death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including contractholder mortality, contract lapses, and premium pattern, as well as interest rate and equity market returns. The Company also issues annuity contracts that provide certain death benefit and/or living benefit guarantees and are accounted for as MRBs. See Note 10 for additional information, including the net amount at risk associated with these guarantees. The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums are as follows:
(1) Excludes contracts without minimum guaranteed crediting rates, such as funds with indexed-linked crediting options. Unearned Revenue Reserve ("URR") The balances of and changes in URR as of and for the periods ended are as follows:
The following tables show a rollforward of MRB balances for variable annuity products, along with a reconciliation to the Company’s total net MRB positions as of the following dates:
(1) Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. The Company issues certain variable annuity insurance contracts where the Company contractually guarantees to the contractholder a return of no less than (1) total deposits made to the contract adjusted for any partial withdrawals plus a minimum return, and/or (2) the highest anniversary contract value on a specified date adjusted for any withdrawals. These guarantees include benefits that are payable in the event of death, annuitization or at specified dates during the accumulation period and withdrawal and income benefits payable during specified periods. The Company also issues indexed variable annuity contracts for which the return is tied to the return of specific indices where the Company contractually guarantees to the contractholder a return of no less than total deposits made to the contract adjusted for any partial withdrawals upon death. In certain of these indexed variable annuity contracts, the Company also contractually guarantees to the contractholder withdrawal benefits payable during specific periods. For guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, contract lapses and contractholder mortality. For guarantees of benefits that are payable at annuitization, the net amount at risk is generally defined as the present value of the minimum guaranteed annuity payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, timing of annuitization, contract lapses and contractholder mortality. For guarantees of benefits that are payable at withdrawal, the net amount at risk is generally defined as the present value of the minimum guaranteed withdrawal payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. For guarantees of accumulation balances, the net amount at risk is generally defined as the guaranteed minimum accumulation balance minus the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including equity market returns, interest rates, market volatility and contractholder behavior. The following table presents accompanying information to the rollforward table above.
(1)For contracts with multiple benefit features, the highest net amount at risk for each contract is included. The table below reconciles MRB asset and liability positions as of the following dates:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholders' Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholders' Liabilities | LIABILITY FOR FUTURE POLICY BENEFITS Liability for Future Policy Benefits primarily consists of the following sub-components, which are discussed in greater detail below. •Benefit Reserves; •Deferred Profit Liability ("DPL"); and •Additional Insurance Reserves ("AIR") Benefit Reserves The balances of and changes in Benefit Reserves as of and for the periods indicated consist of the three tables presented below: Present Value of Expected Net Premiums rollforward, Present Value of Expected Future Policy Benefits rollforward, and Net Liability for Future Policy Benefits.
The following tables provide supplemental information related to the balances of and changes in Benefit Reserves included in the disaggregated tables above, on a gross (direct and assumed) basis, as of and for the periods indicated:
For additional information regarding observable market information and the techniques used to determine the interest rate assumptions seen above, see Note 2 to the Company's Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. For non-participating traditional and limited-payment products, if a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for the present value of expected future policy benefits and non-level claim settlement expenses, then the liability for future policy benefits is adjusted at that time, and thereafter such that all changes, both favorable and unfavorable, in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately as a gain or loss, respectively. For both the first three months of 2025 and 2024, there was an immaterial impact to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts. Deferred Profit Liability The balances of and changes in DPL as of and for the periods indicated are as follows:
AIR represents the additional liability for annuitization, death, or other insurance benefits, including guaranteed minimum death benefits ("GMDB") and guaranteed minimum income benefits ("GMIB") contract features, that are above and beyond the contractholder's account balance for certain long-duration life contracts. The following table shows a rollforward of AIR balances for variable and universal life products for the periods indicated, along with a reconciliation to the Company's total AIR balance:
(1) Represents the portion of gross assessments required to fund the future policy benefits.
Future Policy Benefits Reconciliation The following table presents the reconciliation of the ending balances from the above rollforwards, Benefit Reserves, DPL, and AIR, including other liabilities, gross of related reinsurance recoverables, to the total liability for Future Policy Benefits as reported on the Company's Unaudited Interim Consolidated Statements of Financial Position as of the periods indicated:
(1)Primarily represents balances for which disaggregated rollforward disclosures are not required, including unpaid claims and claims expenses, and incurred but not reported and in course of settlement claim liabilities. Revenue and Interest Expense The following tables present revenue and interest expense related to Benefit Reserves, DPL, and AIR, as well as related revenue and interest expense not presented in the above supplemental tables, in the Company's Consolidated Statement of Operations for the periods indicated:
(1)Represents gross premiums for benefit reserves; revenue for DPL and gross assessments for AIR.
Policyholders' Account Balances The balances of and changes in policyholders' account balances as of and for the periods ended are as follows:
(1) Primarily relates to changes in the value of embedded derivative instruments associated with the indexed options of certain products. (2) The net amount at risk calculation includes both general and separate account balances. (3) Represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. (4) Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. The Company issues variable life and universal life insurance contracts which may also include a “no-lapse guarantee” where the Company contractually guarantees to the contractholder a death benefit even when the account value drops to zero, as long as the “no-lapse guarantee” premium is paid. The net amount at risk is generally defined as the current death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including contractholder mortality, contract lapses, and premium pattern, as well as interest rate and equity market returns. The Company also issues annuity contracts that provide certain death benefit and/or living benefit guarantees and are accounted for as MRBs. See Note 10 for additional information, including the net amount at risk associated with these guarantees. The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums are as follows:
(1) Excludes contracts without minimum guaranteed crediting rates, such as funds with indexed-linked crediting options. Unearned Revenue Reserve ("URR") The balances of and changes in URR as of and for the periods ended are as follows:
The following tables show a rollforward of MRB balances for variable annuity products, along with a reconciliation to the Company’s total net MRB positions as of the following dates:
(1) Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. The Company issues certain variable annuity insurance contracts where the Company contractually guarantees to the contractholder a return of no less than (1) total deposits made to the contract adjusted for any partial withdrawals plus a minimum return, and/or (2) the highest anniversary contract value on a specified date adjusted for any withdrawals. These guarantees include benefits that are payable in the event of death, annuitization or at specified dates during the accumulation period and withdrawal and income benefits payable during specified periods. The Company also issues indexed variable annuity contracts for which the return is tied to the return of specific indices where the Company contractually guarantees to the contractholder a return of no less than total deposits made to the contract adjusted for any partial withdrawals upon death. In certain of these indexed variable annuity contracts, the Company also contractually guarantees to the contractholder withdrawal benefits payable during specific periods. For guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, contract lapses and contractholder mortality. For guarantees of benefits that are payable at annuitization, the net amount at risk is generally defined as the present value of the minimum guaranteed annuity payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, timing of annuitization, contract lapses and contractholder mortality. For guarantees of benefits that are payable at withdrawal, the net amount at risk is generally defined as the present value of the minimum guaranteed withdrawal payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. For guarantees of accumulation balances, the net amount at risk is generally defined as the guaranteed minimum accumulation balance minus the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including equity market returns, interest rates, market volatility and contractholder behavior. The following table presents accompanying information to the rollforward table above.
(1)For contracts with multiple benefit features, the highest net amount at risk for each contract is included. The table below reconciles MRB asset and liability positions as of the following dates:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Risk Benefits |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Risk Benefits | LIABILITY FOR FUTURE POLICY BENEFITS Liability for Future Policy Benefits primarily consists of the following sub-components, which are discussed in greater detail below. •Benefit Reserves; •Deferred Profit Liability ("DPL"); and •Additional Insurance Reserves ("AIR") Benefit Reserves The balances of and changes in Benefit Reserves as of and for the periods indicated consist of the three tables presented below: Present Value of Expected Net Premiums rollforward, Present Value of Expected Future Policy Benefits rollforward, and Net Liability for Future Policy Benefits.
The following tables provide supplemental information related to the balances of and changes in Benefit Reserves included in the disaggregated tables above, on a gross (direct and assumed) basis, as of and for the periods indicated:
For additional information regarding observable market information and the techniques used to determine the interest rate assumptions seen above, see Note 2 to the Company's Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. For non-participating traditional and limited-payment products, if a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for the present value of expected future policy benefits and non-level claim settlement expenses, then the liability for future policy benefits is adjusted at that time, and thereafter such that all changes, both favorable and unfavorable, in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately as a gain or loss, respectively. For both the first three months of 2025 and 2024, there was an immaterial impact to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts. Deferred Profit Liability The balances of and changes in DPL as of and for the periods indicated are as follows:
AIR represents the additional liability for annuitization, death, or other insurance benefits, including guaranteed minimum death benefits ("GMDB") and guaranteed minimum income benefits ("GMIB") contract features, that are above and beyond the contractholder's account balance for certain long-duration life contracts. The following table shows a rollforward of AIR balances for variable and universal life products for the periods indicated, along with a reconciliation to the Company's total AIR balance:
(1) Represents the portion of gross assessments required to fund the future policy benefits.
Future Policy Benefits Reconciliation The following table presents the reconciliation of the ending balances from the above rollforwards, Benefit Reserves, DPL, and AIR, including other liabilities, gross of related reinsurance recoverables, to the total liability for Future Policy Benefits as reported on the Company's Unaudited Interim Consolidated Statements of Financial Position as of the periods indicated:
(1)Primarily represents balances for which disaggregated rollforward disclosures are not required, including unpaid claims and claims expenses, and incurred but not reported and in course of settlement claim liabilities. Revenue and Interest Expense The following tables present revenue and interest expense related to Benefit Reserves, DPL, and AIR, as well as related revenue and interest expense not presented in the above supplemental tables, in the Company's Consolidated Statement of Operations for the periods indicated:
(1)Represents gross premiums for benefit reserves; revenue for DPL and gross assessments for AIR.
Policyholders' Account Balances The balances of and changes in policyholders' account balances as of and for the periods ended are as follows:
(1) Primarily relates to changes in the value of embedded derivative instruments associated with the indexed options of certain products. (2) The net amount at risk calculation includes both general and separate account balances. (3) Represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. (4) Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. The Company issues variable life and universal life insurance contracts which may also include a “no-lapse guarantee” where the Company contractually guarantees to the contractholder a death benefit even when the account value drops to zero, as long as the “no-lapse guarantee” premium is paid. The net amount at risk is generally defined as the current death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including contractholder mortality, contract lapses, and premium pattern, as well as interest rate and equity market returns. The Company also issues annuity contracts that provide certain death benefit and/or living benefit guarantees and are accounted for as MRBs. See Note 10 for additional information, including the net amount at risk associated with these guarantees. The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums are as follows:
(1) Excludes contracts without minimum guaranteed crediting rates, such as funds with indexed-linked crediting options. Unearned Revenue Reserve ("URR") The balances of and changes in URR as of and for the periods ended are as follows:
The following tables show a rollforward of MRB balances for variable annuity products, along with a reconciliation to the Company’s total net MRB positions as of the following dates:
(1) Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. The Company issues certain variable annuity insurance contracts where the Company contractually guarantees to the contractholder a return of no less than (1) total deposits made to the contract adjusted for any partial withdrawals plus a minimum return, and/or (2) the highest anniversary contract value on a specified date adjusted for any withdrawals. These guarantees include benefits that are payable in the event of death, annuitization or at specified dates during the accumulation period and withdrawal and income benefits payable during specified periods. The Company also issues indexed variable annuity contracts for which the return is tied to the return of specific indices where the Company contractually guarantees to the contractholder a return of no less than total deposits made to the contract adjusted for any partial withdrawals upon death. In certain of these indexed variable annuity contracts, the Company also contractually guarantees to the contractholder withdrawal benefits payable during specific periods. For guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, contract lapses and contractholder mortality. For guarantees of benefits that are payable at annuitization, the net amount at risk is generally defined as the present value of the minimum guaranteed annuity payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, timing of annuitization, contract lapses and contractholder mortality. For guarantees of benefits that are payable at withdrawal, the net amount at risk is generally defined as the present value of the minimum guaranteed withdrawal payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. For guarantees of accumulation balances, the net amount at risk is generally defined as the guaranteed minimum accumulation balance minus the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including equity market returns, interest rates, market volatility and contractholder behavior. The following table presents accompanying information to the rollforward table above.
(1)For contracts with multiple benefit features, the highest net amount at risk for each contract is included. The table below reconciles MRB asset and liability positions as of the following dates:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance | REINSURANCE The Company participates in reinsurance with its affiliates PARCC, PAR U, PURE, Lotus Reinsurance Company Ltd. ("Lotus Re"), Prudential of Japan, prior to January 1, 2024 with its affiliates Prudential Universal Reinsurance Company (“PURC”) and Gibraltar Universal Life Reinsurance Company (“GUL Re”), and prior to October 1, 2024 with its affiliates Prudential Arizona Reinsurance Term Company (“PAR Term”), Prudential Term Reinsurance Company (“Term Re”) and Dryden Arizona Reinsurance Term Company (“DART”). The Company also participates in reinsurance with its parent company Prudential Insurance, as well as third-parties. The reinsurance agreements provide risk diversification and additional capacity for future growth, limit the maximum net loss potential, manage statutory capital, and facilitate the Company's capital market hedging program. Life reinsurance is accomplished through various plans of reinsurance, primarily yearly renewable term ("YRT") and coinsurance. Reinsurance ceded arrangements do not discharge the Company as the primary insurer. Ceded balances would represent a liability of the Company in the event the reinsurers were unable to meet their obligations to the Company under the terms of the reinsurance agreements. The Company believes a material reinsurance liability resulting from such inability of reinsurers to meet their obligations is unlikely. Effective October 2024, the Company entered into an agreement with Wilton Re to coinsure a closed block of guaranteed universal life ("GUL") policies, resulting in a DRL of $979 million. To effectuate this transaction the Company recaptured all risks associated with the subject GUL policies from PAR U and subsequently established YRT reinsurance for the subject GUL business with Prudential Insurance. As a result of these transactions, the Company recognized a $270 million pre-tax recapture gain and a $798 million DRG, respectively. The DRL and DRG will be amortized into income over the remaining life of the reinsured policies. Effective January 2024, the Company entered into an agreement with Somerset Reinsurance Ltd. (“Somerset Re”) to coinsure a closed block of GUL policies to PURE, a wholly-owned subsidiary of Prudential Insurance, with retrocession by PURE of such liabilities on a modified coinsurance basis, to Somerset Re. This transaction is effective as of January 1, 2024, whereby, the Company recaptured all risks associated with the subject GUL policies from PAR U, PURC and GUL Re and subsequently established YRT reinsurance for the subject GUL business with Prudential Insurance. As a result of these transactions, the Company recognized a $990 million pre-tax recapture loss and a $1,207 million DRG, respectively. The DRG will be amortized into income over the estimated remaining life of the reinsured policies. Reserves related to reinsured long-duration contracts are accounted for using assumptions consistent with those used to account for the underlying contracts. Amounts recoverable from reinsurers for long-duration reinsurance arrangements are estimated in a manner consistent with the claim liabilities and policy benefits associated with the reinsured policies. Reinsurance policy charges and fee income ceded for universal life and variable annuity products are accounted for as a reduction of policy charges and fee income. Reinsurance premiums ceded for term insurance products are accounted for as a reduction of premiums. Reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss from insurance risk are recorded using the deposit method of accounting. The deposit assets on reinsurance are recorded within “Reinsurance recoverables and deposit receivables” and the corresponding funds withheld liability for assets retained under these reinsurance agreements are recorded within “Reinsurance and funds withheld payables”. Balances associated with these agreements are included in the tables below. "Change in value of market risk benefits, net of related hedging gains (losses)" include the impact of reinsurance agreements, particularly reinsurance agreements involving living benefit guarantees. The Company has entered into reinsurance agreements to transfer the risk related to the living benefit guarantees on variable annuities within the PLNJ business to Prudential Insurance. These reinsurance agreements are market risk benefits and have been accounted for in the same manner. Reinsurance amounts included in the Company’s Unaudited Interim Consolidated Statements of Financial Position were as follows:
Unaffiliated reinsurance amounts included in the table above and in the Company's Unaudited Interim Consolidated Statements of Financial Position were as follows:
Reinsurance recoverables and deposit receivables by counterparty were as follows:
(1)Includes balances with Wilton Re, Fortitude Life Insurance & Annuity Company (“FLIAC”), Somerset Re and other counterparties. See below for further information on significant third-party reinsurance arrangements. Reinsurance amounts, included in the Company’s Unaudited Interim Consolidated Statements of Operations and Comprehensive Income (Loss) were as follows:
(1)Amounts include reinsurance agreements using the deposit method of accounting. (2)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. Unaffiliated reinsurance assumed and ceded amounts included in the table above and in the Company's Unaudited Interim Consolidated Statements of Operations and Comprehensive Income (Loss) were as follows:
(1)Amounts include reinsurance agreements using the deposit method of accounting. (2)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. The gross and net amounts of life insurance face amount in force were as follows:
Significant Affiliated Reinsurance Agreements PAR U Pruco Life reinsures 70% of all the risks associated with Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates prior to January 1, 2011. Effective July 1, 2012, PLNJ reinsures 95% of all the risks associated with Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates through December 31, 2019, excluding those policies that are subject to principle-based reserving. On January 2, 2013, Pruco Life began to assume GUL business from Prudential Insurance in connection with the acquisition of the Hartford Life Business. The GUL business assumed from Prudential Insurance was subsequently retroceded to PAR U. Effective January 1, 2024, Pruco Life recaptured the policies equal to 70% of all the risks associated with Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates prior to January 1, 2011. Effective January 1, 2024, Pruco Life reinsures 25% of the risks associated with universal life policies with effective dates prior to January 1, 2015 and 100% of the risks associated with universal life policies with effective dates beginning January 1, 2015. Effective January 1, 2024, PLNJ recaptured the policies previously reinsured by PAR U with effective dates prior to January 1, 2015. Effective January 1, 2024, PLNJ reinsures 100% of the risks associated with universal life policies, with effective dates from January 1, 2015 to December 31, 2019. Effective October 1, 2024, Pruco Life recaptured the remaining portion of the policies equal to 25% of the risks associated with universal life policies with effective dates prior to January 1, 2015 and 100% of the risks associated with universal life policies with effective dates beginning January 1, 2015. As a result of the recapture, the Company recognized a $270 million pre-tax recapture gain, as discussed above, which includes the recognition of a prior $94 million DRG related to the previous reinsurance agreement. Following the result of this recapture, Pruco Life only cedes the GUL business in connection with the Hartford Life Business to PAR U as of December 31, 2024. Effective October 1, 2024, PLNJ recaptured 100% of the risks associated with the remaining universal life policies, with effective dates from January 1, 2015 to December 31, 2019. As a result of the recapture, the Company recognized a $29 million pre-tax recapture loss which is part of the $270 million pre-tax recapture gain discussed above. The loss includes the recognition of a prior $8 million DRG related to the previous reinsurance agreement. Following the result of this recapture, PLNJ no longer cedes to PAR U as of December 31, 2024. On March 28, 2024, PURC and GUL Re merged into PAR U. PURE Effective January 1, 2024, Pruco Life reinsures 75% of the risks associated with Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates prior to January 1, 2015. Effective January 1, 2024, PLNJ reinsures 100% of the risks associated with Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates prior to January 1, 2015. PURC Pruco Life reinsures 70% of all the risks associated with its Universal Protector policies having no-lapse guarantees as well as certain other universal life policies, with effective dates from January 1, 2011 through December 31, 2013, with PURC and 95% of all the risks associated with Universal Protector policies having no-lapse guarantees, as well as certain other universal life policies, with effective dates from January 1, 2014 through December 31, 2016. Effective January 1, 2024, the Company recaptured the policies previously reinsured by PURC. As a result of the recapture, the Company recorded a write-off of $116 million of DRG that was recognized with the previous reinsurance agreement. On March 28, 2024, PURC merged into PAR U. PARCC Prior to July 1, 2019, the Company reinsured 90% of the risks under its term life insurance policies, with effective dates prior to January 1, 2010 through an automatic coinsurance agreement with PARCC. Effective July 1, 2019, the Company amended the coinsurance agreement to increase the percentage from 90% to 100% of the policy risk amount reinsured. The amended agreement does not impact contracts issued by PLNJ, which remain at the original percentage. Effective October 1, 2024, the Company revised the existing coinsurance terms with PARCC, increasing the quota share of reinsured policies to 100% which includes policies which were previously reinsured to PAR Term, Term Re and DART. As a result of the revised terms, the Company recognized a $351 million DRL that will be amortized into income over the estimated remaining life of the reinsured policies. On November 20, 2024, PAR Term, Term Re and DART merged into PARCC. GUL Re Effective January 1, 2017, Pruco Life entered into an automatic coinsurance agreement with GUL Re to reinsure 95% of all the risks associated with Universal Protector policies having no-lapse guarantees, as well as certain other universal life policies, with effective dates on or after January 1, 2017 through December 31, 2019, excluding those policies that are subject to principle-based reserving. Effective July 1, 2017, Pruco Life amended this agreement to include 30% of Universal Protector policies having no-lapse guarantees as well as certain other universal life policies with effective dates prior to January 1, 2014. Effective January 1, 2024, the Company recaptured the policies previously reinsured by GUL Re. On March 28, 2024, GUL Re merged into PAR U. PAR Term Prior to July 1, 2019, the Company reinsures 95% of the risks under its term life insurance policies with effective dates January 1, 2010 through December 31, 2013, through an automatic coinsurance agreement with PAR Term. Effective July 1, 2019, the Company amended the coinsurance agreement to increase the percentage from 95% to 100% of the policy risk amount reinsured. The amended agreement does not impact contracts issued by PLNJ, which remain at the original percentage. On November 20, 2024, PAR Term merged into PARCC. Term Re The Company reinsures 95% of the risks under its term life insurance policies, with effective dates on or after January 1, 2014 through December 31, 2017, through an automatic coinsurance agreement with Term Re. On November 20, 2024, Term Re merged into PARCC. Prudential Insurance The Company has a YRT reinsurance agreement with Prudential Insurance and reinsures the majority of all mortality risks not otherwise reinsured. This agreement was terminated for new business effective January 1, 2020, with certain new business (primarily universal life policies) terminated as early as 2017. The Company now reinsures a portion of the mortality risk directly to third-party reinsurers and retains all of the non-reinsured portion of the mortality risk. Effective July 1, 2019, certain term life insurance policies were recaptured and subsequently reinsured to PARCC and PAR Term as noted above. As of January 1, 2022, most of the variable life insurance policies were recaptured resulting in a $305 million loss recorded through "Policy charges and fee income". Those policies were then reinsured to Lotus Re as mentioned below. Effective January 1, 2024, the Company recaptured all GUL policies with Prudential Insurance and subsequently entered into a YRT reinsurance agreement with Prudential Insurance to reinsure the mortality risk for the totality of GUL policies reinsured to PURE. Effective October 1, 2024, the Company recaptured the term business from Prudential Insurance, and revised the existing coinsurance terms with PARCC to reflect revised quota share. As a result of the recapture, the Company recognized a $3 million pre-tax recapture loss. Additionally, effective October 1, 2024, the Company entered into a YRT reinsurance agreement with Prudential Insurance to reinsure the mortality risk of recaptured GUL policies from PAR U. On January 2, 2013, Pruco Life began to assume GUL business from Prudential Insurance in connection with the acquisition of the Hartford Financial Services Group, Inc. ("Hartford Financial"). The GUL business assumed from Prudential Insurance was subsequently retroceded to PAR U. In May 2018, Hartford Financial sold a group of operating subsidiaries, which includes two of Prudential Insurance's counterparties to these reinsurance arrangements. There was no impact to the terms, rights or obligations of Prudential Insurance, or operation of these reinsurance arrangements, as a result of this change in control of such counterparties. Similarly, there was no impact to the Company's reinsurance arrangements with respect to such GUL business as a result of this change in control. In January 2021, there was a definitive agreement announced to subsequently sell the two counterparties mentioned above, which were then acquired by Sixth Street in July 2021. There was no impact to the terms, rights or obligations of the Company, or operation of these reinsurance arrangements, as a result of this change in control of such counterparties. The Company has reinsured a group annuity contract with Prudential Insurance, in consideration for a single premium payment by the Company, providing reinsurance equal to 100% of all payments due under the contract. Effective April 1, 2016, PLNJ entered into a reinsurance agreement to reinsure its variable annuity base contracts, along with the living benefit guarantees to Prudential Insurance. This reinsurance agreement covers new and in force business. Effective February 1, 2023, PLNJ began selling indexed variable annuities products, which is reinsured to Prudential Insurance through the existing reinsurance agreement. The reinsurance of the indexed variable annuities transfers all significant risks, including mortality risk, embedded in the reinsured contracts to Prudential Insurance. As a result of the agreement, reinsurance payables includes the ceded modified coinsurance arrangement, which reflects the value of the invested assets retained by the Company and the associated asset returns. Lotus Re Effective October 1, 2021, the Company entered into an automatic coinsurance agreement with Lotus Re to reinsure $32 million of liabilities associated with the risks associated with a portion of its variable life policies in the extended term policy status. Effective January 1, 2022 the Company recaptured the risks that were previously ceded to Lotus Re from October 1, 2021 through December 31, 2021. Immediately thereafter, the Company entered into a reinsurance agreement with Lotus Re to cede 100% of the risks associated with a closed block of variable life business on a coinsurance and modified coinsurance basis including policies in the extended term policy status. The amount of the net liabilities associated with the transaction for coinsurance and modified coinsurance were $1,387 million and $14,037 million, respectively. As part of the consideration, the Company also ceded to Lotus Re $855 million of policy loan assets associated with the reinsured policies while receiving $820 million in cash from Lotus Re. As a result, the Company recorded a $1,352 million deferred gain, which will be recognized over the remaining life of the underlying policies. In tandem with the transaction, effective January 1, 2022, Lotus Re established an automatic YRT agreement with the Company to cede back a portion of the mortality risks associated with the reinsured policies for the purposes of the Company maintaining YRT reinsurance with external counterparties. Effective December 15, 2024, the Company entered into a reinsurance agreement with Lotus Re to cede 100% of the risks associated with certain fixed index annuities and multi-year guaranteed annuity contracts issued on or after the effective date of the agreement on a coinsurance basis. The deposit receivables were $388 million and $52 million as of March 31, 2025 and December 31, 2024, respectively. DART Effective January 1, 2018, the Company entered into an automatic coinsurance agreement with DART to reinsure 95% of the risks associated with its term life insurance policies with effective dates on or after January 1, 2018 through December 31, 2019, excluding those policies that are subject to principle-based reserving. On November 20, 2024, DART merged into PARCC. Prudential of Japan Effective January 2025, the Company entered into an agreement with Prudential of Japan to reinsure GMDB associated with yen-denominated variable whole life policies. As a result of this transaction, the Company assumed $5 million of GMDB liabilities and recognized a $14 million DRG at inception. The DRG will be amortized into income over the estimated remaining life of the reinsured policies. Significant Third-Party Reinsurance Arrangements AuguStar Life Insurance Company (Formerly Known as The Ohio National Life Insurance Company) Effective April 1, 2023, the Company entered into an agreement with AuguStar, an affiliate of Constellation Insurance Holdings, Inc., to reinsure approximately $10 billion of account values of PDI traditional variable annuity contracts with guaranteed living benefits. This block represents approximately 10% of the Company’s remaining legacy in force traditional variable annuity block by account value. The Company ceded 100% of separate account liabilities under modified coinsurance and 100% of general account liabilities under coinsurance of its PDI traditional variable annuity contracts. The general account liabilities associated with PDI's guaranteed living and death benefits and the corresponding reinsurance of those liabilities are accounted for as market risk benefits. As a result of the transaction, the Company recognized a $277 million DRG at inception that is amortized into income over the estimated remaining life of the reinsured policies. FLIAC Effective December 1, 2021, the Company entered into a reinsurance agreement with Prudential Annuities Life Assurance Corporation (“PALAC”), a previously wholly-owned subsidiary of Prudential Financial sold in April 2022, and now known as FLIAC, under which the Company assumed all of FLIAC's indexed variable annuities under modified coinsurance. The reinsurance of the indexed variable annuities transfers all significant risks, including mortality risk, embedded in the reinsured contracts to the Company. As a result of the agreement, "Reinsurance recoverables and deposit receivables" includes the assumed modified coinsurance receivable, which reflects the value of the invested assets retained by FLIAC and the associated asset returns. The Company also assumed via coinsurance all of FLIAC’s fixed indexed annuities and fixed annuities with a guaranteed lifetime withdrawal income feature which are accounted for under the deposit method of accounting. The reinsurance agreement offers the policyholders the opportunity to novate their contracts from FLIAC to the Company and any such novated contracts shall cease to be reinsured under this agreement. As of March 31, 2025, the total account value of contracts novated from FLIAC to the Company were $5.3 billion for indexed variable annuities contracts and $2.0 billion for fixed annuities and fixed indexed annuities contracts, which is approximately 80% of the total reinsured block. Reinsurance recoverables and deposit receivables was $1,398 million and $1,395 million as of March 31,2025 and December 31, 2024, respectively. Somerset Re Effective October 1, 2021, the Company entered into a reinsurance agreement with Somerset Re to coinsure business, on a quota share funds withheld basis, related to fixed indexed annuities. Under the reinsurance agreement, the Company cedes to Somerset Re its quota share of the insurance liabilities with respect to the reinsured contracts. The deposit assets on reinsurance totaled $2,786 million and $2,582 million at March 31, 2025 and December 31, 2024, respectively. The funds withheld payables totaled $2,627 million and $2,434 million at March 31, 2025 and December 31, 2024, respectively. Union Hamilton Between April 1, 2015 and December 31, 2016, the Company, excluding its subsidiary, reinsured approximately 50% of the new business related to “highest daily” living benefits rider guarantees on HDI v.3.0 product, available with Prudential Premier® Retirement Variable Annuity, to Union Hamilton. This reinsurance remains in force for the duration of the underlying annuity contracts. New sales of HDI v.3.0 subsequent to December 31, 2016 are not covered by this external reinsurance agreement. As of March 31, 2025, $1.8 billion of HDI v.3.0 account values are reinsured to Union Hamilton. Wilton Re Effective October 1, 2024, the Company entered into a reinsurance agreement with Wilton Re to coinsure a closed block of GUL policies. Reinsurance recoverables was $7,584 million and $7,478 million as of March 31, 2025 and December 31, 2024, respectively
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes |
3 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Income Tax Disclosure [Abstract] | |
| Income Taxes | INCOME TAXES The Company uses a full year projected effective tax rate approach to calculate year-to-date taxes. In determining the full year projected tax rate, the Company considers the realizability of deferred tax assets, including those associated with unrealized investment losses, and has determined based upon the weight of available evidence that no valuation allowance is necessary related to unrealized investment losses. In addition, certain items impacting total income tax expense are recorded in the periods in which they occur. The projected effective tax rate is the ratio of projected “Income tax expense (benefit)” divided by projected “Income (loss) from operations before income taxes and equity in earnings of operating joint venture”. Taxes attributable to operating joint venture are recorded within “Equity in earnings of operating joint venture, net of taxes”. The interim period tax expense (or benefit) is the difference between the year-to-date income tax provision and the amounts reported for the previous interim periods of the fiscal year. The Company's income tax provision, on a consolidated basis, amounted to an income tax expense of $19.7 million, or 12.75% of income (loss) from operations before income taxes and equity in earnings of operating joint venture, in the first three months of 2025, compared to an income tax benefit of $(67.6) million, or 10.54%, in the first three months of 2024. The Company's current and prior effective tax rates differed from the U.S. statutory tax rate of 21% primarily due to non-taxable investment income and tax credits.
|
Equity |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity | EQUITY Accumulated Other Comprehensive Income (Loss) AOCI represents the cumulative OCI items that are reported separate from net income and detailed on the Unaudited Interim Consolidated Statements of Operations and Comprehensive Income (Loss). The balance of and changes in each component of AOCI as of and for the three months ended March 31, 2025 and 2024, are as follows:
(1)Includes cash flow hedges of $95 million and $111 million as of March 31, 2025 and December 31, 2024, respectively, and $39 million and $12 million as of March 31, 2024 and December 31, 2023, respectively. (2)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. Reclassifications out of Accumulated Other Comprehensive Income (Loss)
(1)All amounts are shown before tax. (2)Positive amounts indicate gains/benefits reclassified out of AOCI. Negative amounts indicate losses/costs reclassified out of AOCI. (3)See Note 4 for additional information on cash flow hedges. (4)See table below for additional information on unrealized investment gains (losses), including the impact on future policy benefits, policyholders’ account balances. Net Unrealized Investment Gains (Losses) Net unrealized investment gains (losses) on available-for-sale fixed maturity securities and certain other invested assets and other assets are included in the Company’s Unaudited Interim Consolidated Statements of Financial Position as a component of AOCI. Changes in these amounts include reclassification adjustments to exclude from OCI those items that are included as part of “Net income (loss)” for a period that had been part of OCI in earlier periods. The amounts for the periods indicated below, split between amounts related to net unrealized investment gains (losses) on available-for-sale fixed maturity securities on which an allowance for credit losses has been recognized, and all other net unrealized investment gains (losses), are as follows:
(1)Includes cash flow hedges. See Note 4 for information on cash flow hedges. (2)"Other costs" primarily includes reinsurance recoverables and deposit receivables and DRL. Noncontrolling interests For certain subsidiaries, the Company owns a controlling interest that is less than 100% ownership of the subsidiary but must consolidate 100% of the subsidiary’s financial statements in accordance with U.S. GAAP. Noncontrolling interests represent the portion of equity ownership in a consolidated subsidiary that is not attributable to the Company.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related Party Transactions [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related Party Transactions | RELATED PARTY TRANSACTIONS The Company has extensive transactions and relationships with Prudential Insurance and other affiliates. Although we seek to ensure that these transactions and relationships are fair and reasonable, it is possible that the terms of these transactions are not the same as those that would result from transactions among unrelated parties. Expense Charges and Allocations The majority of the Company’s expenses are allocations or charges from Prudential Insurance or other affiliates. These expenses can be grouped into general and administrative expenses and agency distribution expenses. The Company’s general and administrative expenses are charged to the Company using allocation methodologies based on business production processes. Management believes that the methodology is reasonable and reflects costs incurred by Prudential Insurance to process transactions on behalf of the Company. The Company operates under service and lease agreements whereby services of officers and employees, supplies, use of equipment and office space are provided by Prudential Insurance. The Company reviews its allocation methodology periodically which it may adjust accordingly. General and administrative expenses include allocations of stock compensation expenses related to a stock-based awards program and a deferred compensation program issued by Prudential Financial. The expense charged to the Company for the stock-based awards program was $0.1 million and $0.2 million for the three months ended March 31, 2025 and 2024, respectively. The expense charged to the Company for the deferred compensation program was $2.5 million and $3.3 million for the three months ended March 31, 2025 and 2024, respectively. The Company is charged for its share of employee benefit expenses. These expenses include costs for funded and non-funded, non-contributory defined benefit pension plans. Some of these benefits are based on final earnings and length of service while others are based on an account balance, which takes into consideration age, service and earnings during a career. The Company’s share of net expense for the pension plans was $3 million for both the three months ended March 31, 2025 and 2024. The Company is also charged for its share of the costs associated with welfare plans issued by Prudential Insurance. These expenses include costs related to medical, dental, life insurance and disability. The Company's share of net expense for the welfare plans was $5 million and $4 million for the three months ended March 31, 2025 and 2024, respectively. Prudential Insurance sponsors voluntary savings plans for its employee 401(k) plans. The plans provide for salary reduction contributions by employees and matching contributions by the Company of up to 4% of annual salary. The Company’s expense for its share of the voluntary savings plan was $2 million for both the three months ended March 31, 2025 and 2024. The Company is charged distribution expenses from Prudential’s proprietary nationwide sales organization, “Prudential Advisors” through a transfer pricing agreement, which is intended to reflect a market-based pricing arrangement. Prudential Advisors distributes Prudential life insurance, annuities, and investment products with proprietary and non-proprietary product options. In November 2024, the Company, along with three other affiliated entities, entered into several agreements with a third-party, LPL Financial Holdings Inc. (“LPL”). Under these agreements, the Company pays distribution expenses to LPL, of which 98% are returned to Prudential Advisors. Distribution expenses paid by the Company to LPL and subsequently returned to Prudential Advisors were $113 million for the three months ended March 31, 2025. The Company pays commissions and certain other fees to Prudential Annuities Distributors, Inc. (“PAD”) in consideration for PAD’s marketing and underwriting of the Company’s annuity products. Commissions and fees are paid by PAD to broker-dealers who sell the Company’s annuity products. Commissions and fees paid by the Company to PAD were $145 million and $178 million for the three months ended March 31, 2025 and 2024, respectively. The Company is charged for its share of corporate expenses incurred by Prudential Financial to benefit its businesses, such as advertising, executive oversight, external affairs and philanthropic activity. The Company’s share of corporate expenses was $29 million and $36 million for the three months ended March 31, 2025 and 2024, respectively. Corporate-Owned Life Insurance The Company has sold five Corporate-Owned Life Insurance (“COLI”) policies to Prudential Insurance, and one to Prudential Financial. The cash surrender value included in separate accounts for these COLI policies was $4,644 million and $4,657 million at March 31, 2025 and December 31, 2024, respectively. Fees related to these COLI policies were $14 million and $13 million for the three months ended March 31, 2025 and 2024, respectively. The Company reinsures the risk associated with these COLI policies to an affiliate reinsurer as part of a broader program related to variable insurance policies. In May 2023, the Company funded a policy loan from the Prudential Financial COLI policy noted above in an amount of $900 million to an affiliated irrevocable trust, commonly referred to as a “rabbi trust”, which Prudential Financial created to support certain non-qualified retirement plans. The outstanding balance of the policy loan with the rabbi trust was $894 million and $897 million as of March 31, 2025 and December 31, 2024, respectively. Interest income related to the policy loan was $10 million for both the three months ended March 31, 2025 and 2024. Affiliated Investment Management Expenses In accordance with an agreement with PGIM, Inc. ("PGIM"), the Company pays investment management expenses to PGIM who acts as investment manager to certain Company general account and separate account assets. Investment management expenses paid to PGIM related to this agreement were $21 million and $15 million for the three months ended March 31, 2025 and 2024, respectively. These expenses are recorded as “Net investment income” in the Unaudited Interim Consolidated Statements of Operations and Comprehensive Income (Loss). Derivative Trades In its ordinary course of business, the Company enters into OTC derivative contracts with an affiliate, PGF. For these OTC derivative contracts, PGF has a substantially equal and offsetting position with an external counterparty. See Note 4 for additional information. The interest income to the Company from PGF related to affiliated cash collateral was $102 million and $128 million for the three months ended March 31, 2025 and 2024, respectively, and are included in "Other income (loss)". Joint Ventures The Company has made investments in joint ventures with certain subsidiaries of Prudential Financial. "Other invested assets" includes $1,513 million and $1,100 million of investments in joint ventures as of March 31, 2025 and December 31, 2024, respectively. "Net investment income" related to these ventures includes gains (losses) of $44 million and $9 million for the three months ended March 31, 2025 and 2024, respectively. Affiliated Asset Administration Fee Income The Company has a revenue sharing agreement with AST Investment Services, Inc. ("ASTISI") and PGIM Investments LLC ("PGIM Investments") whereby the Company receives fee income based on policyholders' separate account balances invested in the Advanced Series Trust. Income received from ASTISI and PGIM Investments related to this agreement was $63 million and $69 million for the three months ended March 31, 2025 and 2024, respectively. These revenues are recorded as “Asset administration fees” in the Unaudited Interim Consolidated Statements of Operations and Comprehensive Income (Loss). The Company has a revenue sharing agreement with PGIM Investments, whereby the Company receives fee income based on policyholders' separate account balances invested in The Prudential Series Fund. Income received from PGIM Investments related to this agreement was $12 million and $11 million for the three months ended March 31, 2025 and 2024, respectively. These revenues are recorded as “Asset administration fees” in the Unaudited Interim Consolidated Statements of Operations and Comprehensive Income (Loss). Affiliated Notes Receivable Affiliated notes receivable included in “Receivables from parent and affiliates” at March 31, 2025 and December 31, 2024 is as follows:
(1)All notes receivable may be called for prepayment prior to the respective maturity dates under specified circumstances. The affiliated notes receivable shown above are classified as available-for-sale securities and other trading assets carried at fair value. The Company monitors the internal and external credit ratings of these loans and loan performance. The Company also considers any guarantees made by Prudential Insurance for loans due from affiliates. Accrued interest receivable related to these loans was $2 million and $1 million at March 31, 2025 and December 31, 2024, respectively, and is included in “Other assets”. Revenues related to these loans were $2 million and $1 million for the three months ended March 31, 2025 and 2024, respectively, and are included in “Other income (loss)”. Affiliated Commercial Mortgage Loan The affiliated commercial mortgage loan included in "Commercial mortgage and other loans" at March 31, 2025 and December 31, 2024 were $0 million. The commercial mortgage loan is carried at unpaid principal balance, net of unamortized deferred loan origination fees and expenses, and net of an allowance for losses. The Company reviews the performance and credit quality of the commercial mortgage loan on an on-going basis. Accrued interest receivable related to the loan was $0 million at both March 31, 2025 and December 31, 2024, and is included in "Accrued investment income". Revenues were $0 million and $2 million for the three months ended March 31, 2025 and 2024, respectively, and are included in "Net investment income". Affiliated Asset Transfers The Company participates in affiliated asset trades with parent and sister companies. Book and market value differences for trades with a parent and sister are recognized within "Additional paid-in capital" (“APIC”) and "Realized investment gains (losses), net", respectively. The table below shows affiliated asset trades for the three months ended March 31, 2025 and for the year ended December 31, 2024.
Debt Agreements The Company is authorized to borrow funds up to $7 billion from affiliates to meet its capital and other funding needs. There was no debt outstanding to affiliates as of March 31, 2025 and December 31, 2024. The total interest expense to the Company related to affiliated loans and cash collateral with PGF was $6 million and $4 million for the three months ended March 31, 2025 and 2024, respectively. Contributed Capital and Dividends In February 2025, the Company received a capital contribution of $220 million from Prudential Insurance. In December 2024, the Company received capital contributions in the amount of $416 million from Prudential Insurance in the form of invested assets. In June 2024, there was a $550 million return of capital to Prudential Insurance. Through March 2025 and December 2024, the Company did not pay any dividends to Prudential Insurance. Reinsurance with Affiliates As discussed in Note 11, the Company participates in reinsurance transactions with certain affiliates.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingent Liabilities | COMMITMENTS AND CONTINGENT LIABILITIES Commitments The Company has made commitments to fund commercial mortgage and agricultural property loans. As of both March 31, 2025 and December 31, 2024, the outstanding balance on these commitments was $230 million. This amount includes unfunded commitments that are not unconditionally cancellable. For related credit exposure, there was an allowance for credit losses of $0.2 million and $0.3 million as of March 31, 2025 and December 31, 2024, respectively, which is a change of $0.1 million for both the three months ended March 31, 2025 and 2024. The Company also made commitments to purchase or fund investments, mostly fund investments and private fixed maturities, some of which are contingent upon events or circumstances not under the Company’s control, including those at the discretion of the Company’s counterparties. The Company anticipates a portion of these commitments will ultimately be funded from its separate accounts. As of March 31, 2025 and December 31, 2024, $1,634 million and $1,359 million, respectively, of these commitments were outstanding. These amounts include unfunded commitments that are not unconditionally cancellable. There were no related charges for credit losses for either the three months ended March 31, 2025 or 2024. Guarantees In July 2017, Pruco Life formed a joint venture with CT Corp to provide life insurance solutions in Indonesia. Pruco Life owns a 49% interest in the joint venture and has entered into a shareholders agreement with CT Corp that sets out their respective rights and obligations with respect to the joint venture. Among other things, the shareholders agreement obligates Pruco Life and CT Corp to provide capital to the joint venture, as necessary to comply with applicable law or to maintain a specified minimum amount of capital in the joint venture. This obligation is not limited to a maximum amount. Pruco Life does not expect to make any payments on this guarantee and is not carrying any liabilities associated with the guarantee. Since 2001, Pruco Life entered into an arrangement with Prudential of Taiwan. In June 2021, PIIH completed the sale of Prudential of Taiwan. As a result of the sale, Pruco Life has a financial guarantee to stand ready to perform in an event that both Prudential of Taiwan and the Buyer default and fail to perform their obligations to make payments to the policyholders. Pruco Life has a liability of $32 million as of both March 31, 2025 and December 31, 2024, which represents the fair value of the guarantee and is amortized in revenue over a period which approximates the life of the underlying insurance in force. Since this obligation is not subject to limitations, it is not possible to determine the maximum potential amount due under this guarantee. Guarantees of Asset Values
Certain contracts underwritten by Pruco Life include guarantees related to financial assets owned by the guaranteed party. These contracts are accounted for as derivatives and carried at fair value. The collateral supporting these guarantees is not reflected on the Unaudited Interim Consolidated Statements of Financial Position. Contingent Liabilities On an ongoing basis, the Company and its regulators review its operations including, but not limited to, sales and other customer interface procedures and practices, and procedures for meeting obligations to its customers and other parties. These reviews may result in the modification or enhancement of processes or the imposition of other action plans, including concerning management oversight, sales and other customer interface procedures and practices, and the timing or computation of payments to customers and other parties. In certain cases, if appropriate, the Company may offer customers or other parties remediation and may incur charges, including the cost of such remediation, administrative costs and regulatory fines. The Company is subject to the laws and regulations of states and other jurisdictions concerning the identification, reporting and escheatment of unclaimed or abandoned funds, and is subject to audit and examination for compliance with these requirements. It is possible that the results of operations or the cash flows of the Company in a particular quarterly or annual period could be materially affected as a result of payments in connection with the matters discussed above or other matters depending, in part, upon the results of operations or cash flows for such period. Management believes, however, that ultimate payments in connection with these matters, after consideration of applicable reserves and rights to indemnification, should not have a material adverse effect on the Company’s financial position. Litigation and Regulatory Matters The Company is subject to legal and regulatory actions in the ordinary course of its business. Pending legal and regulatory actions include proceedings specific to the Company and proceedings generally applicable to business practices in the industry in which it operates. The Company is subject to class action lawsuits and other litigation involving a variety of issues and allegations involving sales practices, claims payments and procedures, premium charges, policy servicing and breach of fiduciary duty to customers. The Company is also subject to litigation arising out of its general business activities, such as its investments, contracts, leases and labor and employment relationships, including claims of discrimination and harassment, and could be exposed to claims or litigation concerning certain business or process patents. In addition, the Company, along with other participants in the businesses in which it engages, may be subject from time to time to investigations, examinations and inquiries, in some cases industry-wide, concerning issues or matters upon which such regulators have determined to focus. In some of the Company’s pending legal and regulatory actions, parties are seeking large and/or indeterminate amounts, including punitive or exemplary damages. The outcome of litigation or a regulatory matter, and the amount or range of potential loss at any particular time, is often inherently uncertain. The Company establishes accruals for litigation and regulatory matters when it is probable that a loss has been incurred and the amount of that loss can be reasonably estimated. For litigation and regulatory matters where a loss may be reasonably possible, but not probable, or is probable but not reasonably estimable, no accrual is established, but the matter, if material, is disclosed. The Company estimates that as of March 31, 2025, the aggregate range of reasonably possible losses in excess of accruals established for those litigation and regulatory matters for which such an estimate currently can be made is less than $100 million. This estimate is not an indication of expected loss, if any, or the Company's maximum possible loss exposure on such matters. The Company reviews relevant information with respect to its litigation and regulatory matters on a quarterly and annual basis and updates its accruals, disclosures and estimates of reasonably possible loss based on such reviews. The following discussion of litigation and regulatory matters provides an update of those matters discussed in Note 16 to the Company's Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and should be read in conjunction with the complete descriptions provided in the Form 10-K. Individual Annuities and Individual Life California Advocates for Nursing Home Reform v. The Prudential Insurance Company of America and Pruco Life Insurance Company, et al. In April 2025, Plaintiff filed a First Amended Complaint removing allegations related to the Unclaimed Life Insurance and Annuities Act, and the Defendant filed a demurrer seeking to dismiss the Amended Complaint. Summary The Company’s litigation and regulatory matters are subject to many uncertainties, and given their complexity and scope, their outcome cannot be predicted. It is possible that the Company’s results of operations or cash flows in a particular quarterly or annual period could be materially affected by an ultimate unfavorable resolution of pending litigation and regulatory matters depending, in part, upon the results of operations or cash flows for such period. In light of the unpredictability of the Company’s litigation and regulatory matters, it is also possible that in certain cases an ultimate unfavorable resolution of one or more pending litigation or regulatory matters could have a material adverse effect on the Company’s financial statements. Management believes, however, that, based on information currently known to it, the ultimate outcome of all pending litigation and regulatory matters, after consideration of applicable reserves and rights to indemnification, is not likely to have a material adverse effect on the Company’s financial statements.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revision to Prior Period Financial Statements |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prior Period Adjustment [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Revision to Prior Year Information | REVISION TO PRIOR YEAR INFORMATION Revision to 2024 Interim Consolidated Financial Statements As previously disclosed in the Company’s Annual Report on Form 10-K for the year-ended December 31, 2024, during the fourth quarter of 2024, the Company identified multiple errors which impacted previously issued Consolidated Financial Statements, including for the three months ended March 31, 2024. Certain reinsurance recoverable balances associated with the coinsurance with funds withheld of fixed indexed annuities, certain deferred acquisition cost balances associated with indexed variable annuities, and certain other immaterial items were not properly accounted for. Prior period amounts have been revised in the Unaudited Interim Consolidated Financial statements to correct these errors as shown below. See the Company’s Annual Report on Form 10-K for the year-ended December 31, 2024 for more information. In connection with this revision, the Company also corrected certain other immaterial adjustments within the Financing Section of the Unaudited Interim Consolidated Statements of Cash Flows for the three months ended March 31, 2024. The following are selected line items from the Consolidated Financial Statements illustrating the effects of these revisions: Unaudited Interim Consolidated Statements of Operations and Comprehensive Income (Loss)
Unaudited Interim Consolidated Statements of Equity
Unaudited Interim Consolidated Statements of Cash Flows
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pay vs Performance Disclosure - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Pay vs Performance Disclosure | ||
| NET INCOME (LOSS) ATTRIBUTABLE TO PRUCO LIFE INSURANCE COMPANY | $ 129,569 | $ (575,576) |
Insider Trading Arrangements |
3 Months Ended |
|---|---|
Mar. 31, 2025 | |
| Trading Arrangements, by Individual | |
| Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
Significant Accounting Policies and Pronouncements (Policies) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Basis of Presentation | Basis of Presentation The Unaudited Interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). The Unaudited Interim Consolidated Financial Statements include the accounts of Pruco Life and entities over which the Company exercises control, including majority-owned subsidiaries. Intercompany balances and transactions have been eliminated. In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company's Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The most significant estimates include those used in determining future policy benefits; policyholders' account balances and reinsurance related to the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products; market risk benefits ("MRBs"); the valuation of investments including derivatives, the measurement of allowance for credit losses, and the recognition of other-than-temporary impairments; reinsurance recoverables; any provision for income taxes and valuation of deferred tax assets; and accruals for contingent liabilities, including estimates for losses in connection with unresolved legal and regulatory matters.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reclassifications | Reclassifications Certain amounts in prior periods have been reclassified to conform to the current period presentation. Revision to Prior Period Interim Financial Statements As previously disclosed in the Company’s Annual Report on Form 10-K for the year-ended December 31, 2024, during the fourth quarter of 2024, the Company identified multiple errors which impacted previously issued Consolidated Financial Statements, including for the three months ended March 31, 2024. Certain reinsurance recoverable balances associated with the coinsurance with funds withheld of fixed indexed annuities, certain deferred acquisition cost balances associated with indexed variable annuities, and certain other immaterial items were not properly accounted for. Prior period amounts have been revised in the Consolidated Financial Statements and related disclosures to correct these errors. In connection with this revision, the Company also corrected certain other immaterial adjustments within the Financing Section of the Unaudited Interim Consolidated Statements of Cash Flows for the three months ended March 31, 2024. Management evaluated these adjustments and concluded they were not material to any previously reported quarterly Consolidated Financial Statements. See Note 16 for a more detailed description of the revisions and for comparisons of amounts previously reported to the revised amounts.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| New Accounting Pronouncements | ASUs issued but not yet adopted as of March 31, 2025
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Maturities, Available-for-sale Securities | The following tables set forth the composition of fixed maturity securities (excluding investments classified as trading), as of the dates indicated:
(1)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans and education loans. (2)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.
(1)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans and education loans. (2)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Duration Of Gross Unrealized Losses On Fixed Maturity Securities | The following tables set forth the fair value and gross unrealized losses on available-for-sale fixed maturity securities without an allowance for credit losses aggregated by investment category and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of the dates indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Maturities Classified by Contractual Maturity Date | The following table sets forth the amortized cost and fair value of fixed maturities by contractual maturities, as of the date indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sources of Fixed Maturity Proceeds, Realized Investment Gains (Losses), and Losses on Impairments | The following table sets forth the sources of fixed maturity proceeds and related investment gains (losses), as well as losses on write-downs and the allowance for credit losses of fixed maturities, for the periods indicated:
(1)Excludes activity from non-cash related proceeds due to the timing of trade settlements of $150.7 million and $(8.7) million for the three months ended March 31, 2025 and 2024, respectively. (2)Amounts represent write-downs on credit adverse securities.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Allowance for Credit Losses for Fixed Maturity Securities | The following tables set forth the balance of and changes in the allowance for credit losses for fixed maturity securities, as of and for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commercial Mortgage and Other Loans | The following table sets forth the composition of “Commercial mortgage and other loans”, as of the dates indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Allowance for Credit Losses | The following table sets forth the balance of and changes in the allowance for credit losses for commercial mortgage and other loans, as of and for the periods ended:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financing Receivable Credit Quality Indicators | The following tables set forth key credit quality indicators based upon the recorded investment gross of allowance for credit losses, as of the dates indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Amortized Cost Basis of Loan Modifications made to Borrowers Experiencing Financial Difficulties | The following table sets forth the amortized cost basis of loan modifications made to borrowers experiencing financial difficulties during the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aging of Past Due Commercial Mortgage and Other Loans and Nonaccrual Status | The following tables set forth an aging of past due commercial mortgage and other loans based upon the recorded investment gross of allowance for credit losses, as well as the amount of commercial mortgage and other loans on non-accrual status, as of the dates indicated:
(1)As of March 31, 2025, there were no loans in this category accruing interest. (2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
(1)As of December 31, 2024, there were no loans in this category accruing interest. (2)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2 to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Invested Assets | The following table sets forth the composition of “Other invested assets,” as of the dates indicated:
(1)Includes tax advantaged investments and investments in separate account funds.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accrued Investment Income | The following table sets forth the composition of “Accrued investment income,” as of the dates indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Investment Income | The following table sets forth “Net investment income” by investment type, for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Realized Investment Gains (Losses), Net | The following table sets forth “Realized investment gains (losses), net” by investment type, for the periods indicated:
(1)Includes fixed maturity securities classified as available-for-sale and excludes fixed maturity securities classified as trading. (2)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. (3)Includes changes in the value of reinsurance and funds withheld payables, primarily reflecting the impact of net investment income on withheld assets that are ceded to certain reinsurance counterparties. (4)Prior period amounts have been updated to conform to current period presentation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Unrealized Gains and (Losses) on Investments | The following table sets forth net unrealized gains (losses) on investments, as of the dates indicated:
(1)For additional information regarding cash flow hedges, see Note 4. (2)Primarily includes net unrealized gains (losses) on certain joint ventures that are strategic in nature and are included in "Other assets."
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Repurchase Agreements and Securities Lending | The following table sets forth the composition of “Cash collateral for loaned securities,” which represents the liability to return cash collateral received for the following types of securities loaned, as of the dates indicated:
(1)The Company did not have any agreements with remaining contractual maturities greater than thirty days, as of the dates indicated.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The table below provides a summary of the gross notional amount and fair value of derivative contracts by the primary underlying risks, excluding embedded derivatives and associated reinsurance recoverables and deposit receivables. Many derivative instruments contain multiple underlying risks. The fair value amounts below represent the value of derivative contracts prior to taking into account the netting effects of master netting agreements and cash collateral.
(1)Excludes embedded derivatives which contain multiple underlying risks. The fair value of these embedded derivatives was a net liability of $11,017 million and $11,968 million as of March 31, 2025 and December 31, 2024, respectively, primarily included in "Policyholders' account balances". (2)Recorded in “Other invested assets” and “Payables to parent and affiliates” on the Unaudited Interim Consolidated Statements of Financial Position.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Offsetting Of Financial Assets | The following table presents recognized derivative instruments (excluding embedded derivatives and associated reinsurance recoverable and deposit receivables), and repurchase and reverse repurchase agreements that are offset in the Unaudited Interim Consolidated Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Unaudited Interim Consolidated Statements of Financial Position.
(1)Amounts exclude the excess of collateral received/pledged from/to the counterparty.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Offsetting Of Financial Liabilities | The following table presents recognized derivative instruments (excluding embedded derivatives and associated reinsurance recoverable and deposit receivables), and repurchase and reverse repurchase agreements that are offset in the Unaudited Interim Consolidated Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Unaudited Interim Consolidated Statements of Financial Position.
(1)Amounts exclude the excess of collateral received/pledged from/to the counterparty.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | The following tables provide the financial statement classification and impact of derivatives used in qualifying and non-qualifying hedge relationships, excluding the offset of the hedged item in an effective hedge relationship.
(1) Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments Recognized in Accumulated Other Comprehensive Income (Loss) Before Taxes | Presented below is a rollforward of current period cash flow hedges in AOCI before taxes:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Assets and Liabilities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value, Assets and Liabilities Measured on Recurring Basis | The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated.
(1)“Netting” amounts represent cash collateral of $(9,412) million and $(8,311) million as of March 31, 2025 and December 31, 2024, respectively, and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting agreements. (2)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans and education loans. (3)Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at net asset value ("NAV") per share (or its equivalent) as a practical expedient. As of March 31, 2025 and December 31, 2024, the fair value of such investments was $40 million and $44 million, respectively. (4)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company's Unaudited Interim Consolidated Statements of Financial Position. (5)Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and a corporate owned life insurance fund. As of March 31, 2025 and December 31, 2024, the fair value of such investments was $6,805 million and $6,444 million, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information | The tables below present quantitative information regarding significant internally-priced Level 3 assets and liabilities.
(1)Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table. (2)Directional impacts for MRB assets and liabilities are associated with the directional impacts of direct and assumed MRBs. (3)Includes assets classified as fixed maturities, available-for-sale and fixed maturities, trading. (4)Represents multiple of earnings before interest, taxes, depreciation and amortization ("EBITDA"), and are amounts used when the Company has determined that market participants would use such multiples when valuing the investments. (5)Market risk benefits primarily represent fair value for all living benefit guarantees including accumulation, withdrawal and income benefits. Since the valuation methodology for these assets and liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (6)Lapse rates for contracts with living benefit guarantees are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates for contracts with index-linked crediting guarantees may be adjusted at the contract level based on the applicability of any surrender charges, product type, and market related factors such as interest rates. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For any given contract, lapse rates vary throughout the period over which cash flows are projected for the purposes of valuing these balances. (7)The spread over the Secured Overnight Financing Rate (“SOFR”) swap curve represents the premium added to the proxy for the risk-free rate (SOFR) to reflect the Company’s estimates of rates that a market participant would use to value the living benefits in both the accumulation and payout phases and index-linked interest crediting guarantees as of March 31, 2025 and December 31, 2024, respectively. This spread includes an estimate of non-performance risk ("NPR"), which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements are insurance liabilities and are therefore senior to debt. Effective April 2023, the Company entered into an agreement with The Ohio National Life Insurance Company, now known as AuguStar Life Insurance Company ("AuguStar"), an affiliate of Constellation Insurance Holdings, Inc., to reinsure approximately $10 billion of account values of Prudential Defined Income ("PDI") traditional variable annuity contracts with guaranteed living benefits. See Note 11 for additional information regarding this transaction. As a result of this transaction, a ceded MRB asset balance was established to fair value the reinsurance reimbursements to the Company. The establishment of the fair value also required an estimate of NPR for AuguStar, which may differ from the Company's; however, the NPR spreads for AuguStar were developed using a methodology similar to that of the Company. (8)The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits. (9)The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of both March 31, 2025 and December 31, 2024, the minimum withdrawal rate assumption is 78% and the maximum withdrawal rate assumption may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%. (10)The range reflects the mortality rates for the vast majority of business with living benefits and other contracts, with policyholders ranging from 50 to 90 years old. While the majority of living benefits have a minimum age requirement, certain other contracts do not have an age restriction. This results in contractholders with mortality rates approaching 0% for certain benefits. Mortality rates may vary by product, age, and duration. A mortality improvement assumption is also incorporated into the overall mortality table. (11)Includes deposit assets related to reinsurance agreements using deposit method of accounting and modified coinsurance agreements, which include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain annuity products. (12)Policyholders’ account balances primarily represent general account liabilities for the index-linked interest credited on certain of the Company’s life and annuity products that are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (13)Option budget estimates the expected long-term cost of options used to hedge exposures associated with equity price and interest rate changes. The level of option budget determines future costs of the options, which impacts the growth in account value and the valuation of embedded derivatives.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods (excluding MRBs disclosed in Note 10). When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
(1)"Other" includes additional activity not allocated to the specific categories within the rollforward of Level 3 Assets and Liabilities. (2)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. (3)Includes U.S. corporate private, foreign corporate public, foreign corporate private, and foreign government bonds. (4)Includes asset-backed and commercial mortgage-backed securities. (5)Purchases/issuances and settlements for Policyholders' account balances and Reinsurance recoverables and deposit receivables are presented net in the rollforward. (6)Excludes MRB assets of $2,509 million and $2,537 million and MRB liabilities of $4,803 million and $4,388 million for the periods ended March 31, 2025 and 2024, respectively. See Note 10 for additional information. (7)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter. (8)Prior period amounts have been updated to conform to current period presentation. (9)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation | The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods (excluding MRBs disclosed in Note 10). When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
(1)"Other" includes additional activity not allocated to the specific categories within the rollforward of Level 3 Assets and Liabilities. (2)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. (3)Includes U.S. corporate private, foreign corporate public, foreign corporate private, and foreign government bonds. (4)Includes asset-backed and commercial mortgage-backed securities. (5)Purchases/issuances and settlements for Policyholders' account balances and Reinsurance recoverables and deposit receivables are presented net in the rollforward. (6)Excludes MRB assets of $2,509 million and $2,537 million and MRB liabilities of $4,803 million and $4,388 million for the periods ended March 31, 2025 and 2024, respectively. See Note 10 for additional information. (7)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter. (8)Prior period amounts have been updated to conform to current period presentation. (9)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosure Financial Instruments Not Carried at Fair Value | The tables below present the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value. The financial instruments presented below are reported at carrying value on the Company’s Unaudited Interim Consolidated Statements of Financial Position. In some cases, as described below, the carrying amount equals or approximates fair value.
(1) Carrying values presented herein differ from those in the Company’s Unaudited Interim Consolidated Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or are out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs, Deferred Reinsurance, and Deferred Sales Inducements (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Charges, Insurers [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Policy Acquisition Costs | The following tables show a rollforward for the lines of business that contain DAC balances, along with a reconciliation to the Company's total DAC balance:
(1)Other includes the impact of the Universal Life reinsurance transaction with Prudential Arizona Reinsurance Universal Company (“PAR U”) and PURE. See Note 11 for additional information. (2)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Reinsurance Losses | The following tables show a rollforward for the lines of business that contain DRL balances, along with a reconciliation to the Company's total DRL balance:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Reinsurance Gains | The following tables show a rollforward for the lines of business that contain DRG balances, along with a reconciliation to the Company's total DRG balance:
(1)Includes the impact of the International reinsurance transaction with The Prudential Life Insurance Company, Ltd. ("Prudential of Japan"), including $14 million of DRG. See Note 11 for additional information.
(1)Other includes the impact of the Universal Life reinsurance transaction with PAR U, PURE and Prudential Insurance, including $1,207 million of DRG, partially offset by a $116 million write-off. See Note 11 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Sale Inducement | The following table shows a rollforward of DSI balances for variable annuity products, which is the only line of business that contains a DSI balance, along with a reconciliation to the Company's total DSI balance:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Separate Accounts (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate Account Assets | The aggregate fair value of assets, by major investment asset category, supporting separate accounts is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate Account Liabilities | The balances of and changes in separate account liabilities as of and for the periods indicated are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability For Future Policy Benefits (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liability for Future Policy Benefit | The balances of and changes in Benefit Reserves as of and for the periods indicated consist of the three tables presented below: Present Value of Expected Net Premiums rollforward, Present Value of Expected Future Policy Benefits rollforward, and Net Liability for Future Policy Benefits.
The following tables provide supplemental information related to the balances of and changes in Benefit Reserves included in the disaggregated tables above, on a gross (direct and assumed) basis, as of and for the periods indicated:
The balances of and changes in DPL as of and for the periods indicated are as follows:
The following table shows a rollforward of AIR balances for variable and universal life products for the periods indicated, along with a reconciliation to the Company's total AIR balance:
(1) Represents the portion of gross assessments required to fund the future policy benefits.
The following table presents the reconciliation of the ending balances from the above rollforwards, Benefit Reserves, DPL, and AIR, including other liabilities, gross of related reinsurance recoverables, to the total liability for Future Policy Benefits as reported on the Company's Unaudited Interim Consolidated Statements of Financial Position as of the periods indicated:
(1)Primarily represents balances for which disaggregated rollforward disclosures are not required, including unpaid claims and claims expenses, and incurred but not reported and in course of settlement claim liabilities. The following tables present revenue and interest expense related to Benefit Reserves, DPL, and AIR, as well as related revenue and interest expense not presented in the above supplemental tables, in the Company's Consolidated Statement of Operations for the periods indicated:
(1)Represents gross premiums for benefit reserves; revenue for DPL and gross assessments for AIR.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholders' Liabilities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholder Account Balance | The balances of and changes in policyholders' account balances as of and for the periods ended are as follows:
(1) Primarily relates to changes in the value of embedded derivative instruments associated with the indexed options of certain products. (2) The net amount at risk calculation includes both general and separate account balances. (3) Represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. (4) Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholder Account Balance, Guaranteed Minimum Crediting Rate | The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums are as follows:
(1) Excludes contracts without minimum guaranteed crediting rates, such as funds with indexed-linked crediting options.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Additional Liability, Long-Duration Insurance | The balances of and changes in URR as of and for the periods ended are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Risk Benefits (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Risk Benefits | The following tables show a rollforward of MRB balances for variable annuity products, along with a reconciliation to the Company’s total net MRB positions as of the following dates:
(1) Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. The following table presents accompanying information to the rollforward table above.
(1)For contracts with multiple benefit features, the highest net amount at risk for each contract is included. The table below reconciles MRB asset and liability positions as of the following dates:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Impact on Statements of Financial Position | Reinsurance amounts included in the Company’s Unaudited Interim Consolidated Statements of Financial Position were as follows:
Unaffiliated reinsurance amounts included in the table above and in the Company's Unaudited Interim Consolidated Statements of Financial Position were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Recoverable by Counterparty | Reinsurance recoverables and deposit receivables by counterparty were as follows:
(1)Includes balances with Wilton Re, Fortitude Life Insurance & Annuity Company (“FLIAC”), Somerset Re and other counterparties. See below for further information on significant third-party reinsurance arrangements.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Impact on Statements of Operations and Comprehensive Income (Loss) | Reinsurance amounts, included in the Company’s Unaudited Interim Consolidated Statements of Operations and Comprehensive Income (Loss) were as follows:
(1)Amounts include reinsurance agreements using the deposit method of accounting. (2)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information. Unaffiliated reinsurance assumed and ceded amounts included in the table above and in the Company's Unaudited Interim Consolidated Statements of Operations and Comprehensive Income (Loss) were as follows:
(1)Amounts include reinsurance agreements using the deposit method of accounting. (2)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross and Net Life Insurance in Force | The gross and net amounts of life insurance face amount in force were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income (Loss) | The balance of and changes in each component of AOCI as of and for the three months ended March 31, 2025 and 2024, are as follows:
(1)Includes cash flow hedges of $95 million and $111 million as of March 31, 2025 and December 31, 2024, respectively, and $39 million and $12 million as of March 31, 2024 and December 31, 2023, respectively. (2)Amounts reflect revision to prior period Financial Statements. See Note 16 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reclassification out of Accumulated Other Comprehensive Income | Reclassifications out of Accumulated Other Comprehensive Income (Loss)
(1)All amounts are shown before tax. (2)Positive amounts indicate gains/benefits reclassified out of AOCI. Negative amounts indicate losses/costs reclassified out of AOCI. (3)See Note 4 for additional information on cash flow hedges. (4)See table below for additional information on unrealized investment gains (losses), including the impact on future policy benefits, policyholders’ account balances.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Unrealized Investment Gains (Losses) on AFS Fixed Maturity Securities wit Allowance for credit losses and All Other Investments AOCI Rollforward | The amounts for the periods indicated below, split between amounts related to net unrealized investment gains (losses) on available-for-sale fixed maturity securities on which an allowance for credit losses has been recognized, and all other net unrealized investment gains (losses), are as follows:
(1)Includes cash flow hedges. See Note 4 for information on cash flow hedges. (2)"Other costs" primarily includes reinsurance recoverables and deposit receivables and DRL.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related Party Transactions [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Affiliated Notes Receivable | Affiliated notes receivable included in “Receivables from parent and affiliates” at March 31, 2025 and December 31, 2024 is as follows:
(1)All notes receivable may be called for prepayment prior to the respective maturity dates under specified circumstances.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Affiliated Asset Transfers | The table below shows affiliated asset trades for the three months ended March 31, 2025 and for the year ended December 31, 2024.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Guarantees | Guarantees of Asset Values
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revision to Prior Year Financial Statement (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prior Period Adjustment [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Revision to Prior Period Financial Statements | The following are selected line items from the Consolidated Financial Statements illustrating the effects of these revisions: Unaudited Interim Consolidated Statements of Operations and Comprehensive Income (Loss)
Unaudited Interim Consolidated Statements of Equity
Unaudited Interim Consolidated Statements of Cash Flows
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business and Basis of Presentation (Narrative) (Details) |
3 Months Ended |
|---|---|
|
Mar. 31, 2025
segment
subsidiary
| |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Number Of Subsidiaries | subsidiary | 1 |
| Number of Reportable Segments | segment | 1 |
Investments (Fixed Maturities Securities Excluding Investments Classified as Trading) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|---|
| Debt Securities, Available-for-sale [Line Items] | ||||
| Amortized Cost | $ 40,807,986 | $ 36,980,933 | ||
| Gross Unrealized Gains | 331,892 | 208,233 | ||
| Gross Unrealized Losses | 1,930,978 | 2,162,592 | ||
| Allowance for Credit Losses | 42,828 | 40,414 | $ 1,650 | $ 2,008 |
| Fair Value | 39,166,072 | 34,986,160 | ||
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||
| Debt Securities, Available-for-sale [Line Items] | ||||
| Amortized Cost | 1,150,479 | 1,199,628 | ||
| Gross Unrealized Gains | 19,881 | 8,357 | ||
| Gross Unrealized Losses | 89,700 | 108,744 | ||
| Allowance for Credit Losses | 0 | 0 | 0 | 0 |
| Fair Value | 1,080,660 | 1,099,241 | ||
| Obligations of U.S. states and their political subdivisions | ||||
| Debt Securities, Available-for-sale [Line Items] | ||||
| Amortized Cost | 551,375 | 570,253 | ||
| Gross Unrealized Gains | 1,254 | 1,156 | ||
| Gross Unrealized Losses | 35,445 | 30,343 | ||
| Allowance for Credit Losses | 0 | 0 | ||
| Fair Value | 517,184 | 541,066 | ||
| Foreign government securities | ||||
| Debt Securities, Available-for-sale [Line Items] | ||||
| Amortized Cost | 439,135 | 362,154 | ||
| Gross Unrealized Gains | 3,108 | 646 | ||
| Gross Unrealized Losses | 49,006 | 52,466 | ||
| Allowance for Credit Losses | 0 | 0 | 0 | 0 |
| Fair Value | 393,237 | 310,334 | ||
| U.S. public corporate securities | ||||
| Debt Securities, Available-for-sale [Line Items] | ||||
| Amortized Cost | 16,328,435 | 14,134,828 | ||
| Gross Unrealized Gains | 124,879 | 60,917 | ||
| Gross Unrealized Losses | 892,473 | 957,316 | ||
| Allowance for Credit Losses | 19 | 1 | ||
| Fair Value | 15,560,822 | 13,238,428 | ||
| U.S. private corporate securities | ||||
| Debt Securities, Available-for-sale [Line Items] | ||||
| Amortized Cost | 6,538,902 | 6,030,898 | ||
| Gross Unrealized Gains | 29,688 | 35,828 | ||
| Gross Unrealized Losses | 250,640 | 301,451 | ||
| Allowance for Credit Losses | 9,164 | 11,178 | ||
| Fair Value | 6,308,786 | 5,754,097 | ||
| Foreign public corporate securities | ||||
| Debt Securities, Available-for-sale [Line Items] | ||||
| Amortized Cost | 4,439,517 | 3,804,503 | ||
| Gross Unrealized Gains | 46,832 | 21,136 | ||
| Gross Unrealized Losses | 113,026 | 126,767 | ||
| Allowance for Credit Losses | 21 | 21 | ||
| Fair Value | 4,373,302 | 3,698,851 | ||
| Foreign private corporate securities | ||||
| Debt Securities, Available-for-sale [Line Items] | ||||
| Amortized Cost | 6,180,964 | 5,838,939 | ||
| Gross Unrealized Gains | 70,080 | 43,334 | ||
| Gross Unrealized Losses | 437,381 | 511,426 | ||
| Allowance for Credit Losses | 33,624 | 29,214 | ||
| Fair Value | 5,780,039 | 5,341,633 | ||
| Asset-backed securities | ||||
| Debt Securities, Available-for-sale [Line Items] | ||||
| Amortized Cost | 3,801,789 | 3,728,073 | ||
| Gross Unrealized Gains | 25,349 | 31,431 | ||
| Gross Unrealized Losses | 10,782 | 8,841 | ||
| Allowance for Credit Losses | 0 | 0 | 0 | 1 |
| Fair Value | 3,816,356 | 3,750,663 | ||
| Commercial mortgage-backed securities | ||||
| Debt Securities, Available-for-sale [Line Items] | ||||
| Amortized Cost | 1,018,053 | 944,652 | ||
| Gross Unrealized Gains | 8,052 | 4,567 | ||
| Gross Unrealized Losses | 44,565 | 53,444 | ||
| Allowance for Credit Losses | 0 | 0 | 0 | 0 |
| Fair Value | 981,540 | 895,775 | ||
| Residential mortgage-backed securities | ||||
| Debt Securities, Available-for-sale [Line Items] | ||||
| Amortized Cost | 359,337 | 367,005 | ||
| Gross Unrealized Gains | 2,769 | 861 | ||
| Gross Unrealized Losses | 7,960 | 11,794 | ||
| Allowance for Credit Losses | 0 | 0 | $ 0 | $ 7 |
| Fair Value | $ 354,146 | $ 356,072 |
Investments (Fair Value and Losses by Investment Category and Length of Time in a Loss Position) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | $ 9,008,882 | $ 10,716,329 |
| Less than Twelve Months, Gross Unrealized Losses | 175,573 | 267,215 |
| Twelve Months or More, Fair Value | 11,462,335 | 11,256,350 |
| Twelve Months or More, Gross Unrealized Losses | 1,754,173 | 1,893,641 |
| Total, Fair Value | 20,471,217 | 21,972,679 |
| Total, Gross Unrealized Losses | 1,929,746 | 2,160,856 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 261,400 | 377,531 |
| Less than Twelve Months, Gross Unrealized Losses | 3,536 | 13,829 |
| Twelve Months or More, Fair Value | 247,293 | 238,723 |
| Twelve Months or More, Gross Unrealized Losses | 86,164 | 94,915 |
| Total, Fair Value | 508,693 | 616,254 |
| Total, Gross Unrealized Losses | 89,700 | 108,744 |
| Obligations of U.S. states and their political subdivisions | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 179,660 | 226,731 |
| Less than Twelve Months, Gross Unrealized Losses | 7,026 | 5,019 |
| Twelve Months or More, Fair Value | 244,108 | 212,060 |
| Twelve Months or More, Gross Unrealized Losses | 28,419 | 25,324 |
| Total, Fair Value | 423,768 | 438,791 |
| Total, Gross Unrealized Losses | 35,445 | 30,343 |
| Foreign government securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 54,388 | 118,168 |
| Less than Twelve Months, Gross Unrealized Losses | 1,173 | 2,615 |
| Twelve Months or More, Fair Value | 173,897 | 171,166 |
| Twelve Months or More, Gross Unrealized Losses | 47,833 | 49,851 |
| Total, Fair Value | 228,285 | 289,334 |
| Total, Gross Unrealized Losses | 49,006 | 52,466 |
| U.S. public corporate securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 2,937,255 | 4,320,552 |
| Less than Twelve Months, Gross Unrealized Losses | 74,371 | 105,145 |
| Twelve Months or More, Fair Value | 4,807,764 | 4,677,336 |
| Twelve Months or More, Gross Unrealized Losses | 818,088 | 852,171 |
| Total, Fair Value | 7,745,019 | 8,997,888 |
| Total, Gross Unrealized Losses | 892,459 | 957,316 |
| U.S. private corporate securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 2,004,535 | 1,999,008 |
| Less than Twelve Months, Gross Unrealized Losses | 27,408 | 41,931 |
| Twelve Months or More, Fair Value | 2,416,353 | 2,379,755 |
| Twelve Months or More, Gross Unrealized Losses | 223,102 | 259,489 |
| Total, Fair Value | 4,420,888 | 4,378,763 |
| Total, Gross Unrealized Losses | 250,510 | 301,420 |
| Foreign public corporate securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 627,642 | 1,088,644 |
| Less than Twelve Months, Gross Unrealized Losses | 9,733 | 20,465 |
| Twelve Months or More, Fair Value | 740,032 | 716,172 |
| Twelve Months or More, Gross Unrealized Losses | 103,289 | 106,294 |
| Total, Fair Value | 1,367,674 | 1,804,816 |
| Total, Gross Unrealized Losses | 113,022 | 126,759 |
| Foreign private corporate securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 1,765,712 | 1,977,169 |
| Less than Twelve Months, Gross Unrealized Losses | 47,356 | 69,399 |
| Twelve Months or More, Fair Value | 2,109,881 | 2,107,705 |
| Twelve Months or More, Gross Unrealized Losses | 388,941 | 440,330 |
| Total, Fair Value | 3,875,593 | 4,084,874 |
| Total, Gross Unrealized Losses | 436,297 | 509,729 |
| Asset-backed securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 1,116,137 | 363,744 |
| Less than Twelve Months, Gross Unrealized Losses | 4,194 | 5,510 |
| Twelve Months or More, Fair Value | 119,537 | 140,090 |
| Twelve Months or More, Gross Unrealized Losses | 6,588 | 3,331 |
| Total, Fair Value | 1,235,674 | 503,834 |
| Total, Gross Unrealized Losses | 10,782 | 8,841 |
| Commercial mortgage-backed securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 38,559 | 101,821 |
| Less than Twelve Months, Gross Unrealized Losses | 429 | 1,356 |
| Twelve Months or More, Fair Value | 479,676 | 489,490 |
| Twelve Months or More, Gross Unrealized Losses | 44,136 | 52,088 |
| Total, Fair Value | 518,235 | 591,311 |
| Total, Gross Unrealized Losses | 44,565 | 53,444 |
| Residential mortgage-backed securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Less than Twelve Months, Fair Value | 23,594 | 142,961 |
| Less than Twelve Months, Gross Unrealized Losses | 347 | 1,946 |
| Twelve Months or More, Fair Value | 123,794 | 123,853 |
| Twelve Months or More, Gross Unrealized Losses | 7,613 | 9,848 |
| Total, Fair Value | 147,388 | 266,814 |
| Total, Gross Unrealized Losses | $ 7,960 | $ 11,794 |
Investments (Narrative) (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
|
| Schedule of Investments [Line Items] | |||
| Loans acquired | $ 0 | $ 0 | |
| Loans sold | 0 | 0 | |
| Gross Unrealized Losses | 1,929,746 | $ 2,160,856 | |
| Fixed maturity purchased with credit deterioration | 0 | 0 | |
| Accrued Investment Income Write Down | 0 | 0 | |
| Securities sold under agreements to repurchase | $ 0 | $ 0 | |
| Commercial mortgage loans, Percentage | 100.00% | 100.00% | |
| Loans on non-accrual status recognized in interest income | $ 1,000 | $ 0 | |
| Loans on non-accrual status, do not have allowance for credit losses | 5,000 | $ 2,000 | |
| Commercial mortgage and other loans purchased with credit deterioration | 0 | 0 | |
| Twelve Months or More, Gross Unrealized Losses | 1,754,173 | 1,893,641 | |
| Commercial mortgage loans | Extended Maturity | |||
| Schedule of Investments [Line Items] | |||
| Financing Receivable, Modified, Weighted Average Term Increase from Modification | 1 year | ||
| NAIC high or highest quality rating | Fixed maturities | |||
| Schedule of Investments [Line Items] | |||
| Gross Unrealized Losses | 1,849,000 | 2,059,000 | |
| NAIC other than high or highest quality rating | Fixed maturities | |||
| Schedule of Investments [Line Items] | |||
| Gross Unrealized Losses | $ 81,000 | 102,000 | |
| California | |||
| Schedule of Investments [Line Items] | |||
| Commercial mortgage loans, Percentage | 24.00% | ||
| Florida | |||
| Schedule of Investments [Line Items] | |||
| Commercial mortgage loans, Percentage | 8.00% | ||
| Texas | |||
| Schedule of Investments [Line Items] | |||
| Commercial mortgage loans, Percentage | 8.00% | ||
| Europe | |||
| Schedule of Investments [Line Items] | |||
| Commercial mortgage loans, Percentage | 9.00% | ||
| Mexico | |||
| Schedule of Investments [Line Items] | |||
| Commercial mortgage loans, Percentage | 1.00% | ||
| Australia | |||
| Schedule of Investments [Line Items] | |||
| Commercial mortgage loans, Percentage | 1.00% | ||
| Other Income | Fixed maturities | Trading | |||
| Schedule of Investments [Line Items] | |||
| Net unrealized investment gains (losses) | $ 87,800 | $ (81,300) | |
| Other Income | Equity securities | |||
| Schedule of Investments [Line Items] | |||
| Net unrealized investment gains (losses) | (93,600) | $ (12,200) | |
| Fixed maturities | |||
| Schedule of Investments [Line Items] | |||
| Twelve Months or More, Gross Unrealized Losses | $ 1,754,000 | $ 1,894,000 | |
Investments (Amortized Cost and Fair Value of Fixed Maturities by Contractual Maturities) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Amortized Cost | ||
| Due in one year or less | $ 2,712,978 | |
| Due after one year through five years | 14,221,040 | |
| Due after five years through ten years | 9,501,783 | |
| Due after ten years | 9,193,006 | |
| Amortized Cost | 40,807,986 | $ 36,980,933 |
| Fair Value | ||
| Due in one year or less | 2,661,173 | |
| Due after one year through five years | 14,064,348 | |
| Due after five years through ten years | 9,267,750 | |
| Due after ten years | 8,020,759 | |
| Fair Value | 39,166,072 | 34,986,160 |
| Asset-backed securities | ||
| Amortized Cost | ||
| Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost | 3,801,789 | |
| Amortized Cost | 3,801,789 | 3,728,073 |
| Fair Value | ||
| Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value | 3,816,356 | |
| Fair Value | 3,816,356 | 3,750,663 |
| Commercial mortgage-backed securities | ||
| Amortized Cost | ||
| Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost | 1,018,053 | |
| Amortized Cost | 1,018,053 | 944,652 |
| Fair Value | ||
| Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value | 981,540 | |
| Fair Value | 981,540 | 895,775 |
| Residential mortgage-backed securities | ||
| Amortized Cost | ||
| Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost | 359,337 | |
| Amortized Cost | 359,337 | 367,005 |
| Fair Value | ||
| Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value | 354,146 | |
| Fair Value | $ 354,146 | $ 356,072 |
Investments (Fixed Maturities Securities Proceeds) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Debt Securities, Available-for-sale [Line Items] | ||
| Proceeds from maturities/prepayments | $ 1,418,413 | $ 534,863 |
| Fixed maturities | Available-for-sale | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Proceeds from sales | 422,037 | 106,155 |
| Proceeds from maturities/prepayments | 845,709 | 437,443 |
| Gross investment gains from sales and maturities | 4,608 | 937 |
| Gross investment losses from sales and maturities | (7,802) | (8,132) |
| Write-downs recognized in earnings | (6,336) | 0 |
| (Addition to) release of allowance for credit losses | (2,414) | 358 |
| Noncash or part noncash divestiture, amount of consideration received | $ 150,700 | $ (8,700) |
Investments (Credit Losses Recognized In Earnings on Fixed Maturity Securities Held by the Company) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | $ 40,414 | $ 2,008 |
| Additions to allowance for credit losses not previously recorded | 5,512 | 57 |
| Reductions for securities sold during the period | (76) | (41) |
| Additions (reductions) on securities with previous allowance | 1,126 | (853) |
| Assets transferred to parent and affiliates | 479 | |
| Write-downs charged against the allowance | (4,148) | |
| Balance, end of period | 42,828 | 1,650 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 0 |
| Additions to allowance for credit losses not previously recorded | 0 | 0 |
| Reductions for securities sold during the period | 0 | 0 |
| Additions (reductions) on securities with previous allowance | 0 | 0 |
| Assets transferred to parent and affiliates | 0 | |
| Write-downs charged against the allowance | 0 | |
| Balance, end of period | 0 | 0 |
| Foreign Government Securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 0 |
| Additions to allowance for credit losses not previously recorded | 0 | 0 |
| Reductions for securities sold during the period | 0 | 0 |
| Additions (reductions) on securities with previous allowance | 0 | 0 |
| Assets transferred to parent and affiliates | 0 | |
| Write-downs charged against the allowance | 0 | |
| Balance, end of period | 0 | 0 |
| U.S. and Foreign Corporate Securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 40,414 | 2,000 |
| Additions to allowance for credit losses not previously recorded | 5,512 | 57 |
| Reductions for securities sold during the period | (76) | (41) |
| Additions (reductions) on securities with previous allowance | 1,126 | (845) |
| Assets transferred to parent and affiliates | 479 | |
| Write-downs charged against the allowance | (4,148) | |
| Balance, end of period | 42,828 | 1,650 |
| Asset-backed securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 1 |
| Additions to allowance for credit losses not previously recorded | 0 | 0 |
| Reductions for securities sold during the period | 0 | 0 |
| Additions (reductions) on securities with previous allowance | 0 | (1) |
| Assets transferred to parent and affiliates | 0 | |
| Write-downs charged against the allowance | 0 | |
| Balance, end of period | 0 | 0 |
| Commercial mortgage-backed securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 0 |
| Additions to allowance for credit losses not previously recorded | 0 | 0 |
| Reductions for securities sold during the period | 0 | 0 |
| Additions (reductions) on securities with previous allowance | 0 | 0 |
| Assets transferred to parent and affiliates | 0 | |
| Write-downs charged against the allowance | 0 | |
| Balance, end of period | 0 | 0 |
| Residential Mortgage-Backed Securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 7 |
| Additions to allowance for credit losses not previously recorded | 0 | 0 |
| Reductions for securities sold during the period | 0 | 0 |
| Additions (reductions) on securities with previous allowance | 0 | (7) |
| Assets transferred to parent and affiliates | 0 | |
| Write-downs charged against the allowance | 0 | |
| Balance, end of period | $ 0 | $ 0 |
Investments (Commercial Mortgage and Other Loans) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 8,081,694 | $ 7,785,059 |
| Commercial mortgage loans, Percentage | 100.00% | 100.00% |
| Allowance for Credit Losses | $ (39,784) | $ (37,715) |
| Commercial Mortgage Loans | 8,054,419 | 7,759,323 |
| Total net Commercial Mortgage and Other Loans | 8,054,419 | 7,759,323 |
| Other loans | 12,509 | 11,979 |
| Commercial Mortgage and Agricultural Loans | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial Mortgage Loans | 8,041,910 | 7,747,344 |
| Total net Commercial Mortgage and Other Loans | 8,041,910 | 7,747,344 |
| Other Collateralized Loans | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Other loans | 12,509 | 11,979 |
| Total Net Commercial Mortgage and Other Loans | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial Mortgage Loans | 8,054,419 | 7,759,323 |
| Total net Commercial Mortgage and Other Loans | 8,054,419 | 7,759,323 |
| Apartments/Multi-Family | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 2,070,419 | $ 1,949,926 |
| Commercial mortgage loans, Percentage | 25.60% | 25.00% |
| Health Care Senior Living | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 133,731 | $ 134,195 |
| Commercial mortgage loans, Percentage | 1.70% | 1.70% |
| Hospitality | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 95,008 | $ 97,603 |
| Commercial mortgage loans, Percentage | 1.20% | 1.30% |
| Industrial | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 3,014,351 | $ 2,906,413 |
| Commercial mortgage loans, Percentage | 37.30% | 37.30% |
| Office | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 545,065 | $ 556,586 |
| Commercial mortgage loans, Percentage | 6.70% | 7.10% |
| Retail | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 693,519 | $ 693,949 |
| Commercial mortgage loans, Percentage | 8.60% | 9.00% |
| Self-Storage | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 598,911 | $ 543,701 |
| Commercial mortgage loans, Percentage | 7.40% | 7.00% |
| Other | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 72,554 | $ 72,645 |
| Commercial mortgage loans, Percentage | 0.90% | 0.90% |
| Total commercial mortgage loans | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 7,223,558 | $ 6,955,018 |
| Commercial mortgage loans, Percentage | 89.40% | 89.30% |
| Agricultural property loans | ||
| Commercial Mortgage and Other Loans [Line Items] | ||
| Commercial mortgage and agricultural property loans | $ 858,136 | $ 830,041 |
| Commercial mortgage loans, Percentage | 10.60% | 10.70% |
Investments (Allowance for Credit Losses) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Allowance for Loan and Lease Losses [Roll Forward] | ||
| Balance, beginning of year | $ 37,715 | $ 37,689 |
| Addition to (release of) allowance for expected losses | 2,069 | 4,993 |
| Total ending balance | 39,784 | 42,682 |
| Commercial mortgage loans | ||
| Allowance for Loan and Lease Losses [Roll Forward] | ||
| Balance, beginning of year | 33,004 | 36,758 |
| Addition to (release of) allowance for expected losses | 1,766 | 5,011 |
| Total ending balance | 34,770 | 41,769 |
| Agricultural Property Loans | ||
| Allowance for Loan and Lease Losses [Roll Forward] | ||
| Balance, beginning of year | 4,711 | 931 |
| Addition to (release of) allowance for expected losses | 303 | (18) |
| Total ending balance | $ 5,014 | $ 913 |
Investments (Credit Quality Indicators) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Recording investment gross of allowance for credit losses | $ 8,094,203 | $ 7,797,038 |
| Total commercial mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 286,127 | 1,788,998 |
| One Year Prior | 1,796,239 | 1,139,236 |
| Two Year Prior | 1,141,663 | 770,354 |
| Three Year Prior | 765,856 | 1,258,169 |
| Four Year Prior | 1,262,729 | 255,562 |
| Prior | 1,962,277 | 1,736,220 |
| Revolving Loans | 8,667 | 6,479 |
| Recording investment gross of allowance for credit losses | 7,223,558 | 6,955,018 |
| Total commercial mortgage loans | ≥ 1.2X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 286,127 | 1,728,895 |
| One Year Prior | 1,736,155 | 962,290 |
| Two Year Prior | 963,036 | 755,350 |
| Three Year Prior | 750,965 | 1,256,699 |
| Four Year Prior | 1,261,264 | 255,562 |
| Prior | 1,843,067 | 1,616,904 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 6,840,614 | 6,575,700 |
| Total commercial mortgage loans | 1.0X to 1.2X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 60,103 |
| One Year Prior | 60,084 | 176,946 |
| Two Year Prior | 178,627 | 15,004 |
| Three Year Prior | 14,891 | 0 |
| Four Year Prior | 0 | 0 |
| Prior | 55,934 | 59,871 |
| Revolving Loans | 8,667 | 6,479 |
| Recording investment gross of allowance for credit losses | 318,203 | 318,403 |
| Total commercial mortgage loans | Less than 1.0X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 0 |
| One Year Prior | 0 | 0 |
| Two Year Prior | 0 | 0 |
| Three Year Prior | 0 | 1,470 |
| Four Year Prior | 1,465 | 0 |
| Prior | 63,276 | 59,445 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 64,741 | 60,915 |
| Agricultural Property Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 40,299 | 271,275 |
| One Year Prior | 270,935 | 108,965 |
| Two Year Prior | 94,408 | 220,325 |
| Three Year Prior | 218,650 | 131,581 |
| Four Year Prior | 131,519 | 25,145 |
| Prior | 62,320 | 38,478 |
| Revolving Loans | 40,005 | 34,272 |
| Recording investment gross of allowance for credit losses | 858,136 | 830,041 |
| Agricultural Property Loans | ≥ 1.2X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 40,299 | 259,647 |
| One Year Prior | 259,307 | 95,087 |
| Two Year Prior | 92,050 | 211,030 |
| Three Year Prior | 206,492 | 129,865 |
| Four Year Prior | 124,641 | 23,488 |
| Prior | 48,428 | 38,478 |
| Revolving Loans | 24,338 | 18,834 |
| Recording investment gross of allowance for credit losses | 795,555 | 776,429 |
| Agricultural Property Loans | 1.0X to 1.2X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 11,628 |
| One Year Prior | 11,628 | 13,878 |
| Two Year Prior | 2,358 | 9,295 |
| Three Year Prior | 12,158 | 0 |
| Four Year Prior | 0 | 0 |
| Prior | 10,240 | 0 |
| Revolving Loans | 15,667 | 15,438 |
| Recording investment gross of allowance for credit losses | 52,051 | 50,239 |
| Agricultural Property Loans | Less than 1.0X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 0 |
| One Year Prior | 0 | 0 |
| Two Year Prior | 0 | 0 |
| Three Year Prior | 0 | 1,716 |
| Four Year Prior | 6,878 | 1,657 |
| Prior | 3,652 | 0 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 10,530 | 3,373 |
| 0%-59.99% | Total commercial mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 38,195 | 452,940 |
| One Year Prior | 457,963 | 232,276 |
| Two Year Prior | 333,678 | 306,684 |
| Three Year Prior | 306,930 | 482,596 |
| Four Year Prior | 481,026 | 134,403 |
| Prior | 1,295,238 | 1,138,394 |
| Revolving Loans | 8,667 | 6,479 |
| Recording investment gross of allowance for credit losses | 2,921,697 | 2,753,772 |
| 0%-59.99% | Agricultural Property Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 22,300 | 241,715 |
| One Year Prior | 241,375 | 89,569 |
| Two Year Prior | 75,069 | 163,820 |
| Three Year Prior | 162,037 | 126,368 |
| Four Year Prior | 126,284 | 23,488 |
| Prior | 60,701 | 38,478 |
| Revolving Loans | 24,338 | 18,834 |
| Recording investment gross of allowance for credit losses | 712,104 | 702,272 |
| 60%-69.99% | Total commercial mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 247,932 | 972,161 |
| One Year Prior | 972,650 | 541,849 |
| Two Year Prior | 443,420 | 273,258 |
| Three Year Prior | 276,319 | 360,457 |
| Four Year Prior | 362,180 | 110,515 |
| Prior | 387,446 | 303,107 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 2,689,947 | 2,561,347 |
| 60%-69.99% | Agricultural Property Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 29,560 |
| One Year Prior | 29,560 | 19,396 |
| Two Year Prior | 19,339 | 49,210 |
| Three Year Prior | 49,210 | 0 |
| Four Year Prior | 0 | 0 |
| Prior | 1,619 | 0 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 99,728 | 98,166 |
| 70%-79.99% | Total commercial mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 362,701 |
| One Year Prior | 364,430 | 365,111 |
| Two Year Prior | 364,565 | 134,208 |
| Three Year Prior | 170,981 | 330,355 |
| Four Year Prior | 334,446 | 6,774 |
| Prior | 81,122 | 77,399 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 1,315,544 | 1,276,548 |
| 70%-79.99% | Agricultural Property Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 17,999 | 0 |
| One Year Prior | 0 | 0 |
| Two Year Prior | 0 | 0 |
| Three Year Prior | 0 | 5,213 |
| Four Year Prior | 5,235 | 0 |
| Prior | 0 | 0 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 23,234 | 5,213 |
| 80% or greater | Total commercial mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 1,196 |
| One Year Prior | 1,196 | 0 |
| Two Year Prior | 0 | 56,204 |
| Three Year Prior | 11,626 | 84,761 |
| Four Year Prior | 85,077 | 3,870 |
| Prior | 198,471 | 217,320 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 296,370 | 363,351 |
| 80% or greater | Agricultural Property Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 0 |
| One Year Prior | 0 | 0 |
| Two Year Prior | 0 | 7,295 |
| Three Year Prior | 7,403 | 0 |
| Four Year Prior | 0 | 1,657 |
| Prior | 0 | 0 |
| Revolving Loans | 15,667 | 15,438 |
| Recording investment gross of allowance for credit losses | $ 23,070 | $ 24,390 |
Investments (Amortized Cost Basis of Loan Modifications made to Borrowers Experiencing Financial Difficulties) (Details) - Commercial Portfolio Segment - Term Extension - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Financing Receivable, Modified [Line Items] | ||
| Financing Receivable, Modified in Period, Amount | $ 0 | $ 6,469 |
| Financing Receivable, Modified in Period, to Total Financing Receivables, Percentage | 0.00% | 0.00% |
Investments (Analysis of Past Due Commercial Mortgage, Agricultural and Other Loans) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | $ 8,094,203 | $ 7,797,038 |
| Non-Accrual Status | 32,716 | 29,885 |
| Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 8,048,628 | 7,767,876 |
| 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 1,196 | 0 |
| 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 17,386 | 2,505 |
| 90 Days or More Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 26,993 | 26,657 |
| Total commercial mortgage loans | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 7,223,558 | 6,955,018 |
| Non-Accrual Status | 5,120 | 5,120 |
| Total commercial mortgage loans | Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 7,218,438 | 6,951,093 |
| Total commercial mortgage loans | 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 1,196 | 0 |
| Total commercial mortgage loans | 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 0 | 0 |
| Total commercial mortgage loans | 90 Days or More Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 3,924 | 3,925 |
| Agricultural Loan | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 858,136 | 830,041 |
| Non-Accrual Status | 27,596 | 24,765 |
| Agricultural Loan | Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 817,681 | 804,804 |
| Agricultural Loan | 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 0 | 0 |
| Agricultural Loan | 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 17,386 | 2,505 |
| Agricultural Loan | 90 Days or More Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 23,069 | 22,732 |
| Other Collateralized Loans | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 12,509 | 11,979 |
| Non-Accrual Status | 0 | 0 |
| Other Collateralized Loans | Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 12,509 | 11,979 |
| Other Collateralized Loans | 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 0 | 0 |
| Other Collateralized Loans | 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 0 | 0 |
| Other Collateralized Loans | 90 Days or More Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Recording investment gross of allowance for credit losses | 0 | 0 |
| Loans | 90 Days or More Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Accruing Interest | $ 0 | $ 0 |
Investments (Other Invested Assets) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Other Invested Assets [Line Items] | ||
| Other invested assets | $ 2,040,612 | $ 1,582,094 |
| Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets | 1,935,074 | 1,533,210 |
| Derivative Instruments | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets | 80,482 | 24,499 |
| Other | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets | 25,056 | 24,385 |
| Equity Method | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets | 1,895,158 | 1,489,086 |
| Equity Method | Private equity | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets | 397,782 | 388,822 |
| Equity Method | Hedge funds | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets | 1,422,821 | 1,024,534 |
| Equity Method | Real estate-related | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets | 74,555 | 75,730 |
| Fair Value | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets | 39,916 | 44,124 |
| Fair Value | Private equity | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets | 24,326 | 28,094 |
| Fair Value | Hedge funds | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets | 15 | 14 |
| Fair Value | Real estate-related | Total LPs/LLCs | ||
| Other Invested Assets [Line Items] | ||
| Other invested assets | $ 15,575 | $ 16,016 |
Investments (Accrued Investment Income) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Net Investment Income | ||
| Accrued investment income | $ 502,312 | $ 466,394 |
| Fixed maturities | ||
| Net Investment Income | ||
| Accrued investment income | 423,507 | 396,173 |
| Equity securities | ||
| Net Investment Income | ||
| Accrued investment income | 218 | 436 |
| Commercial mortgage and other loans | ||
| Net Investment Income | ||
| Accrued investment income | 31,636 | 29,437 |
| Policy loans | ||
| Net Investment Income | ||
| Accrued investment income | 41,601 | 30,820 |
| Short-term investments and cash equivalents | ||
| Net Investment Income | ||
| Accrued investment income | $ 5,350 | $ 9,528 |
Investments (Net Investment Income) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | ||
| Gross investment income | $ 765,166 | $ 532,063 |
| Less: investment expenses | (30,370) | (26,743) |
| Net investment income | 734,796 | 505,320 |
| Equity securities | ||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | ||
| Gross investment income | 18,584 | 3,747 |
| Commercial mortgage and other loans | ||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | ||
| Gross investment income | 97,247 | 73,758 |
| Policy loans | ||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | ||
| Gross investment income | 16,216 | 14,445 |
| Other invested assets | ||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | ||
| Gross investment income | 63,879 | 23,320 |
| Short-term investments and cash equivalents | ||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | ||
| Gross investment income | 34,837 | 46,315 |
| Available-for-sale | Fixed maturities | ||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | ||
| Gross investment income | 487,200 | 338,809 |
| Trading | Fixed maturities | ||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | ||
| Gross investment income | $ 47,203 | $ 31,669 |
Investments (Realized Investment Gains Losses, Net) (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||
|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
||||
| Schedule Of Gain Loss On Investments [Line Items] | |||||
| Realized Investment gains (losses), net | $ (106,374) | $ (2,805) | [1] | ||
| Fixed maturities | |||||
| Schedule Of Gain Loss On Investments [Line Items] | |||||
| Realized Investment gains (losses), net | (11,944) | (6,837) | |||
| Commercial mortgage and other loans | |||||
| Schedule Of Gain Loss On Investments [Line Items] | |||||
| Realized Investment gains (losses), net | (2,597) | (5,781) | |||
| LPs/LLCs | |||||
| Schedule Of Gain Loss On Investments [Line Items] | |||||
| Realized Investment gains (losses), net | (6) | 0 | |||
| Derivatives | |||||
| Schedule Of Gain Loss On Investments [Line Items] | |||||
| Realized Investment gains (losses), net | (49,859) | (5,351) | |||
| Short-term investments and cash equivalents | |||||
| Schedule Of Gain Loss On Investments [Line Items] | |||||
| Realized Investment gains (losses), net | (83) | (347) | |||
| Ceded income on modified coinsurance investments | |||||
| Schedule Of Gain Loss On Investments [Line Items] | |||||
| Realized Investment gains (losses), net | (176,702) | 33,505 | |||
| Other | |||||
| Schedule Of Gain Loss On Investments [Line Items] | |||||
| Realized Investment gains (losses), net | $ 134,817 | $ (17,994) | |||
| |||||
Investments (Net Unrealized Gains Losses on Investments by Asset Class) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Gain (Loss) on Securities [Line Items] | ||
| Net Unrealized Gains (Losses) on Investments | $ (1,501,425) | $ (1,846,285) |
| Fixed maturities | Available-for-sale | With an allowance | ||
| Gain (Loss) on Securities [Line Items] | ||
| Net Unrealized Gains (Losses) on Investments | 3,913 | 893 |
| Fixed maturities | Available-for-sale | Without an allowance | ||
| Gain (Loss) on Securities [Line Items] | ||
| Net Unrealized Gains (Losses) on Investments | (1,602,999) | (1,955,252) |
| Derivatives designated as cash flow hedges | ||
| Gain (Loss) on Securities [Line Items] | ||
| Net Unrealized Gains (Losses) on Investments | 95,244 | 110,565 |
| Affiliated notes | ||
| Gain (Loss) on Securities [Line Items] | ||
| Net Unrealized Gains (Losses) on Investments | (2,752) | (3,276) |
| Other investments | ||
| Gain (Loss) on Securities [Line Items] | ||
| Net Unrealized Gains (Losses) on Investments | $ 5,169 | $ 785 |
Investments (Repurchase Agreement and Securities Lending) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | $ 236,793 | $ 121,372 |
| Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 236,793 | 121,372 |
| Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| 30 days or greater | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| Obligations of U.S. states and their political subdivisions | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 1,139 |
| Obligations of U.S. states and their political subdivisions | Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 1,139 |
| Obligations of U.S. states and their political subdivisions | Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| Foreign government securities | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 975 | 0 |
| Foreign government securities | Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 975 | 0 |
| Foreign government securities | Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| U.S. public corporate securities | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 59,256 | 6,949 |
| U.S. public corporate securities | Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 59,256 | 6,949 |
| U.S. public corporate securities | Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| U.S. private corporate securities | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 18 |
| U.S. private corporate securities | Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 18 |
| U.S. private corporate securities | Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| Foreign public corporate securities | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 14,978 | 10,100 |
| Foreign public corporate securities | Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 14,978 | 10,100 |
| Foreign public corporate securities | Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| Equity securities | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 161,584 | 103,166 |
| Equity securities | Overnight & Continuous | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 161,584 | 103,166 |
| Equity securities | Up to 30 Days | ||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | $ 0 | $ 0 |
Derivative Instruments (Gross Notional Amount and Fair Value of Derivatives Contracts) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Derivative [Line Items] | ||
| Gross Notional | $ 388,747,778 | $ 358,596,065 |
| Assets | 12,753,979 | 15,332,694 |
| Liabilities | (26,322,221) | (27,242,213) |
| Derivatives Designated as Hedge Accounting Instruments: | ||
| Derivative [Line Items] | ||
| Gross Notional | 3,588,852 | 3,311,693 |
| Assets | 176,794 | 202,606 |
| Liabilities | (39,646) | (27,732) |
| Derivatives Designated as Hedge Accounting Instruments: | Interest Rate Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 2,805 | 2,851 |
| Assets | 0 | 0 |
| Liabilities | (146) | (209) |
| Derivatives Designated as Hedge Accounting Instruments: | Foreign Currency Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 3,586,047 | 3,308,842 |
| Assets | 176,794 | 202,606 |
| Liabilities | (39,500) | (27,523) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | ||
| Derivative [Line Items] | ||
| Gross Notional | 385,158,926 | 355,284,372 |
| Assets | 12,577,185 | 15,130,088 |
| Liabilities | (26,282,575) | (27,214,481) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 187,208,760 | 174,170,160 |
| Assets | 8,122,373 | 9,029,399 |
| Liabilities | (20,044,578) | (20,888,553) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Future | ||
| Derivative [Line Items] | ||
| Gross Notional | 847,100 | 1,518,400 |
| Assets | 1,268 | 1,967 |
| Liabilities | (408) | (1,443) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Foreign Currency Forwards | ||
| Derivative [Line Items] | ||
| Gross Notional | 1,463,163 | 1,146,861 |
| Assets | 1,573 | 30,078 |
| Liabilities | (28,151) | (181) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit Default Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 881,065 | 911,850 |
| Assets | 2,029 | 9,606 |
| Liabilities | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Foreign Currency Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 2,356,636 | 2,285,052 |
| Assets | 145,909 | 164,152 |
| Liabilities | (7,809) | (9,277) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity Options | ||
| Derivative [Line Items] | ||
| Gross Notional | 133,213,703 | 117,107,059 |
| Assets | 3,055,272 | 4,453,762 |
| Liabilities | (4,073,912) | (3,717,637) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Option | ||
| Derivative [Line Items] | ||
| Gross Notional | 28,680,000 | 29,135,000 |
| Assets | 176,217 | 279,414 |
| Liabilities | (1,250,893) | (1,406,265) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Forward | ||
| Derivative [Line Items] | ||
| Gross Notional | 0 | 0 |
| Assets | 0 | 0 |
| Liabilities | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Total Return Swap | ||
| Derivative [Line Items] | ||
| Gross Notional | 24,151,584 | 23,025,217 |
| Assets | 1,061,295 | 1,160,080 |
| Liabilities | (862,924) | (1,182,913) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity Future | ||
| Derivative [Line Items] | ||
| Gross Notional | 2,174,052 | 1,802,205 |
| Assets | 9,676 | 15 |
| Liabilities | (1,364) | (6,060) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Synthetic Gics | ||
| Derivative [Line Items] | ||
| Gross Notional | 3,959,550 | 3,958,847 |
| Assets | 32 | 143 |
| Liabilities | (12,536) | (31) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Total Return Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 223,313 | 223,721 |
| Assets | 1,541 | 1,472 |
| Liabilities | $ 0 | $ (2,121) |
Derivative Instruments (Offsetting Assets and Liabilities) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Offsetting Derivative Assets [Abstract] | ||
| Derivatives, Gross Amounts of Recognized Financial Instruments | $ 12,753,932 | $ 15,332,538 |
| Derivatives, Gross Amounts Offset in the Consolidated Statement of Financial Position | (12,673,497) | (15,308,195) |
| Derivatives, Net Amounts Presented in the Consolidated Statements of Financial Position | 80,435 | 24,343 |
| Derivatives, Financial Instruments/Collateral | 0 | 0 |
| Derivatives, Net Amount | 80,435 | 24,343 |
| Offsetting of Financial Assets, Total Assets | ||
| Total Assets, Gross Amounts of Recognized Financial Instruments | 12,753,932 | 15,332,538 |
| Total Assets, Gross Amounts Offset in the Consolidated Statement of Financial Position | (12,673,497) | (15,308,195) |
| Total Assets, Net Amounts Presented in the Consolidated Statements of Financial Position | 80,435 | 24,343 |
| Total Assets, Financial Instruments/Collateral | 0 | 0 |
| Total Assets, Net Amount | 80,435 | 24,343 |
| Offsetting of Financial Liabilities, Derivatives | ||
| Derivatives, Gross Amounts of Recognized Financial Instruments | 26,309,685 | 27,242,182 |
| Derivatives, Gross Amounts Offset in the Consolidated Statement of Financial Position | (22,085,694) | (23,619,586) |
| Derivatives, Net Amounts Presented in the Consolidated Statements of Financial Position | 4,223,991 | 3,622,596 |
| Derivatives, Financial Instruments/Collateral | (4,110,368) | (3,622,596) |
| Derivatives, Net Amount | 113,623 | 0 |
| Offsetting of Financial Liabilities, Total Liabilities | ||
| Total Liabilities, Gross Amounts of Recognized Financial Instruments | 26,309,685 | 27,242,182 |
| Total Liabilities, Gross Amounts Offset in the Consolidated Statement of Financial Position | (22,085,694) | (23,619,586) |
| Total Liabilities, Net Amounts Presented in the Consolidated Statements of Financial Position | 4,223,991 | 3,622,596 |
| Total Liabilities, Financial Instruments/Collateral | (4,110,368) | (3,622,596) |
| Total Liabilities, Net Amount | $ 113,623 | $ 0 |
Derivative Instruments (Financial Statement Classification and Impact of Derivatives Used in Qualifying and Non-qualifying Hedge Relationships) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Realized Investment Gains (Losses) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | $ (49,859) | $ (5,351) |
| Market Risk Benefit, Increase (Decrease) from Equity Market Change) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 286,755 | (1,286,793) |
| Net Investment Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 14,874 | 10,665 |
| Other Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | (25,235) | 12,529 |
| AOCI | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | (15,321) | 27,179 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Realized Investment Gains (Losses) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 5,433 | (107) |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Market Risk Benefit, Increase (Decrease) from Equity Market Change) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Net Investment Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 14,874 | 10,665 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Other Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | (25,255) | 12,346 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | AOCI | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | (15,321) | 27,179 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Interest Rate | Realized Investment Gains (Losses) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 1 | 1 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Interest Rate | Market Risk Benefit, Increase (Decrease) from Equity Market Change) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Interest Rate | Net Investment Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | (63) |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Interest Rate | Other Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Interest Rate | AOCI | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 11 | 11 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Currency/Interest Rate | Realized Investment Gains (Losses) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 5,432 | (108) |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Currency/Interest Rate | Market Risk Benefit, Increase (Decrease) from Equity Market Change) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Currency/Interest Rate | Net Investment Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 14,874 | 10,728 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Currency/Interest Rate | Other Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | (25,255) | 12,346 |
| Derivatives Designated as Hedge Accounting Instruments: | Cash flow hedges | Currency/Interest Rate | AOCI | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | (15,332) | 27,168 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Realized Investment Gains (Losses) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | (55,292) | (5,244) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Market Risk Benefit, Increase (Decrease) from Equity Market Change) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 286,755 | (1,286,793) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Net Investment Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Other Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 20 | 183 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | AOCI | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate | Realized Investment Gains (Losses) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 58,165 | 44,472 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate | Market Risk Benefit, Increase (Decrease) from Equity Market Change) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 97,184 | (855,925) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate | Net Investment Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate | Other Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate | AOCI | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency | Realized Investment Gains (Losses) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | (46,401) | 13,121 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency | Market Risk Benefit, Increase (Decrease) from Equity Market Change) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency | Net Investment Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency | Other Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency | AOCI | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency/Interest Rate | Realized Investment Gains (Losses) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | (12,496) | 31,976 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency/Interest Rate | Market Risk Benefit, Increase (Decrease) from Equity Market Change) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency/Interest Rate | Net Investment Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency/Interest Rate | Other Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 20 | 183 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Currency/Interest Rate | AOCI | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit | Realized Investment Gains (Losses) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | (2,863) | 7,886 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit | Market Risk Benefit, Increase (Decrease) from Equity Market Change) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit | Net Investment Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit | Other Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit | AOCI | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity | Realized Investment Gains (Losses) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | (1,496,519) | 1,426,177 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity | Market Risk Benefit, Increase (Decrease) from Equity Market Change) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 189,571 | (430,868) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity | Net Investment Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity | Other Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity | AOCI | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Embedded Derivatives | Realized Investment Gains (Losses) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 1,444,822 | (1,528,876) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Embedded Derivatives | Market Risk Benefit, Increase (Decrease) from Equity Market Change) | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Embedded Derivatives | Net Investment Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Embedded Derivatives | Other Income | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Embedded Derivatives | AOCI | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Derivative, gain (loss) on derivatives, net | $ 0 | $ 0 |
Derivative Instruments (Current Period Cash Flow Hedges in AOCI (loss) before Taxes) (Details) $ in Thousands |
3 Months Ended |
|---|---|
|
Mar. 31, 2025
USD ($)
| |
| AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |
| Begining Balance | $ 4,701,980 |
| Ending Balance | 5,468,127 |
| Derivatives designated as cash flow hedges | |
| AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |
| Begining Balance | 110,565 |
| Total amount recorded in AOCI | (20,269) |
| Total amount reclassified from AOCI to income | 4,948 |
| Ending Balance | 95,244 |
| Interest Rate | Derivatives designated as cash flow hedges | |
| AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |
| Total amount recorded in AOCI | 12 |
| Total amount reclassified from AOCI to income | (1) |
| Currency/Interest Rate | Derivatives designated as cash flow hedges | |
| AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] | |
| Total amount recorded in AOCI | (20,281) |
| Total amount reclassified from AOCI to income | $ 4,949 |
Derivative Instruments (Narrative) (Details) - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
|
| Derivative [Line Items] | ||
| Embedded Derivative, Fair Value of Embedded Derivative, Net | $ (11,017) | $ (11,968) |
| Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | 40 | |
| Credit Default Swaps Referencing Indices, Sell Protection | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 881 | 912 |
| Credit Risk Derivatives, at Fair Value, Net Asset | 2 | $ 10 |
| Credit Default Swaps Referencing Indices, Sell Protection | NAIC 3 | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 849 | |
| Credit Default Swaps Referencing Indices, Sell Protection | NAIC 6 | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | $ 32 |
Fair Value of Assets and Liabilities (Balances of Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
Mar. 31, 2024 |
|---|---|---|---|
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | $ 39,166,072 | $ 34,986,160 | |
| Market risk benefit assets | 2,508,967 | 2,637,363 | $ 2,537,000 |
| Fixed maturities, trading | 4,278,652 | 3,845,045 | |
| Equity securities | 2,384,261 | 2,623,820 | |
| Other invested assets | 2,040,612 | 1,582,094 | |
| Reinsurance recoverables and deposit receivables | 49,168,211 | 48,247,817 | |
| Receivables from parent and affiliates | 641,061 | 678,028 | |
| Separate account assets | 113,586,513 | 118,143,256 | |
| TOTAL ASSETS | 238,575,786 | 238,454,729 | |
| Market risk benefit liabilities | 4,803,284 | 4,281,244 | $ 4,388,000 |
| Payables to parent and affiliates | 4,267,511 | 3,653,848 | |
| Total liabilities | 233,107,659 | 233,752,749 | |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 1,080,660 | 1,099,241 | |
| Obligations of U.S. states and their political subdivisions | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 517,184 | 541,066 | |
| Foreign government securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 393,237 | 310,334 | |
| U.S. corporate public securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 15,560,822 | 13,238,428 | |
| U.S. corporate private securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 6,308,786 | 5,754,097 | |
| Foreign corporate public securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 4,373,302 | 3,698,851 | |
| Foreign corporate private securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 5,780,039 | 5,341,633 | |
| Asset-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 3,816,356 | 3,750,663 | |
| Commercial mortgage-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 981,540 | 895,775 | |
| Residential mortgage-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 354,146 | 356,072 | |
| Fair Value, Measurements, Recurring | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 39,166,072 | 34,986,160 | |
| Market risk benefit assets | 2,508,967 | 2,637,363 | |
| Fixed maturities, trading | 4,278,652 | 3,845,045 | |
| Equity securities | 2,384,261 | 2,623,820 | |
| Short-term investments | 459,613 | 496,285 | |
| Cash equivalents | 1,828,424 | 2,851,283 | |
| Other invested assets | 80,482 | 24,499 | |
| Reinsurance recoverables and deposit receivables | 716,745 | 645,193 | |
| Receivables from parent and affiliates | 567,031 | 520,462 | |
| Subtotal excluding separate account assets | 51,990,247 | 48,630,110 | |
| Separate account assets | 106,781,195 | 111,699,552 | |
| TOTAL ASSETS | 158,771,442 | 160,329,662 | |
| Market risk benefit liabilities | 4,803,284 | 4,281,244 | |
| Policyholders’ account balances | 11,817,734 | 12,624,585 | |
| Payables to parent and affiliates | 4,218,150 | 3,615,277 | |
| Other liabilities | 18,377 | 7,350 | |
| Total liabilities | 20,857,545 | 20,528,456 | |
| Assets netting | (12,673,497) | (15,308,195) | |
| Liabilities netting | (22,085,694) | (23,619,586) | |
| Derivative liability, cash collateral | (9,412,000) | (8,311,000) | |
| Fair Value, Measurements, Recurring | Payables to parent and affiliates | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Liabilities netting | (22,078,754) | (23,617,643) | |
| Fair Value, Measurements, Recurring | Other liabilities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Liabilities netting | (6,940) | (1,943) | |
| Fair Value, Measurements, Recurring | U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 1,080,660 | 1,099,241 | |
| Fair Value, Measurements, Recurring | Obligations of U.S. states and their political subdivisions | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 517,184 | 541,066 | |
| Fair Value, Measurements, Recurring | Foreign government securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 393,237 | 310,334 | |
| Fair Value, Measurements, Recurring | U.S. corporate public securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 15,560,822 | 13,238,428 | |
| Fair Value, Measurements, Recurring | U.S. corporate private securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 6,308,786 | 5,754,097 | |
| Fair Value, Measurements, Recurring | Foreign corporate public securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 4,373,302 | 3,698,851 | |
| Fair Value, Measurements, Recurring | Foreign corporate private securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 5,780,039 | 5,341,633 | |
| Fair Value, Measurements, Recurring | Asset-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 3,816,356 | 3,750,663 | |
| Fair Value, Measurements, Recurring | Commercial mortgage-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 981,540 | 895,775 | |
| Fair Value, Measurements, Recurring | Residential mortgage-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 354,146 | 356,072 | |
| Fair Value, Measurements, Recurring | Level 1 | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Market risk benefit assets | 0 | 0 | |
| Fixed maturities, trading | 0 | 0 | |
| Equity securities | 2,342,713 | 2,587,791 | |
| Short-term investments | 0 | 0 | |
| Cash equivalents | 0 | 0 | |
| Other invested assets | 12,288 | 2,302 | |
| Reinsurance recoverables and deposit receivables | 0 | 0 | |
| Receivables from parent and affiliates | 0 | 0 | |
| Subtotal excluding separate account assets | 2,355,001 | 2,590,093 | |
| Separate account assets | 319,136 | 273,288 | |
| TOTAL ASSETS | 2,674,137 | 2,863,381 | |
| Market risk benefit liabilities | 0 | 0 | |
| Policyholders’ account balances | 0 | 0 | |
| Payables to parent and affiliates | 0 | 0 | |
| Other liabilities | 7,660 | 7,988 | |
| Total liabilities | 7,660 | 7,988 | |
| Fair Value, Measurements, Recurring | Level 1 | U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 1 | Obligations of U.S. states and their political subdivisions | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 1 | Foreign government securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 1 | U.S. corporate public securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 1 | U.S. corporate private securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 1 | Foreign corporate public securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 1 | Foreign corporate private securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 1 | Asset-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 1 | Commercial mortgage-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 1 | Residential mortgage-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 2 | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 36,793,550 | 33,086,013 | |
| Market risk benefit assets | 0 | 0 | |
| Fixed maturities, trading | 4,126,571 | 3,778,760 | |
| Equity securities | 21,274 | 15,514 | |
| Short-term investments | 354,852 | 390,745 | |
| Cash equivalents | 1,828,321 | 2,851,250 | |
| Other invested assets | 12,741,659 | 15,330,249 | |
| Reinsurance recoverables and deposit receivables | 0 | 0 | |
| Receivables from parent and affiliates | 187,671 | 169,072 | |
| Subtotal excluding separate account assets | 56,053,898 | 55,621,603 | |
| Separate account assets | 106,449,817 | 111,415,717 | |
| TOTAL ASSETS | 162,503,715 | 167,037,320 | |
| Market risk benefit liabilities | 0 | 0 | |
| Policyholders’ account balances | 0 | 0 | |
| Payables to parent and affiliates | 26,296,904 | 27,232,920 | |
| Other liabilities | 5,153 | 1,274 | |
| Total liabilities | 26,302,057 | 27,234,194 | |
| Fair Value, Measurements, Recurring | Level 2 | U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 1,080,660 | 1,099,241 | |
| Fair Value, Measurements, Recurring | Level 2 | Obligations of U.S. states and their political subdivisions | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 517,184 | 541,066 | |
| Fair Value, Measurements, Recurring | Level 2 | Foreign government securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 393,237 | 309,686 | |
| Fair Value, Measurements, Recurring | Level 2 | U.S. corporate public securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 15,560,822 | 13,238,428 | |
| Fair Value, Measurements, Recurring | Level 2 | U.S. corporate private securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 5,307,604 | 4,996,400 | |
| Fair Value, Measurements, Recurring | Level 2 | Foreign corporate public securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 4,366,433 | 3,692,124 | |
| Fair Value, Measurements, Recurring | Level 2 | Foreign corporate private securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 5,346,922 | 4,906,450 | |
| Fair Value, Measurements, Recurring | Level 2 | Asset-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 2,961,274 | 3,126,089 | |
| Fair Value, Measurements, Recurring | Level 2 | Commercial mortgage-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 905,268 | 820,457 | |
| Fair Value, Measurements, Recurring | Level 2 | Residential mortgage-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 354,146 | 356,072 | |
| Fair Value, Measurements, Recurring | Level 3 | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 2,372,522 | 1,900,147 | |
| Market risk benefit assets | 2,508,967 | 2,637,363 | |
| Fixed maturities, trading | 152,081 | 66,285 | |
| Equity securities | 20,274 | 20,515 | |
| Short-term investments | 104,761 | 105,540 | |
| Cash equivalents | 103 | 33 | |
| Other invested assets | 32 | 143 | |
| Reinsurance recoverables and deposit receivables | 716,745 | 645,193 | |
| Receivables from parent and affiliates | 379,360 | 351,390 | |
| Subtotal excluding separate account assets | 6,254,845 | 5,726,609 | |
| Separate account assets | 12,242 | 10,547 | |
| TOTAL ASSETS | 6,267,087 | 5,737,156 | |
| Market risk benefit liabilities | 4,803,284 | 4,281,244 | |
| Policyholders’ account balances | 11,817,734 | 12,624,585 | |
| Payables to parent and affiliates | 0 | 0 | |
| Other liabilities | 12,504 | 31 | |
| Total liabilities | 16,633,522 | 16,905,860 | |
| Fair Value, Measurements, Recurring | Level 3 | U.S. Treasury securities and obligations of U.S. government authorities and agencies | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 3 | Obligations of U.S. states and their political subdivisions | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 3 | Foreign government securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 648 | |
| Fair Value, Measurements, Recurring | Level 3 | U.S. corporate public securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Fair Value, Measurements, Recurring | Level 3 | U.S. corporate private securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 1,001,182 | 757,697 | |
| Fair Value, Measurements, Recurring | Level 3 | Foreign corporate public securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 6,869 | 6,727 | |
| Fair Value, Measurements, Recurring | Level 3 | Foreign corporate private securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 433,117 | 435,183 | |
| Fair Value, Measurements, Recurring | Level 3 | Asset-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 855,082 | 624,574 | |
| Fair Value, Measurements, Recurring | Level 3 | Commercial mortgage-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 76,272 | 75,318 | |
| Fair Value, Measurements, Recurring | Level 3 | Residential mortgage-backed securities | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fixed maturities, available-for-sale | 0 | 0 | |
| Other invested assets | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fair value investment measured at NAV per share | 40,000 | 44,000 | |
| Separate account assets | |||
| Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Fair value investment measured at NAV per share | $ 6,805,000 | $ 6,444,000 |
Fair Value of Assets and Liabilities (Quantitative Info for Level 3 Inputs) (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
Mar. 31, 2024 |
|
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Corporate securities | $ 2,478,826 | $ 2,650,542 | |
| Market risk benefit assets | 2,508,967 | 2,637,363 | $ 2,537,000 |
| Reinsurance recoverables and deposit receivables | 49,168,211 | 48,247,817 | |
| Receivables from parent and affiliates | 641,061 | 678,028 | |
| Market risk benefit liabilities | 4,803,284 | 4,281,244 | $ 4,388,000 |
| Fair Value, Measurements, Recurring | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Market risk benefit assets | 2,508,967 | 2,637,363 | |
| Reinsurance recoverables and deposit receivables | 716,745 | 645,193 | |
| Receivables from parent and affiliates | 567,031 | 520,462 | |
| Market risk benefit liabilities | 4,803,284 | 4,281,244 | |
| Policyholders’ account balances | 11,817,734 | 12,624,585 | |
| Level 3 | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Funds held under reinsurance agreements | $ 10,000,000 | ||
| Level 3 | Minimum | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Fair Value Inputs, Policyholder Age | 50 years | ||
| Level 3 | Minimum | Market risk benefit liabilities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Mortality rate | 0.00% | ||
| Level 3 | Maximum | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Fair Value Inputs, Policyholder Age | 90 years | ||
| Level 3 | Fair Value, Measurements, Recurring | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Market risk benefit assets | $ 2,508,967 | 2,637,363 | |
| Reinsurance recoverables and deposit receivables | 716,745 | 645,193 | |
| Receivables from parent and affiliates | 379,360 | 351,390 | |
| Market risk benefit liabilities | 4,803,284 | 4,281,244 | |
| Policyholders’ account balances | $ 11,817,734 | $ 12,624,585 | |
| Level 3 | Internal | Minimum | Discounted cash flow | Market risk benefit liabilities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Lapse rate | 1.00% | 1.00% | |
| Spread over SOFR | 0.41% | 0.29% | |
| Utilization rate | 37.00% | 37.00% | |
| Withdrawal rate (greater than maximum range) | 78.00% | 78.00% | |
| Mortality rate | 0.00% | 0.00% | |
| Equity volatility curve | 16.00% | 16.00% | |
| Level 3 | Internal | Minimum | Discounted cash flow | Policyholders' account balances | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Lapse rate | 0.00% | 0.00% | |
| Spread over SOFR | 0.41% | 0.29% | |
| Mortality rate | 0.00% | 0.00% | |
| Option budget | (1.00%) | (1.00%) | |
| Level 3 | Internal | Minimum | Discounted cash flow | Corporate securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Discount rate | 5.74% | 2.15% | |
| Level 3 | Internal | Minimum | Discounted cash flow | Asset-backed securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Discount rate | 2.43% | 2.30% | |
| Liquidity premium | 1.90% | ||
| Level 3 | Internal | Minimum | Discounted cash flow | Commercial mortgage-backed securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Liquidity premium | 0.90% | 1.00% | |
| Level 3 | Internal | Minimum | Discounted cash flow | Market risk benefit assets | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Lapse rate | 1.00% | 1.00% | |
| Spread over SOFR | 0.41% | 0.29% | |
| Utilization rate | 37.00% | 37.00% | |
| Withdrawal rate (greater than maximum range) | 78.00% | 78.00% | |
| Mortality rate | 0.00% | 0.00% | |
| Equity volatility curve | 16.00% | 16.00% | |
| Level 3 | Internal | Minimum | Discounted cash flow | Reinsurance recoverables and deposit receivables | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Lapse rate | 0.00% | 0.00% | |
| Spread over SOFR | 0.41% | 0.29% | |
| Option budget | (1.00%) | (1.00%) | |
| Level 3 | Internal | Minimum | Market comparables | Corporate securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| EBITDA multiples | 5.0 | 5.0 | |
| Level 3 | Internal | Minimum | Liquidation | Corporate securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Liquidation value | 29.66% | 75.00% | |
| Level 3 | Internal | Minimum | Liquidation | Receivables from parent and affiliates | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Liquidation value | 100.00% | 100.00% | |
| Level 3 | Internal | Maximum | Discounted cash flow | Market risk benefit liabilities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Lapse rate | 20.00% | 20.00% | |
| Spread over SOFR | 1.84% | 1.79% | |
| Utilization rate | 94.00% | 94.00% | |
| Withdrawal rate (greater than maximum range) | 100.00% | 100.00% | |
| Mortality rate | 16.00% | 16.00% | |
| Equity volatility curve | 25.00% | 25.00% | |
| Level 3 | Internal | Maximum | Discounted cash flow | Policyholders' account balances | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Lapse rate | 80.00% | 80.00% | |
| Spread over SOFR | 1.83% | 1.73% | |
| Mortality rate | 23.00% | 23.00% | |
| Option budget | 7.00% | 7.00% | |
| Level 3 | Internal | Maximum | Discounted cash flow | Corporate securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Discount rate | 21.50% | 20.00% | |
| Level 3 | Internal | Maximum | Discounted cash flow | Asset-backed securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Discount rate | 10.10% | 10.70% | |
| Liquidity premium | 1.90% | ||
| Level 3 | Internal | Maximum | Discounted cash flow | Commercial mortgage-backed securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Liquidity premium | 0.90% | 1.00% | |
| Level 3 | Internal | Maximum | Discounted cash flow | Market risk benefit assets | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Lapse rate | 20.00% | 20.00% | |
| Spread over SOFR | 1.84% | 1.79% | |
| Utilization rate | 94.00% | 94.00% | |
| Withdrawal rate (greater than maximum range) | 100.00% | 100.00% | |
| Mortality rate | 16.00% | 16.00% | |
| Equity volatility curve | 25.00% | 25.00% | |
| Level 3 | Internal | Maximum | Discounted cash flow | Reinsurance recoverables and deposit receivables | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Lapse rate | 80.00% | 80.00% | |
| Spread over SOFR | 1.83% | 1.71% | |
| Option budget | 7.00% | 7.00% | |
| Level 3 | Internal | Maximum | Market comparables | Corporate securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| EBITDA multiples | 5.0 | 5.0 | |
| Level 3 | Internal | Maximum | Liquidation | Corporate securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Liquidation value | 84.21% | 75.00% | |
| Level 3 | Internal | Maximum | Liquidation | Receivables from parent and affiliates | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Liquidation value | 100.00% | 100.00% | |
| Level 3 | Internal | Weighted Average | Discounted cash flow | Corporate securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Discount rate | 11.08% | 11.15% | |
| Level 3 | Internal | Weighted Average | Discounted cash flow | Asset-backed securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Discount rate | 4.35% | 6.18% | |
| Liquidity premium | 1.90% | ||
| Level 3 | Internal | Weighted Average | Discounted cash flow | Commercial mortgage-backed securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Liquidity premium | 0.90% | 1.00% | |
| Level 3 | Internal | Weighted Average | Market comparables | Corporate securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| EBITDA multiples | 5.0 | 5.0 | |
| Level 3 | Internal | Weighted Average | Liquidation | Corporate securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Liquidation value | 75.45% | 75.00% | |
| Level 3 | Internal | Weighted Average | Liquidation | Receivables from parent and affiliates | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Liquidation value | 100.00% | 100.00% | |
| Level 3 | Internal | Fair Value, Measurements, Recurring | Market risk benefit liabilities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Market risk benefit liabilities | $ 4,803,284 | $ 4,281,244 | |
| Level 3 | Internal | Fair Value, Measurements, Recurring | Policyholders' account balances | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Policyholders’ account balances | 11,817,734 | 12,624,585 | |
| Level 3 | Internal | Fair Value, Measurements, Recurring | Corporate securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Corporate securities | 1,360,498 | 1,130,627 | |
| Level 3 | Internal | Fair Value, Measurements, Recurring | Asset-backed securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Asset backed securities | 104,566 | 90,370 | |
| Level 3 | Internal | Fair Value, Measurements, Recurring | Commercial mortgage-backed securities | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Commercial mortgage-backed securities | 76,272 | 75,318 | |
| Level 3 | Internal | Fair Value, Measurements, Recurring | Market risk benefit assets | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Market risk benefit assets | 2,508,967 | 2,637,363 | |
| Level 3 | Internal | Fair Value, Measurements, Recurring | Reinsurance recoverables and deposit receivables | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Reinsurance recoverables and deposit receivables | 716,745 | 645,193 | |
| Level 3 | Internal | Fair Value, Measurements, Recurring | Receivables from parent and affiliates | |||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | |||
| Receivables from parent and affiliates | $ 374,029 | $ 328,001 |
Fair Value of Assets and Liabilities (Changes in Level 3 Assets and Liabilities) (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
|
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Market risk benefit assets | $ 2,508,967 | $ 2,537,000 | $ 2,637,363 |
| Market risk benefit liabilities | 4,803,284 | 4,388,000 | $ 4,281,244 |
| Equity securities | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 20,515 | 28,709 | |
| Purchases | 0 | 273 | |
| Sales | 0 | 0 | |
| Issuances | 0 | 0 | |
| Settlements | 0 | 0 | |
| Other | 0 | 0 | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 20,274 | 28,650 | |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (241) | (332) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (241) | (332) | |
| Equity securities | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Equity securities | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (241) | (332) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (241) | (332) | |
| Equity securities | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Equity securities | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Equity securities | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Other invested assets | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 143 | 1 | |
| Purchases | 0 | (1) | |
| Sales | 0 | 0 | |
| Issuances | 0 | 0 | |
| Settlements | 0 | 0 | |
| Other | 0 | 0 | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 32 | 1 | |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (111) | 1 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (111) | 1 | |
| Other invested assets | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (111) | 1 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (111) | 1 | |
| Other invested assets | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Other invested assets | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Other invested assets | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Other invested assets | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Short-term investments | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 105,540 | 1,759 | |
| Purchases | 2,500 | 2,002 | |
| Sales | (1,524) | 0 | |
| Issuances | 0 | 0 | |
| Settlements | (34) | (94) | |
| Other | (1,398) | 0 | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 104,761 | 3,351 | |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (323) | (316) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (323) | (316) | |
| Short-term investments | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 28 | (316) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 28 | (316) | |
| Short-term investments | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Short-term investments | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Short-term investments | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (351) | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (351) | 0 | |
| Short-term investments | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Cash equivalents | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 33 | ||
| Purchases | 206 | ||
| Sales | 0 | ||
| Issuances | 0 | ||
| Settlements | (16) | ||
| Other | (33) | ||
| Transfers into Level 3 | 0 | ||
| Transfers out of Level 3 | 0 | ||
| Fair Value, end of period | 103 | ||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (87) | ||
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (87) | ||
| Cash equivalents | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (87) | ||
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (87) | ||
| Cash equivalents | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | ||
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | ||
| Cash equivalents | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | ||
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | ||
| Cash equivalents | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | ||
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | ||
| Cash equivalents | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | ||
| Receivables from parents and affiliates | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 351,390 | 0 | |
| Purchases | 55,295 | 121,378 | |
| Sales | (9,253) | 0 | |
| Issuances | 0 | 0 | |
| Settlements | (2,789) | 0 | |
| Other | 5,867 | 0 | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | (18,098) | 0 | |
| Fair Value, end of period | 379,360 | 121,378 | |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (3,052) | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (3,093) | 0 | |
| Receivables from parents and affiliates | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (4,071) | ||
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (3,899) | ||
| Receivables from parents and affiliates | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | ||
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | ||
| Receivables from parents and affiliates | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | ||
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | ||
| Receivables from parents and affiliates | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 1,019 | ||
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 806 | ||
| Receivables from parents and affiliates | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | ||
| Reinsurance recoverables and deposit receivables | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 645,193 | 192,642 | |
| Purchases | 72,293 | 72,576 | |
| Sales | 0 | 0 | |
| Issuances | 0 | 0 | |
| Settlements | 0 | 0 | |
| Other | 0 | 0 | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 716,745 | 250,878 | |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (741) | (14,340) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 41,155 | (51,458) | |
| Reinsurance recoverables and deposit receivables | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (741) | (14,340) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 41,155 | (51,458) | |
| Reinsurance recoverables and deposit receivables | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Reinsurance recoverables and deposit receivables | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Reinsurance recoverables and deposit receivables | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Reinsurance recoverables and deposit receivables | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Separate account assets | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 10,547 | 5,985 | |
| Purchases | 1,876 | 2,633 | |
| Sales | (69) | (1,256) | |
| Issuances | 0 | 0 | |
| Settlements | (11) | (125) | |
| Other | 0 | 0 | |
| Transfers into Level 3 | 0 | 458 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 12,242 | 7,894 | |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (101) | 199 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (101) | 200 | |
| Separate account assets | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Separate account assets | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Separate account assets | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (101) | 199 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (101) | 200 | |
| Separate account assets | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Separate account assets | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Policyholders' account balances | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | (12,624,585) | (7,697,627) | |
| Purchases | 0 | 0 | |
| Sales | 0 | 0 | |
| Issuances | (627,295) | (560,400) | |
| Settlements | 0 | 0 | |
| Other | 0 | 813 | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | (11,817,734) | (9,752,538) | |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 1,434,146 | (1,495,324) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 403,703 | (134,807) | |
| Policyholders' account balances | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 1,434,146 | (1,495,324) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 403,703 | (134,807) | |
| Policyholders' account balances | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Policyholders' account balances | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Policyholders' account balances | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Policyholders' account balances | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Other liabilities | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | (31) | 0 | |
| Purchases | 0 | 0 | |
| Sales | 0 | 0 | |
| Issuances | 0 | 0 | |
| Settlements | 0 | 0 | |
| Other | 0 | 0 | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | (12,504) | (207) | |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (12,473) | (207) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (12,473) | (207) | |
| Other liabilities | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (12,473) | (207) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (12,473) | (207) | |
| Other liabilities | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Other liabilities | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Other liabilities | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Other liabilities | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Available-for-sale | Fixed maturities | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (6,667) | (1,696) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (6,178) | 626 | |
| Available-for-sale | Fixed maturities | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Available-for-sale | Fixed maturities | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Available-for-sale | Fixed maturities | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 8,780 | (9,842) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 8,900 | (10,521) | |
| Available-for-sale | Fixed maturities | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (942) | 598 | |
| Available-for-sale | Fixed maturities | Foreign government securities | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 648 | 682 | |
| Purchases | 0 | 0 | |
| Sales | 0 | 0 | |
| Issuances | 0 | 0 | |
| Settlements | (640) | 0 | |
| Other | 0 | 0 | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 0 | 671 | |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (8) | (11) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | (13) | |
| Available-for-sale | Fixed maturities | Corporate securities | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 1,199,607 | 1,014,343 | |
| Purchases | 416,528 | 125,041 | |
| Sales | (159,562) | (65,052) | |
| Issuances | 0 | 0 | |
| Settlements | (40,372) | (53,892) | |
| Other | (4,435) | 0 | |
| Transfers into Level 3 | 31,000 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 1,441,168 | 1,009,650 | |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (1,598) | (10,790) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (759) | (9,602) | |
| Available-for-sale | Fixed maturities | Structured securities | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 699,892 | 177,237 | |
| Purchases | 321,883 | 484,340 | |
| Sales | (203,502) | 0 | |
| Issuances | 0 | 0 | |
| Settlements | (36,655) | (1,895) | |
| Other | (58,357) | 0 | |
| Transfers into Level 3 | 261,816 | 34,578 | |
| Transfers out of Level 3 | (56,500) | 0 | |
| Fair Value, end of period | 931,354 | 694,121 | |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 2,777 | (139) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 3,481 | (280) | |
| Trading | Fixed maturities | |||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 66,285 | 34,048 | |
| Purchases | 82,403 | 113,343 | |
| Sales | 0 | 0 | |
| Issuances | 0 | 0 | |
| Settlements | (26,130) | 0 | |
| Other | 58,357 | 0 | |
| Transfers into Level 3 | 2,001 | 0 | |
| Transfers out of Level 3 | (34,428) | 0 | |
| Fair Value, end of period | 152,081 | 146,543 | |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 3,593 | (848) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 6,190 | (848) | |
| Trading | Fixed maturities | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Trading | Fixed maturities | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 6,190 | (848) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 6,190 | (848) | |
| Trading | Fixed maturities | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Trading | Fixed maturities | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Trading | Fixed maturities | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | $ (2,597) | $ 0 | |
Fair Value of Assets and Liabilities (Financial Instruments where Carrying Amounts and Fair Values May Differ) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Assets: | ||
| Policy loans | $ 1,556,658 | $ 1,541,480 |
| Cash and cash equivalents | 2,102,338 | 3,325,698 |
| Accrued investment income | 502,312 | 466,394 |
| Reinsurance recoverables and deposit receivables | 49,168,211 | 48,247,817 |
| Receivables from parent and affiliates | 641,061 | 678,028 |
| Liabilities | ||
| Cash collateral for loaned securities | 236,793 | 121,372 |
| Fair Value | ||
| Assets: | ||
| Commercial mortgage and other loans | 7,943,756 | 7,534,909 |
| Policy loans | 1,556,658 | 1,541,480 |
| Short-term investments | 101 | 21,101 |
| Cash and cash equivalents | 273,914 | 474,415 |
| Accrued investment income | 502,312 | 466,394 |
| Reinsurance recoverables and deposit receivables | 2,347,998 | 2,355,489 |
| Receivables from parent and affiliates | 74,030 | 157,566 |
| Other assets | 184,107 | 203,493 |
| Total assets | 12,882,876 | 12,754,847 |
| Liabilities | ||
| Policyholders’ account balances - investment contracts | 11,752,336 | 10,811,361 |
| Cash collateral for loaned securities | 236,793 | 121,372 |
| Reinsurance and funds withheld payable | 2,643,105 | 2,602,140 |
| Payables to parent and affiliates | 49,361 | 38,571 |
| Other liabilities | 925,587 | 880,884 |
| Total liabilities | 15,607,182 | 14,454,328 |
| Carrying Amount | ||
| Assets: | ||
| Commercial mortgage and other loans | 8,054,419 | 7,759,323 |
| Policy loans | 1,556,658 | 1,541,480 |
| Short-term investments | 101 | 21,101 |
| Cash and cash equivalents | 273,914 | 474,415 |
| Accrued investment income | 502,312 | 466,394 |
| Reinsurance recoverables and deposit receivables | 2,349,003 | 2,357,292 |
| Receivables from parent and affiliates | 74,030 | 157,566 |
| Other assets | 184,107 | 203,493 |
| Total assets | 12,994,544 | 12,981,064 |
| Liabilities | ||
| Policyholders’ account balances - investment contracts | 11,764,366 | 10,826,931 |
| Cash collateral for loaned securities | 236,793 | 121,372 |
| Reinsurance and funds withheld payable | 2,643,105 | 2,602,140 |
| Payables to parent and affiliates | 49,361 | 38,571 |
| Other liabilities | 925,587 | 880,884 |
| Total liabilities | 15,619,212 | 14,469,898 |
| Level 1 | Fair Value | ||
| Assets: | ||
| Commercial mortgage and other loans | 0 | 0 |
| Policy loans | 0 | 0 |
| Short-term investments | 0 | 21,101 |
| Cash and cash equivalents | 263,914 | 474,415 |
| Accrued investment income | 0 | 0 |
| Reinsurance recoverables and deposit receivables | 0 | 0 |
| Receivables from parent and affiliates | 0 | 0 |
| Other assets | 0 | 0 |
| Total assets | 263,914 | 495,516 |
| Liabilities | ||
| Policyholders’ account balances - investment contracts | 0 | 0 |
| Cash collateral for loaned securities | 0 | 0 |
| Reinsurance and funds withheld payable | 0 | 0 |
| Payables to parent and affiliates | 0 | 0 |
| Other liabilities | 0 | 0 |
| Total liabilities | 0 | 0 |
| Level 2 | Fair Value | ||
| Assets: | ||
| Commercial mortgage and other loans | 0 | 0 |
| Policy loans | 0 | 0 |
| Short-term investments | 101 | 0 |
| Cash and cash equivalents | 10,000 | 0 |
| Accrued investment income | 502,312 | 466,394 |
| Reinsurance recoverables and deposit receivables | 0 | 0 |
| Receivables from parent and affiliates | 74,030 | 157,566 |
| Other assets | 184,107 | 203,493 |
| Total assets | 770,550 | 827,453 |
| Liabilities | ||
| Policyholders’ account balances - investment contracts | 803,362 | 815,520 |
| Cash collateral for loaned securities | 236,793 | 121,372 |
| Reinsurance and funds withheld payable | 2,643,105 | 2,602,140 |
| Payables to parent and affiliates | 49,361 | 38,571 |
| Other liabilities | 893,981 | 849,278 |
| Total liabilities | 4,626,602 | 4,426,881 |
| Level 3 | Fair Value | ||
| Assets: | ||
| Commercial mortgage and other loans | 7,943,756 | 7,534,909 |
| Policy loans | 1,556,658 | 1,541,480 |
| Short-term investments | 0 | 0 |
| Cash and cash equivalents | 0 | 0 |
| Accrued investment income | 0 | 0 |
| Reinsurance recoverables and deposit receivables | 2,347,998 | 2,355,489 |
| Receivables from parent and affiliates | 0 | 0 |
| Other assets | 0 | 0 |
| Total assets | 11,848,412 | 11,431,878 |
| Liabilities | ||
| Policyholders’ account balances - investment contracts | 10,948,974 | 9,995,841 |
| Cash collateral for loaned securities | 0 | 0 |
| Reinsurance and funds withheld payable | 0 | 0 |
| Payables to parent and affiliates | 0 | 0 |
| Other liabilities | 31,606 | 31,606 |
| Total liabilities | $ 10,980,580 | $ 10,027,447 |
Deferred Policy Acquisition Costs, Deferred Reinsurance, and Deferred Sales Inducements (DAC) (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||
|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||
| Balance, beginning of period | $ 7,807,060 | $ 7,144,736 | |||
| Capitalization | 358,789 | 342,130 | |||
| Amortization expense | (160,223) | 129,157 | [1] | ||
| Amortization expense | (147,664) | ||||
| Other | (1,165) | (38,017) | |||
| Balance, end of period | 8,004,461 | 7,301,185 | |||
| Fixed Annuities | |||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||
| Balance, beginning of period | 371,642 | 197,937 | |||
| Capitalization | 42,749 | 64,744 | |||
| Amortization expense | (13,216) | ||||
| Amortization expense | (8,725) | ||||
| Other | (1,236) | 0 | |||
| Balance, end of period | 399,939 | 253,956 | |||
| Variable Annuities | |||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||
| Balance, beginning of period | 3,373,201 | 3,298,935 | |||
| Capitalization | 116,925 | 87,337 | |||
| Amortization expense | (96,183) | ||||
| Amortization expense | (86,116) | ||||
| Other | 0 | 0 | |||
| Balance, end of period | 3,393,943 | 3,300,156 | |||
| Term Life | |||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||
| Balance, beginning of period | 614,068 | 743,888 | |||
| Capitalization | 43,182 | 43,874 | |||
| Amortization expense | (11,901) | ||||
| Amortization expense | (18,180) | ||||
| Other | 0 | 0 | |||
| Balance, end of period | 645,349 | 769,582 | |||
| Variable/Universal Life | |||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||
| Balance, beginning of period | 3,448,149 | 2,903,976 | |||
| Capitalization | 155,933 | 146,175 | |||
| Amortization expense | (38,923) | ||||
| Amortization expense | (34,643) | ||||
| Other | 71 | (38,017) | |||
| Balance, end of period | $ 3,565,230 | $ 2,977,491 | |||
| |||||
Deferred Policy Acquisition Costs, Deferred Reinsurance, and Deferred Sales Inducements (DRL) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | $ 1,530,394 | $ 255,113 |
| Amortization expense | (26,622) | (9,011) |
| Other | (2) | 1 |
| Balance, end of period | 1,503,770 | 246,103 |
| Variable Annuities | ||
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 164,238 | 194,110 |
| Amortization expense | (7,668) | (7,040) |
| Other | (2) | 1 |
| Balance, end of period | 156,568 | 187,071 |
| Term Life | ||
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 396,684 | 61,003 |
| Amortization expense | (9,458) | (1,971) |
| Other | 0 | 0 |
| Balance, end of period | 387,226 | 59,032 |
| Variable/Universal Life | ||
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 969,472 | 0 |
| Amortization expense | (9,496) | 0 |
| Other | 0 | 0 |
| Balance, end of period | $ 959,976 | $ 0 |
Deferred Policy Acquisition Costs, Deferred Reinsurance, and Deferred Sales Inducements (DRG) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | ||
| Balance, beginning of period | $ 3,318,785 | $ 1,673,290 |
| Amortization expense | (41,819) | (38,388) |
| Other | 13,723 | 1,099,783 |
| Foreign currency adjustment | 107 | |
| Balance, end of period | 3,290,796 | 2,734,685 |
| Fixed Annuities | ||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | ||
| Balance, beginning of period | 37,548 | 48,073 |
| Amortization expense | (2,460) | (2,688) |
| Other | (8) | (9) |
| Foreign currency adjustment | 0 | |
| Balance, end of period | 35,080 | 45,376 |
| Variable Annuities | ||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | ||
| Balance, beginning of period | 241,628 | 261,721 |
| Amortization expense | (4,908) | (5,056) |
| Other | 33 | (40) |
| Foreign currency adjustment | 0 | |
| Balance, end of period | 236,753 | 256,625 |
| Variable/Universal Life | ||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | ||
| Balance, beginning of period | 3,039,609 | 1,363,496 |
| Amortization expense | (34,289) | (30,644) |
| Other | 0 | 1,099,832 |
| Foreign currency adjustment | 0 | |
| Balance, end of period | 3,005,320 | 2,432,684 |
| Variable/Universal Life | Somerset Re | ||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | ||
| Other | 1,207,000 | |
| Variable/Universal Life | PURC | ||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | ||
| Other | 116,000 | |
| International | ||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | ||
| Balance, beginning of period | 0 | 0 |
| Amortization expense | (162) | 0 |
| Other | 13,698 | 0 |
| Foreign currency adjustment | 107 | |
| Balance, end of period | 13,643 | $ 0 |
| International | Prudential of Japan | ||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | ||
| Balance, end of period | $ 14,000 | |
Deferred Policy Acquisition Costs, Deferred Reinsurance, and Deferred Sales Inducements (DSI) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Movement in Deferred Sales Inducements [Roll Forward] | ||
| Balance, beginning of period | $ 322,351 | |
| Balance, end of period | 316,062 | |
| Variable Annuities | ||
| Movement in Deferred Sales Inducements [Roll Forward] | ||
| Balance, beginning of period | 322,351 | $ 351,424 |
| Capitalization | 1,018 | 1,253 |
| Amortization expense | (7,307) | (7,784) |
| Balance, end of period | $ 316,062 | $ 344,893 |
Separate Accounts (Separate Account Assets) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | $ 113,586,513 | $ 118,143,256 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 18,498 | 15,548 |
| Obligations of U.S. states and their political subdivisions authorities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 140 | 115 |
| U.S. corporate securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 28,128 | 24,458 |
| Foreign corporate securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 3,052 | 3,158 |
| Asset-backed securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 1,263 | 1,099 |
| Mortgage-backed securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 129 | 82 |
| Equity | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 69,189,973 | 73,226,610 |
| Fixed Income | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 32,508,482 | 33,828,097 |
| Other | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 4,851,887 | 4,431,975 |
| Equity securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 150,205 | 126,792 |
| Other invested assets | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 6,805,838 | 6,444,077 |
| Short-term investments | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 1,449 | 2,559 |
| Cash and cash equivalents | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | $ 27,469 | $ 38,686 |
Separate Accounts (Separate Account Liabilities) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Separate Account, Liability [Roll Forward] | ||
| Balance, beginning of period | $ 118,143,256 | $ 119,188,485 |
| Deposits | 1,023,061 | 846,928 |
| Investment performance | (920,739) | 6,174,133 |
| Policy charges | (756,955) | (778,505) |
| Surrenders and withdrawals | (3,729,451) | (3,409,965) |
| Benefit payments | (118,257) | (89,013) |
| Net transfers (to) from general account | (113,985) | (78,080) |
| Other | 59,583 | 41,040 |
| Balance, end of period | 113,586,513 | 121,895,023 |
| Cash surrender value | 109,306,357 | 117,516,414 |
| Variable Annuities | ||
| Separate Account, Liability [Roll Forward] | ||
| Balance, beginning of period | 85,183,055 | 92,383,121 |
| Deposits | 151,359 | 149,538 |
| Investment performance | (166,036) | 4,150,157 |
| Policy charges | (508,620) | (557,722) |
| Surrenders and withdrawals | (3,587,214) | (3,293,055) |
| Benefit payments | (23,567) | (15,282) |
| Net transfers (to) from general account | (23,157) | 6,723 |
| Other | 1,798 | 877 |
| Balance, end of period | 81,027,618 | 92,824,357 |
| Cash surrender value | 80,187,666 | 91,713,815 |
| Variable Life | ||
| Separate Account, Liability [Roll Forward] | ||
| Balance, beginning of period | 32,960,201 | 26,805,364 |
| Deposits | 871,702 | 697,390 |
| Investment performance | (754,703) | 2,023,976 |
| Policy charges | (248,335) | (220,783) |
| Surrenders and withdrawals | (142,237) | (116,910) |
| Benefit payments | (94,690) | (73,731) |
| Net transfers (to) from general account | (90,828) | (84,803) |
| Other | 57,785 | 40,163 |
| Balance, end of period | 32,558,895 | 29,070,666 |
| Cash surrender value | $ 29,118,691 | $ 25,802,599 |
Liability For Future Policy Benefits (Benefit Reserves) (Details) - USD ($) $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Other adjustments | $ (6,582) | $ 12,005 | ||
| Balance, end of period | 18,137,748 | 18,227,141 | ||
| Other Businesses | ||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Balance, end of period | 1,410 | 1,675 | ||
| Term Life | ||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
| Balance, beginning of period | 10,414,702 | 10,927,833 | ||
| Effect of cumulative changes in discount rate assumptions, beginning of period | 567,443 | 225,711 | ||
| Balance at original discount rate, beginning of period | 10,982,145 | 11,153,544 | ||
| Effect of actual variances from expected experience and other activity | $ (56,837) | $ (54,196) | ||
| Adjusted balance, beginning of period | 10,925,308 | 11,099,348 | ||
| Issuances | 194,679 | 192,492 | ||
| Net premiums / considerations collected | (325,511) | (329,743) | ||
| Interest accrual | 128,423 | 129,053 | ||
| Other adjustments | 9 | (78) | ||
| Balance at original discount rate, end of period | 10,922,908 | 11,091,072 | ||
| Effect of cumulative changes in discount rate assumptions, end of period | (453,082) | (434,791) | ||
| Balance, end of period | 10,469,826 | 10,656,281 | ||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Balance, beginning of period | 17,689,399 | 18,426,207 | ||
| Effect of cumulative changes in discount rate assumptions, beginning of period | 1,091,673 | 331,571 | ||
| Balance at original discount rate, beginning of period | 18,781,072 | 18,757,778 | ||
| Effect of actual variances from expected experience and other activity | (65,080) | (65,431) | ||
| Adjusted balance, beginning of period | 18,715,992 | 18,692,347 | ||
| Issuances | 194,678 | 192,492 | ||
| Interest accrual | 225,260 | 223,989 | ||
| Benefit payments | (362,895) | (368,247) | ||
| Other adjustments | 1,937 | (23) | ||
| Balance at original discount rate, end of period | 18,774,972 | 18,740,558 | ||
| Effect of cumulative changes in discount rate assumptions, end of period | (887,904) | (742,789) | ||
| Balance, end of period | 17,887,068 | 17,997,769 | ||
| Balance, end of period, pre-flooring | 7,417,242 | 7,341,488 | ||
| Flooring impact, end of period | 44 | 44 | ||
| Balance, end of period, post flooring | 7,417,286 | 7,341,532 | ||
| Reinsurance recoverable | 6,832,580 | 6,650,332 | ||
| Balance after reinsurance recoverables, end of period, post-flooring | 584,706 | 691,200 | ||
| Term Life | Gross Basis | ||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Undiscounted expected future gross premiums | 21,792,468 | 21,812,112 | ||
| Discounted expected future gross premiums (at original discount rate) | 14,843,715 | 14,968,218 | ||
| Discounted expected future gross premiums (at current discount rate) | 14,266,715 | 14,408,614 | ||
| Undiscounted expected future benefits and expenses | $ 29,143,806 | $ 29,069,972 | ||
| Weighted-average duration of the liability in years (at original discount rate) | 10 years | 10 years | ||
| Weighted-average duration of the liability in years (at current discount rate) | 9 years | 10 years | ||
| Weighted-average interest rate (at original discount rate) | 5.12% | 5.16% | ||
| Weighted-average interest rate (at current discount rate) | 5.44% | 5.29% | ||
| Fixed Annuities | ||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
| Balance, beginning of period | $ 0 | $ 0 | ||
| Effect of cumulative changes in discount rate assumptions, beginning of period | 0 | 0 | ||
| Balance at original discount rate, beginning of period | 0 | 0 | ||
| Effect of actual variances from expected experience and other activity | 0 | (290) | ||
| Issuances | 11,076 | 8,595 | ||
| Net premiums / considerations collected | (11,076) | (8,305) | ||
| Interest accrual | 0 | 0 | ||
| Other adjustments | 0 | 0 | ||
| Balance at original discount rate, end of period | 0 | 0 | ||
| Effect of cumulative changes in discount rate assumptions, end of period | 0 | 0 | ||
| Balance, end of period | 0 | 0 | ||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Balance, beginning of period | 238,086 | 228,788 | ||
| Effect of cumulative changes in discount rate assumptions, beginning of period | 19,442 | 19,521 | ||
| Balance at original discount rate, beginning of period | 257,528 | 248,309 | ||
| Effect of actual variances from expected experience and other activity | 1,139 | (369) | ||
| Adjusted balance, beginning of period | 258,667 | 247,940 | ||
| Issuances | 11,076 | 8,595 | ||
| Interest accrual | 2,492 | 2,204 | ||
| Benefit payments | (8,633) | (7,544) | ||
| Other adjustments | 0 | (34) | ||
| Balance at original discount rate, end of period | 263,602 | 251,161 | ||
| Effect of cumulative changes in discount rate assumptions, end of period | (14,332) | (23,464) | ||
| Balance, end of period | 249,270 | 227,697 | ||
| Balance, end of period, pre-flooring | 249,270 | 227,697 | ||
| Flooring impact, end of period | 0 | 0 | ||
| Balance, end of period, post flooring | 249,270 | 227,697 | ||
| Reinsurance recoverable | 20,954 | 18,428 | ||
| Balance after reinsurance recoverables, end of period, post-flooring | 228,316 | 209,269 | ||
| Fixed Annuities | Gross Basis | ||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Undiscounted expected future gross premiums | 0 | 0 | ||
| Discounted expected future gross premiums (at original discount rate) | 0 | 0 | ||
| Discounted expected future gross premiums (at current discount rate) | 0 | 0 | ||
| Undiscounted expected future benefits and expenses | $ 357,084 | $ 336,830 | ||
| Weighted-average duration of the liability in years (at original discount rate) | 7 years | 7 years | ||
| Weighted-average duration of the liability in years (at current discount rate) | 6 years | 6 years | ||
| Weighted-average interest rate (at original discount rate) | 4.00% | 3.76% | ||
| Weighted-average interest rate (at current discount rate) | 5.33% | 5.26% | ||
| Fixed Annuity Netting | ||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
| Adjusted balance, beginning of period | $ 0 | $ (290) | ||
| Term Life And Fixed Annuities | ||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||
| Balance, beginning of period | 10,414,702 | 10,927,833 | ||
| Effect of cumulative changes in discount rate assumptions, beginning of period | 567,443 | 225,711 | ||
| Balance at original discount rate, beginning of period | 10,982,145 | 11,153,544 | ||
| Effect of actual variances from expected experience and other activity | (56,837) | (54,486) | ||
| Adjusted balance, beginning of period | 10,925,308 | 11,099,058 | ||
| Issuances | 205,755 | 201,087 | ||
| Net premiums / considerations collected | (336,587) | (338,048) | ||
| Interest accrual | 128,423 | 129,053 | ||
| Other adjustments | 9 | (78) | ||
| Balance at original discount rate, end of period | 10,922,908 | 11,091,072 | ||
| Effect of cumulative changes in discount rate assumptions, end of period | (453,082) | (434,791) | ||
| Balance, end of period | 10,469,826 | 10,656,281 | ||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Balance, end of period, pre-flooring | 7,666,512 | 7,569,185 | ||
| Flooring impact, end of period | 44 | 44 | ||
| Balance, end of period, post flooring | 7,666,556 | 7,569,229 | ||
| Reinsurance recoverable | 6,853,534 | 6,668,760 | ||
| Balance after reinsurance recoverables, end of period, post-flooring | 813,022 | 900,469 | ||
| Term Life And Fixed Annuities | Total | ||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Balance, beginning of period | 17,927,485 | 18,654,995 | ||
| Effect of cumulative changes in discount rate assumptions, beginning of period | 1,111,115 | 351,092 | ||
| Balance at original discount rate, beginning of period | 19,038,600 | 19,006,087 | ||
| Effect of actual variances from expected experience and other activity | $ (63,941) | $ (65,800) | ||
| Adjusted balance, beginning of period | 18,974,659 | 18,940,287 | ||
| Issuances | 205,754 | 201,087 | ||
| Interest accrual | 227,752 | 226,193 | ||
| Benefit payments | (371,528) | (375,791) | ||
| Other adjustments | 1,937 | (57) | ||
| Balance at original discount rate, end of period | 19,038,574 | 18,991,719 | ||
| Effect of cumulative changes in discount rate assumptions, end of period | (902,236) | (766,253) | ||
| Balance, end of period | $ 18,136,338 | $ 18,225,466 | ||
Liability For Future Policy Benefits (Deferred Profit Liability) (Details) - USD ($) $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Other adjustments | $ (6,582) | $ 12,005 | ||
| Fixed Annuities | ||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Effect of actual variances from expected experience and other activity | $ 1,139 | $ (369) | ||
| Adjusted balance, beginning of period | 258,667 | 247,940 | ||
| Interest accrual | 2,492 | 2,204 | ||
| Other adjustments | 0 | (34) | ||
| Balance, end of period, post-flooring | 249,270 | 227,697 | ||
| Reinsurance recoverable | 20,954 | 18,428 | ||
| Balance after reinsurance recoverables, end of period, post-flooring | 228,316 | 209,269 | ||
| Fixed Annuities | Deferred profit liability | ||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||
| Balance, beginning of period, post-flooring | 22,939 | 14,818 | ||
| Effect of actual variances from expected experience and other activity | (650) | 330 | ||
| Adjusted balance, beginning of period | $ 22,289 | $ 15,148 | ||
| Profits deferred | 1,580 | 216 | ||
| Interest accrual | 234 | 133 | ||
| Amortization | (711) | (456) | ||
| Other adjustments | (1) | (3) | ||
| Balance, end of period, post-flooring | 23,391 | 15,038 | ||
| Reinsurance recoverable | 2,019 | 1,576 | ||
| Balance after reinsurance recoverables, end of period, post-flooring | $ 21,372 | $ 13,462 | ||
Liability For Future Policy Benefits (Additional Insurance Reserves) (Details) - USD ($) $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Additional Liability, Long-Duration Insurance [Line Items] | ||||
| Weighted-average duration of the liability in years (at original discount rate) | 22 years | 22 years | ||
| Weighted-average interest rate (at original discount rate) | 3.34% | 3.39% | ||
| Variable/Universal Life | ||||
| Additional Liability, Long-Duration Insurance [Line Items] | ||||
| Balance after reinsurance recoverables, including amounts in AOCI, end of period | $ 250,015 | $ 179,987 | ||
| Variable/Universal Life | Other Businesses | ||||
| Additional Liability, Long-Duration Insurance [Line Items] | ||||
| Balance after reinsurance recoverables, including amounts in AOCI, end of period | 7,610 | 0 | ||
| Variable/Universal Life | Total | ||||
| Additional Liability, Long-Duration Insurance [Line Items] | ||||
| Balance, including amounts in AOCI, post-flooring | 16,351,053 | 14,280,792 | ||
| Flooring impact and amounts in AOCI | 617,186 | 831,583 | ||
| Balance, excluding amounts in AOCI, beginning of period, pre-flooring | 16,968,239 | 15,112,375 | ||
| Effect of actual variances from expected experience and other activity | $ 9,840 | $ 191,104 | ||
| Adjusted balance, beginning of period | $ 16,978,079 | $ 15,303,479 | ||
| Assessments collected | 269,478 | 297,419 | ||
| Interest accrual | 142,506 | 128,241 | ||
| Benefits paid | (86,194) | (68,233) | ||
| Balance, excluding amounts in AOCI, end of period, pre-flooring | 17,303,869 | 15,660,906 | ||
| Flooring impact and amounts in AOCI | (513,439) | (1,014,852) | ||
| Balance, including amounts in AOCI, end of period, post-flooring | 16,790,430 | 14,646,054 | ||
| Less: Reinsurance recoverables | 16,548,025 | 14,466,067 | ||
| Balance after reinsurance recoverables, including amounts in AOCI, end of period | $ 242,405 | $ 179,987 | ||
Liability For Future Policy Benefits (Future Policy Benefits) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
Mar. 31, 2024 |
|---|---|---|---|
| Insurance [Abstract] | |||
| Benefit reserves, end of period, post-flooring | $ 7,666,556 | $ 7,569,229 | |
| Deferred profit liability, end of period, post-flooring | 23,391 | 15,038 | |
| Additional insurance reserves, including amounts in AOCI, end of period, post-flooring | 16,798,040 | 14,646,054 | |
| Subtotal of amounts disclosed above | 24,487,987 | 22,230,321 | |
| Other Future Policy Benefits reserves | 1,055,140 | 1,181,796 | |
| Total Future policy Benefits | $ 25,543,127 | $ 25,113,767 | $ 23,412,117 |
Liability For Future Policy Benefits (Revenue and Interest Expense) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Benefit Reserves | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | $ 453,746 | $ 455,425 |
| Interest expense | 99,329 | 97,139 |
| Benefit Reserves | Term Life | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 441,000 | 446,853 |
| Interest expense | 96,837 | 94,935 |
| Benefit Reserves | Variable/Universal Life | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 0 | 0 |
| Interest expense | 0 | 0 |
| Benefit Reserves | Fixed Annuities | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 12,746 | 8,572 |
| Interest expense | 2,492 | 2,204 |
| Deferred profit liability | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Interest expense | 234 | 133 |
| Deferred profit liability | Term Life | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Interest expense | 0 | 0 |
| Deferred profit liability | Variable/Universal Life | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Interest expense | 0 | 0 |
| Deferred profit liability | Fixed Annuities | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Interest expense | 234 | 133 |
| Additional insurance reserves | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 458,049 | 419,396 |
| Interest expense | 142,506 | 128,241 |
| Additional insurance reserves | Term Life | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 0 | 0 |
| Interest expense | 0 | 0 |
| Additional insurance reserves | Variable/Universal Life | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 458,049 | 419,396 |
| Interest expense | 142,506 | 128,241 |
| Additional insurance reserves | Fixed Annuities | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 0 | 0 |
| Interest expense | 0 | 0 |
| Deferred Profit Liability Netting | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | (452) | (221) |
| Deferred Profit Liability Netting | Term Life | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 0 | 0 |
| Deferred Profit Liability Netting | Variable/Universal Life | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 0 | 0 |
| Deferred Profit Liability Netting | Fixed Annuities | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | (452) | (221) |
| Revenues | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 911,343 | 874,600 |
| Revenues | Term Life | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 441,000 | 446,853 |
| Revenues | Variable/Universal Life | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 458,049 | 419,396 |
| Revenues | Fixed Annuities | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Revenue | 12,294 | 8,351 |
| Interest Expense | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Interest expense | 242,069 | 225,513 |
| Interest Expense | Term Life | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Interest expense | 96,837 | 94,935 |
| Interest Expense | Variable/Universal Life | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Interest expense | 142,506 | 128,241 |
| Interest Expense | Fixed Annuities | ||
| Liability for Future Policy Benefit, Activity [Line Items] | ||
| Interest expense | $ 2,726 | $ 2,337 |
Policyholders' Liabilities (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Additional Liability, Long-Duration Insurance [Roll Forward] | ||
| Balance, beginning of period | $ 69,628,318 | |
| Transfer to (from) Policyholder Account Balance (to) from Separate Account | 113,985 | $ 78,080 |
| Unearned revenue reserve | 4,576,066 | 3,908,497 |
| Other | 108,240 | 103,851 |
| Total Policyholders' account balance | $ 71,559,381 | $ 57,764,158 |
| Weighted-average crediting rate | 2.21% | 2.44% |
| Net amount at risk | $ 350,942,454 | $ 327,231,579 |
| Cash surrender value | 62,734,038 | 48,856,565 |
| Total | ||
| Additional Liability, Long-Duration Insurance [Roll Forward] | ||
| Balance, beginning of period | 65,105,807 | 49,142,691 |
| Deposits | 3,930,982 | 3,708,020 |
| Interest credited(4) | 364,898 | 313,520 |
| Policy charges | (486,573) | (457,032) |
| Surrenders and withdrawals | (639,085) | (483,591) |
| Benefit payments | (62,503) | (35,661) |
| Transfer to (from) Policyholder Account Balance (to) from Separate Account | 113,985 | 78,080 |
| Change in market value and other adjustments | (1,452,436) | 1,485,783 |
| Balance, end of period | 66,875,075 | 53,751,810 |
| Fixed Annuities | ||
| Additional Liability, Long-Duration Insurance [Roll Forward] | ||
| Balance, beginning of period | 11,197,337 | 6,164,313 |
| Deposits | 1,118,299 | 1,553,852 |
| Interest credited(4) | 70,850 | 43,517 |
| Policy charges | 2,208 | |
| Policy charges | (11,409) | |
| Surrenders and withdrawals | (157,652) | (103,696) |
| Benefit payments | (26,429) | (12,879) |
| Transfer to (from) Policyholder Account Balance (to) from Separate Account | 0 | 0 |
| Change in market value and other adjustments | (49,620) | 88,291 |
| Balance, end of period | 12,141,376 | 7,735,606 |
| Total Policyholders' account balance | $ 5,528,553 | $ 3,148,584 |
| Weighted-average crediting rate | 2.43% | 2.50% |
| Net amount at risk | $ 1,458 | $ 18 |
| Cash surrender value | 10,896,794 | 6,674,346 |
| Variable Annuity | ||
| Additional Liability, Long-Duration Insurance [Roll Forward] | ||
| Balance, beginning of period | 33,217,331 | 22,810,665 |
| Deposits | 2,229,851 | 1,624,956 |
| Interest credited(4) | 148,597 | 131,944 |
| Policy charges | (15,546) | (3,702) |
| Surrenders and withdrawals | (250,968) | (179,988) |
| Benefit payments | (4,163) | (4,926) |
| Transfer to (from) Policyholder Account Balance (to) from Separate Account | 23,157 | (6,723) |
| Change in market value and other adjustments | (1,412,076) | 1,360,323 |
| Balance, end of period | 33,936,183 | 25,732,549 |
| Total Policyholders' account balance | $ 2,454,759 | $ 2,821,316 |
| Weighted-average crediting rate | 1.77% | 2.17% |
| Net amount at risk | $ 0 | $ 0 |
| Cash surrender value | 32,338,553 | 23,282,269 |
| Variable/Universal Life | ||
| Additional Liability, Long-Duration Insurance [Roll Forward] | ||
| Balance, beginning of period | 20,691,139 | 20,167,713 |
| Deposits | 582,832 | 529,212 |
| Interest credited(4) | 145,451 | 138,059 |
| Policy charges | (459,618) | (455,538) |
| Surrenders and withdrawals | (230,465) | (199,907) |
| Benefit payments | (31,911) | (17,856) |
| Transfer to (from) Policyholder Account Balance (to) from Separate Account | 90,828 | 84,803 |
| Change in market value and other adjustments | 9,260 | 37,169 |
| Balance, end of period | 20,797,516 | 20,283,655 |
| Total Policyholders' account balance | $ 17,526,199 | $ 17,462,288 |
| Weighted-average crediting rate | 2.80% | 2.73% |
| Net amount at risk | $ 350,940,996 | $ 327,231,561 |
| Cash surrender value | $ 19,498,691 | $ 18,899,950 |
Policyholders' Liabilities (Guaranteed Minimum Crediting Rate) (Details) $ in Thousands |
Mar. 31, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
Mar. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
|---|---|---|---|---|
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 71,559,381 | $ 69,628,318 | $ 57,764,158 | |
| 1 - 50 bps above guaranteed minimum | Minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Policyholder account balance above guaranteed minimum crediting rate | 1 | 1 | ||
| 1 - 50 bps above guaranteed minimum | Maximum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Policyholder account balance above guaranteed minimum crediting rate | 50 | 50 | ||
| 51 - 150 bps above guaranteed minimum | Minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Policyholder account balance above guaranteed minimum crediting rate | 51 | 51 | ||
| 51 - 150 bps above guaranteed minimum | Maximum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Policyholder account balance above guaranteed minimum crediting rate | 150 | 150 | ||
| Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Policyholder account balance above guaranteed minimum crediting rate | 150 | 150 | ||
| Fixed Annuities | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 5,528,553 | 11,197,337 | $ 3,148,584 | $ 6,164,313 |
| Fixed Annuities | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 3,111,506 | 1,098,331 | ||
| Fixed Annuities | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 523,143 | 542,427 | ||
| Fixed Annuities | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 744,586 | 790,155 | ||
| Fixed Annuities | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 1,149,318 | 717,671 | ||
| Variable Annuity | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 2,454,759 | 33,217,331 | 2,821,316 | 22,810,665 |
| Variable Annuity | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 1,153,998 | 1,984,021 | ||
| Variable Annuity | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 690,169 | 762,131 | ||
| Variable Annuity | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 610,456 | 74,969 | ||
| Variable Annuity | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 136 | 195 | ||
| Variable/Universal Life | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 17,526,199 | $ 20,691,139 | 17,462,288 | $ 20,167,713 |
| Variable/Universal Life | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 6,496,343 | 6,288,393 | ||
| Variable/Universal Life | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 3,258,830 | 3,839,363 | ||
| Variable/Universal Life | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 5,606,020 | 5,434,330 | ||
| Variable/Universal Life | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 2,165,006 | $ 1,900,202 | ||
| Less than 1.00% | Fixed Annuities | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 1.00% | 1.00% | ||
| Account Values with Crediting Rates | $ 1,078,250 | $ 629,911 | ||
| Less than 1.00% | Fixed Annuities | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 435 | 285 | ||
| Less than 1.00% | Fixed Annuities | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 2,879 | 1,923 | ||
| Less than 1.00% | Fixed Annuities | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 13,419 | 6,312 | ||
| Less than 1.00% | Fixed Annuities | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 1,061,517 | $ 621,391 | ||
| Less than 1.00% | Variable Annuity | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 1.00% | 1.00% | ||
| Account Values with Crediting Rates | $ 1,173,856 | $ 1,663,027 | ||
| Less than 1.00% | Variable Annuity | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 232,418 | 865,767 | ||
| Less than 1.00% | Variable Annuity | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 337,436 | 727,194 | ||
| Less than 1.00% | Variable Annuity | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 603,866 | 69,871 | ||
| Less than 1.00% | Variable Annuity | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 136 | $ 195 | ||
| Less than 1.00% | Variable/Universal Life | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 1.00% | 1.00% | ||
| Account Values with Crediting Rates | $ 194,655 | $ 184,308 | ||
| Less than 1.00% | Variable/Universal Life | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| Less than 1.00% | Variable/Universal Life | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| Less than 1.00% | Variable/Universal Life | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| Less than 1.00% | Variable/Universal Life | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 194,655 | 184,308 | ||
| 1.00% - 1.99% | Fixed Annuities | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 710,103 | $ 843,781 | ||
| 1.00% - 1.99% | Fixed Annuities | Minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 1.00% | 1.00% | ||
| 1.00% - 1.99% | Fixed Annuities | Maximum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 1.99% | 1.99% | ||
| 1.00% - 1.99% | Fixed Annuities | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 414,878 | $ 473,330 | ||
| 1.00% - 1.99% | Fixed Annuities | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 58,998 | 72,870 | ||
| 1.00% - 1.99% | Fixed Annuities | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 166,957 | 217,461 | ||
| 1.00% - 1.99% | Fixed Annuities | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 69,270 | 80,120 | ||
| 1.00% - 1.99% | Variable Annuity | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 451,415 | $ 241,200 | ||
| 1.00% - 1.99% | Variable Annuity | Minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 1.00% | 1.00% | ||
| 1.00% - 1.99% | Variable Annuity | Maximum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 1.99% | 1.99% | ||
| 1.00% - 1.99% | Variable Annuity | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 100,050 | $ 216,457 | ||
| 1.00% - 1.99% | Variable Annuity | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 348,924 | 23,819 | ||
| 1.00% - 1.99% | Variable Annuity | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 2,441 | 924 | ||
| 1.00% - 1.99% | Variable Annuity | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| 1.00% - 1.99% | Variable/Universal Life | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 3,733,861 | $ 3,402,503 | ||
| 1.00% - 1.99% | Variable/Universal Life | Minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 1.00% | 1.00% | ||
| 1.00% - 1.99% | Variable/Universal Life | Maximum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 1.99% | 1.99% | ||
| 1.00% - 1.99% | Variable/Universal Life | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 310,277 | $ 226,470 | ||
| 1.00% - 1.99% | Variable/Universal Life | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| 1.00% - 1.99% | Variable/Universal Life | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 1,845,100 | 1,661,933 | ||
| 1.00% - 1.99% | Variable/Universal Life | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 1,578,484 | 1,514,100 | ||
| 2.00% - 2.99% | Fixed Annuities | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 1,325,803 | $ 1,346,001 | ||
| 2.00% - 2.99% | Fixed Annuities | Minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 2.00% | 2.00% | ||
| 2.00% - 2.99% | Fixed Annuities | Maximum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 2.99% | 2.99% | ||
| 2.00% - 2.99% | Fixed Annuities | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 302,047 | $ 300,163 | ||
| 2.00% - 2.99% | Fixed Annuities | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 455,549 | 465,693 | ||
| 2.00% - 2.99% | Fixed Annuities | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 553,053 | 564,226 | ||
| 2.00% - 2.99% | Fixed Annuities | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 15,154 | 15,919 | ||
| 2.00% - 2.99% | Variable Annuity | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 24,583 | $ 29,282 | ||
| 2.00% - 2.99% | Variable Annuity | Minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 2.00% | 2.00% | ||
| 2.00% - 2.99% | Variable Annuity | Maximum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 2.99% | 2.99% | ||
| 2.00% - 2.99% | Variable Annuity | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 16,625 | $ 20,916 | ||
| 2.00% - 2.99% | Variable Annuity | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 3,809 | 4,192 | ||
| 2.00% - 2.99% | Variable Annuity | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 4,149 | 4,174 | ||
| 2.00% - 2.99% | Variable Annuity | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| 2.00% - 2.99% | Variable/Universal Life | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 4,668,669 | $ 4,548,336 | ||
| 2.00% - 2.99% | Variable/Universal Life | Minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 2.00% | 2.00% | ||
| 2.00% - 2.99% | Variable/Universal Life | Maximum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 2.99% | 2.99% | ||
| 2.00% - 2.99% | Variable/Universal Life | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 36,188 | $ 29,823 | ||
| 2.00% - 2.99% | Variable/Universal Life | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 1,547,089 | 1,462,438 | ||
| 2.00% - 2.99% | Variable/Universal Life | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 2,693,525 | 2,854,281 | ||
| 2.00% - 2.99% | Variable/Universal Life | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 391,867 | 201,794 | ||
| 3.00% - 4.00% | Fixed Annuities | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 2,414,397 | $ 328,891 | ||
| 3.00% - 4.00% | Fixed Annuities | Minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 3.00% | 3.00% | ||
| 3.00% - 4.00% | Fixed Annuities | Maximum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 4.00% | 4.00% | ||
| 3.00% - 4.00% | Fixed Annuities | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 2,394,146 | $ 324,553 | ||
| 3.00% - 4.00% | Fixed Annuities | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 5,717 | 1,941 | ||
| 3.00% - 4.00% | Fixed Annuities | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 11,157 | 2,156 | ||
| 3.00% - 4.00% | Fixed Annuities | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 3,377 | 241 | ||
| 3.00% - 4.00% | Variable Annuity | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 802,908 | $ 885,741 | ||
| 3.00% - 4.00% | Variable Annuity | Minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 3.00% | 3.00% | ||
| 3.00% - 4.00% | Variable Annuity | Maximum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 4.00% | 4.00% | ||
| 3.00% - 4.00% | Variable Annuity | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 802,908 | $ 878,815 | ||
| 3.00% - 4.00% | Variable Annuity | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 6,926 | ||
| 3.00% - 4.00% | Variable Annuity | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| 3.00% - 4.00% | Variable Annuity | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| 3.00% - 4.00% | Variable/Universal Life | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 6,849,382 | $ 7,199,615 | ||
| 3.00% - 4.00% | Variable/Universal Life | Minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 3.00% | 3.00% | ||
| 3.00% - 4.00% | Variable/Universal Life | Maximum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 4.00% | 4.00% | ||
| 3.00% - 4.00% | Variable/Universal Life | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 4,070,246 | $ 3,904,574 | ||
| 3.00% - 4.00% | Variable/Universal Life | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 1,711,741 | 2,376,925 | ||
| 3.00% - 4.00% | Variable/Universal Life | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 1,067,395 | 918,116 | ||
| 3.00% - 4.00% | Variable/Universal Life | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 0 | $ 0 | ||
| Greater than 4.00% | Fixed Annuities | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 4.00% | 4.00% | ||
| Account Values with Crediting Rates | $ 0 | $ 0 | ||
| Greater than 4.00% | Fixed Annuities | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| Greater than 4.00% | Fixed Annuities | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| Greater than 4.00% | Fixed Annuities | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| Greater than 4.00% | Fixed Annuities | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 0 | $ 0 | ||
| Greater than 4.00% | Variable Annuity | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 4.00% | 4.00% | ||
| Account Values with Crediting Rates | $ 1,997 | $ 2,066 | ||
| Greater than 4.00% | Variable Annuity | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 1,997 | 2,066 | ||
| Greater than 4.00% | Variable Annuity | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| Greater than 4.00% | Variable Annuity | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| Greater than 4.00% | Variable Annuity | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 0 | $ 0 | ||
| Greater than 4.00% | Variable/Universal Life | ||||
| Policyholder Account Balance [Line Items] | ||||
| Range of Guaranteed Minimum Crediting Rates | 4.00% | 4.00% | ||
| Account Values with Crediting Rates | $ 2,079,632 | $ 2,127,526 | ||
| Greater than 4.00% | Variable/Universal Life | At guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 2,079,632 | 2,127,526 | ||
| Greater than 4.00% | Variable/Universal Life | 1 - 50 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| Greater than 4.00% | Variable/Universal Life | 51 - 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | 0 | 0 | ||
| Greater than 4.00% | Variable/Universal Life | Greater than 150 bps above guaranteed minimum | ||||
| Policyholder Account Balance [Line Items] | ||||
| Account Values with Crediting Rates | $ 0 | $ 0 |
Policyholders' Liabilities (Additional Insurance Reserves) (Details) - Variable/Universal Life - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||
| Balance, beginning of period | $ 4,415,188 | $ 3,741,426 |
| Unearned revenue | 211,830 | 211,542 |
| Amortization Expense | (50,952) | (44,470) |
| Other adjustments | 0 | (1) |
| Balance, end of period | $ 4,576,066 | $ 3,908,497 |
Market Risk Benefits - Rollforward of Balances for Variable Annuity Products (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Variable Annuities | ||
| Market Risk Benefit [Roll Forward] | ||
| Balance, beginning of period | $ 2,488,463 | $ 3,707,407 |
| Effect of cumulative changes in non-performance risk | 626,845 | 1,067,983 |
| Balance, beginning of period, before effect of changes in non-performance risk | 3,115,308 | 4,775,390 |
| Attributed fees collected | 259,010 | 281,171 |
| Claims paid | (14,280) | (16,417) |
| Interest accrual | 37,780 | 68,360 |
| Actual in force different from expected | 18,542 | 2,495 |
| Effect of changes in interest rates | 414,243 | (832,834) |
| Effect of changes in equity markets | 227,938 | (846,759) |
| Issuances | 23,528 | 12,766 |
| Other adjustments | (294) | 612 |
| Effect of changes in current period counterparty non-performance risk | 0 | 0 |
| Balance, end of period, before effect of changes in non-performance risk | 4,081,775 | 3,444,784 |
| Effect of cumulative changes in non-performance risk | (788,058) | (829,061) |
| Balance, end of period | 3,293,717 | 2,615,723 |
| Less: Reinsured Market Risk Benefits | ||
| Market Risk Benefit [Roll Forward] | ||
| Balance, beginning of period | (844,582) | (917,792) |
| Effect of cumulative changes in non-performance risk | 0 | 0 |
| Balance, beginning of period, before effect of changes in non-performance risk | (844,582) | (917,792) |
| Interest accrual | (11,107) | (15,642) |
| Actual in force different from expected | (5,273) | (4,539) |
| Effect of changes in interest rates | (105,463) | 180,022 |
| Effect of changes in equity markets | (24,533) | 87,042 |
| Other adjustments | 40 | (603) |
| Effect of changes in current period counterparty non-performance risk | 52,228 | (26,662) |
| Balance, end of period, before effect of changes in non-performance risk | (999,400) | (764,249) |
| Effect of cumulative changes in non-performance risk | 0 | 0 |
| Balance, end of period | (999,400) | (764,249) |
| Less: Reinsured Market Risk Benefits | ||
| Market Risk Benefit [Roll Forward] | ||
| Attributed fees collected | (60,167) | (66,967) |
| Claims paid | 1,634 | 1,511 |
| Issuances | (2,177) | (619) |
| Total, Net of Reinsurance | ||
| Market Risk Benefit [Roll Forward] | ||
| Balance, beginning of period | 1,643,881 | 2,789,615 |
| Effect of cumulative changes in non-performance risk | 626,845 | 1,067,983 |
| Balance, beginning of period, before effect of changes in non-performance risk | 2,270,726 | 3,857,598 |
| Attributed fees collected | 198,843 | 214,204 |
| Claims paid | (12,646) | (14,906) |
| Interest accrual | 26,673 | 52,718 |
| Actual in force different from expected | 13,269 | (2,044) |
| Effect of changes in interest rates | 308,780 | (652,812) |
| Effect of changes in equity markets | 203,405 | (759,717) |
| Issuances | 21,351 | 12,147 |
| Other adjustments | (254) | 9 |
| Effect of changes in current period counterparty non-performance risk | 52,228 | (26,662) |
| Balance, end of period, before effect of changes in non-performance risk | 3,082,375 | 2,680,535 |
| Effect of cumulative changes in non-performance risk | (788,058) | (829,061) |
| Balance, end of period | $ 2,294,317 | $ 1,851,474 |
Market Risk Benefits - Market Risk Benefits In Asset and Liability Positions (Details) - USD ($) $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Liability for Future Policy Benefit, Activity [Line Items] | ||||
| Total market risk benefit assets | $ 2,508,967 | $ 2,537,000 | $ 2,637,363 | |
| Total market risk benefit liabilities | 4,803,284 | 4,388,000 | 4,281,244 | |
| Variable Annuities | ||||
| Liability for Future Policy Benefit, Activity [Line Items] | ||||
| Net amount at risk | $ 9,113,461 | $ 8,350,431 | ||
| Weighted-average attained age of contractholders | 71 years | 70 years | ||
| Direct and assumed | $ 1,255,404 | $ 1,472,957 | ||
| Ceded | 1,253,563 | 1,063,886 | ||
| Total market risk benefit assets | 2,508,967 | 2,536,843 | ||
| Direct and assumed | 4,549,121 | 4,088,679 | ||
| Ceded | 254,163 | 299,638 | ||
| Total market risk benefit liabilities | 4,803,284 | 4,388,317 | ||
| Net liability | $ 2,294,317 | $ 1,851,474 | 2,488,463 | $ 3,707,407 |
| Total, Net of Reinsurance | ||||
| Liability for Future Policy Benefit, Activity [Line Items] | ||||
| Net liability | $ 1,643,881 | $ 2,789,615 | ||
Reinsurance (Reinsurance amounts included in the Statements of Financial Position) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|---|
| Effects of Reinsurance [Line Items] | ||||
| Reinsurance recoverables and deposit receivables | $ 49,168,211 | $ 48,247,817 | ||
| Policy loans | (1,556,658) | (1,541,480) | ||
| Deferred policy acquisition costs | (8,004,461) | (7,807,060) | $ (7,301,185) | $ (7,144,736) |
| Deferred sales inducements | (316,062) | (322,351) | ||
| Market risk benefit assets | 2,508,967 | 2,637,363 | 2,537,000 | |
| Other assets | 1,803,131 | 1,850,800 | ||
| Future policy benefits | 25,543,127 | 25,113,767 | 23,412,117 | |
| Market risk benefit liabilities | 4,803,284 | 4,281,244 | $ 4,388,000 | |
| Other liabilities | 4,221,908 | 4,199,803 | ||
| Impacts of Reinsurance | ||||
| Effects of Reinsurance [Line Items] | ||||
| Reinsurance recoverables and deposit receivables | 49,168,211 | 48,247,817 | ||
| Policy loans | (1,144,906) | (1,143,726) | ||
| Deferred policy acquisition costs | (3,286,351) | (3,319,067) | ||
| Deferred sales inducements | (31,971) | (32,573) | ||
| Market risk benefit assets | 1,253,961 | 1,145,580 | ||
| Other assets | 1,511,709 | 1,538,231 | ||
| Policyholders’ account balances | 5,452,802 | 5,567,661 | ||
| Future policy benefits | 7,597,732 | 7,443,997 | ||
| Market risk benefit liabilities | 256,287 | 302,310 | ||
| Reinsurance and funds withheld payables | 8,889,142 | 8,611,141 | ||
| Other liabilities | 3,250,307 | 3,282,713 | ||
| Unaffiliated activity | ||||
| Effects of Reinsurance [Line Items] | ||||
| Market risk benefit assets | 861,899 | 804,015 | ||
| Other assets | 1,102,141 | 1,118,974 | ||
| Policyholders’ account balances | 1,623,421 | 1,665,998 | ||
| Future policy benefits | 267 | 160 | ||
| Market risk benefit liabilities | 128,112 | 151,432 | ||
| Reinsurance and funds withheld payables | 3,344,608 | 3,360,901 | ||
| Other liabilities | 250,850 | 257,929 | ||
| Unaffiliated activity | ||||
| Effects of Reinsurance [Line Items] | ||||
| Policy loans | (48,960) | (48,644) | ||
| Deferred policy acquisition costs | $ (635,819) | $ (637,555) |
Reinsurance (Reinsurance Recoverable by Counterparty) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverable and deposit receivables | $ 49,168,211 | $ 48,247,817 |
| PAR U | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverable and deposit receivables | 11,415,651 | 11,426,975 |
| PURE | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverable and deposit receivables | 7,962,181 | 7,951,965 |
| Prudential Insurance | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverable and deposit receivables | 7,874,836 | 7,507,414 |
| PARCC | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverable and deposit receivables | 7,042,276 | 7,049,164 |
| Lotus Re | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverable and deposit receivables | 2,524,184 | 2,130,095 |
| Prudential of Japan | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverable and deposit receivables | 10,841 | 0 |
| Unaffiliated activity | ||
| Effects of Reinsurance [Line Items] | ||
| Total reinsurance recoverable and deposit receivables | $ 12,338,242 | $ 12,182,204 |
Reinsurance (Reinsurance amounts included in the Statement of Operations and Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||
|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
||||
| Premiums: | |||||
| Direct | $ 463,449 | $ 459,628 | |||
| Assumed | 10,662 | 33 | |||
| Ceded | (350,651) | (367,479) | |||
| Net Premiums | 123,460 | 92,182 | |||
| Policy charges and fee income: | |||||
| Direct | 797,210 | 771,189 | |||
| Assumed | 180,179 | 258,770 | |||
| Ceded | (579,043) | 1,879,246 | |||
| Net policy charges and fee income | 398,346 | 2,909,205 | |||
| Net investment income: | |||||
| Direct | 747,545 | 519,052 | |||
| Assumed | 319 | 330 | |||
| Ceded | (13,068) | (14,062) | |||
| Net investment income | 734,796 | 505,320 | |||
| Asset administration fees: | |||||
| Direct | 78,905 | 82,688 | |||
| Assumed | 0 | 0 | |||
| Ceded | (26,825) | (26,056) | |||
| Net asset administration fees | 52,080 | 56,632 | |||
| Other income (loss): | |||||
| Direct | 104,643 | 44,816 | |||
| Assumed | 20 | 325 | |||
| Ceded | 71,778 | 169,854 | |||
| Net other income (loss) | 176,441 | 214,995 | [1] | ||
| Realized investment gains (losses), net: | |||||
| Direct | (82,883) | 20,056 | |||
| Assumed | 32,439 | (9,167) | |||
| Ceded | (55,930) | (13,694) | |||
| Realized investment gains (losses), net | (106,374) | (2,805) | [1] | ||
| Change in value of market risk benefits, net of related hedging gains (losses): | |||||
| Direct | (418,994) | 324,375 | |||
| Assumed | (484) | 1,450 | |||
| Ceded | 93,407 | (221,829) | |||
| Net change in value of market risk benefits, net of related hedging gain (loss) | (326,071) | 103,996 | [1] | ||
| Policyholders’ benefits (including change in reserves): | |||||
| Direct | 988,124 | 1,001,446 | |||
| Assumed | 292,478 | 287,411 | |||
| Ceded | (1,137,266) | 2,817,551 | |||
| Net policyholders’ benefits (including change in reserves | 143,336 | 4,106,408 | |||
| Change in estimates of liability for future policy benefits: | |||||
| Direct | 6,255 | 139,586 | |||
| Assumed | 1,292 | (9,510) | |||
| Ceded | (965) | (142,081) | |||
| Net change in estimates of liability for future policy benefits | 6,582 | (12,005) | |||
| Interest credited to policyholders’ account balances: | |||||
| Direct | 366,527 | 312,190 | |||
| Assumed | 33,104 | 46,148 | |||
| Ceded | (105,869) | (99,988) | |||
| Net interest credited to policyholders’ account balances | 293,762 | 258,350 | [1] | ||
| Reinsurance expense allowances and general and administrative expenses, net of capitalization and amortization | (106,548) | (391,443) | |||
| Unaffiliated activity | |||||
| Premiums: | |||||
| Assumed | 27 | 30 | |||
| Ceded | (35,400) | (25,152) | |||
| Policy charges and fee income: | |||||
| Assumed | 212 | 272 | |||
| Ceded | (750,027) | (42,012) | |||
| Net investment income: | |||||
| Ceded | (443) | 0 | |||
| Asset administration fees: | |||||
| Ceded | (6,414) | (7,316) | |||
| Other income (loss): | |||||
| Assumed | (142) | 325 | |||
| Ceded | 42,077 | 23,314 | |||
| Realized investment gains (losses), net: | |||||
| Assumed | 32,439 | (9,167) | |||
| Ceded | (37,911) | (8,280) | |||
| Change in value of market risk benefits, net of related hedging gains (losses): | |||||
| Assumed | (484) | 1,450 | |||
| Ceded | 44,351 | (98,008) | |||
| Policyholders’ benefits (including change in reserves): | |||||
| Assumed | 45 | 333 | |||
| Ceded | (765,259) | (146,828) | |||
| Change in estimates of liability for future policy benefits: | |||||
| Ceded | (9,886) | 91,873 | |||
| Interest credited to policyholders’ account balances: | |||||
| Assumed | 6,477 | 17,459 | |||
| Ceded | $ (24,477) | $ 0 | |||
| |||||
Reinsurance (Life Insurance In Force) (Details) - USD ($) $ in Thousands |
Mar. 31, 2025 |
Mar. 31, 2024 |
|---|---|---|
| Reinsurance Disclosures [Abstract] | ||
| Direct gross life insurance face amount in force | $ 1,191,661,368 | $ 1,136,350,824 |
| Assumed gross life insurance face amount in force | 45,780,036 | 35,289,794 |
| Reinsurance ceded | (1,088,730,529) | (1,034,508,027) |
| Net life insurance face amount in force | $ 148,710,875 | $ 137,132,591 |
Reinsurance (Narrative) (Details) $ in Thousands |
3 Months Ended | 21 Months Ended | 24 Months Ended | 36 Months Ended | 48 Months Ended | 60 Months Ended | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 15, 2024 |
Oct. 01, 2024
USD ($)
|
Apr. 01, 2023
USD ($)
|
Jan. 01, 2022
USD ($)
|
Jul. 01, 2019 |
Jan. 01, 2015 |
Dec. 31, 2014 |
Dec. 31, 2013 |
Jul. 01, 2012 |
Dec. 31, 2010 |
Dec. 31, 2009 |
Mar. 31, 2025
USD ($)
|
Mar. 31, 2024
USD ($)
|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2016 |
Dec. 31, 2019 |
Dec. 31, 2019 |
Dec. 31, 2016 |
Dec. 31, 2013 |
Dec. 31, 2017 |
Dec. 31, 2013 |
Dec. 31, 2019 |
Jan. 01, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
Jan. 01, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
Oct. 01, 2021
USD ($)
|
Jan. 01, 2021
counterparty
|
May 01, 2018
counterparty
|
|
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Deferred Reinsurance Gain | $ 3,290,796 | $ 2,734,685 | $ 3,318,785 | $ 1,673,290 | |||||||||||||||||||||||||
| Deferred Reinsurance Loss | 1,503,770 | 246,103 | 1,530,394 | 255,113 | |||||||||||||||||||||||||
| Policy charges and fee income | (398,346) | (2,909,205) | |||||||||||||||||||||||||||
| Policy loan assets | 1,556,658 | 1,541,480 | |||||||||||||||||||||||||||
| Reinsurance recoverables and deposit receivables | 49,168,211 | 48,247,817 | |||||||||||||||||||||||||||
| Impacts of Reinsurance | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Policy loan assets | 1,144,906 | 1,143,726 | |||||||||||||||||||||||||||
| Reinsurance recoverables and deposit receivables | 49,168,211 | 48,247,817 | |||||||||||||||||||||||||||
| PAR U | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance recoverables and deposit receivables | 11,415,651 | 11,426,975 | |||||||||||||||||||||||||||
| PURE | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance recoverables and deposit receivables | 7,962,181 | 7,951,965 | |||||||||||||||||||||||||||
| PARCC | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance recoverables and deposit receivables | 7,042,276 | 7,049,164 | |||||||||||||||||||||||||||
| Prudential Insurance | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance recoverables and deposit receivables | 7,874,836 | 7,507,414 | |||||||||||||||||||||||||||
| Lotus Re | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance recoverables and deposit receivables | 2,524,184 | 2,130,095 | |||||||||||||||||||||||||||
| Prudential of Japan | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Deferred Reinsurance Gain | $ 14,000 | ||||||||||||||||||||||||||||
| Guaranteed Minimum Death Benefit | $ 5,000 | ||||||||||||||||||||||||||||
| Reinsurance recoverables and deposit receivables | 10,841 | 0 | |||||||||||||||||||||||||||
| AuguStar | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Deferred Reinsurance Gain | $ 277,000 | ||||||||||||||||||||||||||||
| Reinsured Amount | $ 10,000,000 | ||||||||||||||||||||||||||||
| Percent of total reinsured block | 0.10 | ||||||||||||||||||||||||||||
| AuguStar | Separate account liabilities under MODCO | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | ||||||||||||||||||||||||||||
| AuguStar | General account liabilities under MODCO | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | ||||||||||||||||||||||||||||
| FLIAC | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance recoverables and deposit receivables | 1,398,000 | 1,395,000 | |||||||||||||||||||||||||||
| Somerset Re | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Recapture loss | $ (990,000) | ||||||||||||||||||||||||||||
| Deferred Reinsurance Gain | 1,207,000 | ||||||||||||||||||||||||||||
| Deposit assets on reinsurance | 2,786,000 | 2,582,000 | |||||||||||||||||||||||||||
| Funds witheld liabilities | 2,627,000 | 2,434,000 | |||||||||||||||||||||||||||
| Union Hamilton | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance recoverables | 1,800,000 | ||||||||||||||||||||||||||||
| Union Hamilton | Quote Share Reinsurance | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 50.00% | ||||||||||||||||||||||||||||
| Wilton Re | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Recapture gain | $ 270,000 | ||||||||||||||||||||||||||||
| Deferred Reinsurance Gain | 798,000 | ||||||||||||||||||||||||||||
| Deferred Reinsurance Loss | 979,000 | ||||||||||||||||||||||||||||
| Reinsurance recoverables | 7,584,000 | 7,478,000 | |||||||||||||||||||||||||||
| Variable Annuity | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Deferred Reinsurance Gain | 236,753 | 256,625 | 241,628 | 261,721 | |||||||||||||||||||||||||
| Deferred Reinsurance Loss | 156,568 | 187,071 | 164,238 | 194,110 | |||||||||||||||||||||||||
| Variable Annuity | FLIAC | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Funds held under reinsurance agreements | 5,300,000 | ||||||||||||||||||||||||||||
| Fixed Annuities | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Deferred Reinsurance Gain | $ 35,080 | $ 45,376 | 37,548 | $ 48,073 | |||||||||||||||||||||||||
| Fixed Annuities | FLIAC | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Percent of total reinsured block | 0.80 | ||||||||||||||||||||||||||||
| Funds held under reinsurance agreements | $ 2,000,000 | ||||||||||||||||||||||||||||
| Affiliated Entity | PAR U | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Recapture gain | 270,000 | ||||||||||||||||||||||||||||
| Deferred Reinsurance Gain | 94,000 | ||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | 25.00% | 70.00% | ||||||||||||||||||||||||||
| Affiliated Entity | PURE | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 75.00% | ||||||||||||||||||||||||||||
| Affiliated Entity | PURC | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Deferred Reinsurance Gain | $ 116,000 | ||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 95.00% | 70.00% | |||||||||||||||||||||||||||
| Affiliated Entity | PARCC | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Deferred Reinsurance Loss | $ 351,000 | ||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | 100.00% | 90.00% | ||||||||||||||||||||||||||
| Affiliated Entity | GUL Re | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 30.00% | 95.00% | |||||||||||||||||||||||||||
| Affiliated Entity | PAR Term | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | 95.00% | |||||||||||||||||||||||||||
| Affiliated Entity | Term Re | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 95.00% | ||||||||||||||||||||||||||||
| Affiliated Entity | Prudential Insurance | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | ||||||||||||||||||||||||||||
| Affiliated Entity | Prudential Insurance | Impacts of Reinsurance | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Recapture loss | $ 3,000 | ||||||||||||||||||||||||||||
| Policy charges and fee income | $ (305,000) | ||||||||||||||||||||||||||||
| Number of counterparties | counterparty | 2 | 2 | |||||||||||||||||||||||||||
| Affiliated Entity | Lotus Re | Impacts of Reinsurance | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance liabilities associated with the risks of the coinsurance agreement | $ 32,000 | ||||||||||||||||||||||||||||
| Reinsurance agreement ceded risk | 100.00% | 100.00% | |||||||||||||||||||||||||||
| Net liabilities associated with the transaction for coinsurance | $ 1,387,000 | ||||||||||||||||||||||||||||
| Net liabilities associated with the transaction for modified coinsurance | 14,037,000 | ||||||||||||||||||||||||||||
| Policy loan assets | 855,000 | ||||||||||||||||||||||||||||
| Cash received | 820,000 | ||||||||||||||||||||||||||||
| Recognized gain | $ 1,352,000 | ||||||||||||||||||||||||||||
| Deposit receivables | $ 388,000 | $ 52,000 | |||||||||||||||||||||||||||
| Affiliated Entity | DART | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 95.00% | ||||||||||||||||||||||||||||
| PLNJ | PAR U | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Recapture loss | (29,000) | ||||||||||||||||||||||||||||
| Deferred Reinsurance Gain | 8,000 | ||||||||||||||||||||||||||||
| PLNJ | Affiliated Entity | PAR U | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Recapture gain | $ 270,000 | ||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 95.00% | 100.00% | |||||||||||||||||||||||||||
| PLNJ | Affiliated Entity | PURE | |||||||||||||||||||||||||||||
| Effects of Reinsurance [Line Items] | |||||||||||||||||||||||||||||
| Reinsurance Retention Policy, Reinsured Risk, Percentage | 100.00% | ||||||||||||||||||||||||||||
Income Taxes (Narrative) (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||
|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
||||
| Income Tax Disclosure [Abstract] | |||||
| Income tax expense (benefit) | $ 19,677 | $ (67,647) | [1] | ||
| Effective Income Tax Rate, Percent | 12.75% | 10.54% | |||
| Federal Statutory Income Tax Rate, Percent | 21.00% | ||||
| |||||
Equity (Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
||||||
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||||||
| Begining Balance | $ 4,701,980 | ||||||
| Income tax benefit (expense) | (88,942) | $ 109,279 | [1] | ||||
| Ending Balance | 5,468,127 | ||||||
| Foreign Currency Translation Adjustments | |||||||
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||||||
| Begining Balance | (21,941) | (18,085) | |||||
| Change in OCI before reclassifications | 201 | (2,362) | |||||
| Amounts reclassified from AOCI | 0 | 0 | |||||
| Income tax benefit (expense) | (543) | 212 | |||||
| Ending Balance | (22,283) | (20,235) | |||||
| Net unrealized investment gains (losses) | |||||||
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||||||
| Begining Balance | (1,192,702) | (927,778) | |||||
| Change in OCI before reclassifications | 256,144 | (297,240) | |||||
| Amounts reclassified from AOCI | 16,892 | (16,067) | |||||
| Income tax benefit (expense) | (57,176) | 65,788 | |||||
| Ending Balance | (976,842) | (1,175,297) | |||||
| Interest Rate Remeasurement of Future Policy Benefits | |||||||
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||||||
| Begining Balance | 117,558 | 71,195 | |||||
| Change in OCI before reclassifications | (12,540) | 32,830 | |||||
| Amounts reclassified from AOCI | 0 | 0 | |||||
| Income tax benefit (expense) | 2,632 | (6,894) | |||||
| Ending Balance | 107,650 | 97,131 | |||||
| Gain (Loss) from Changes in Non-Performance Risk on Market Risk Benefits | |||||||
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||||||
| Begining Balance | 495,208 | 843,707 | |||||
| Change in OCI before reclassifications | 161,213 | (238,921) | |||||
| Amounts reclassified from AOCI | 0 | 0 | |||||
| Income tax benefit (expense) | (33,855) | 50,173 | |||||
| Ending Balance | 622,566 | 654,959 | |||||
| Accumulated Other Comprehensive Income (Loss) | |||||||
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||||||
| Begining Balance | (601,877) | (30,961) | |||||
| Change in OCI before reclassifications | 405,018 | (505,693) | |||||
| Amounts reclassified from AOCI | 16,892 | (16,067) | |||||
| Income tax benefit (expense) | (88,942) | 109,279 | |||||
| Ending Balance | (268,909) | (443,442) | [2] | ||||
| Cash flow hedges | Net unrealized investment gains (losses) | |||||||
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||||||
| Begining Balance | 111,000 | 12,000 | |||||
| Ending Balance | $ 95,000 | $ 39,000 | |||||
| |||||||
Equity (Reclassification out of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Net unrealized investment gains (losses) | ||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
| Amounts reclassified from AOCI | $ 16,892 | $ (16,067) |
| AOCI Attributable to Parent | ||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
| Amounts reclassified from AOCI | 16,892 | (16,067) |
| Amounts reclassified from AOCI | Net unrealized investment gains (losses) | ||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
| Amounts reclassified from AOCI | (16,892) | 16,067 |
| Amounts reclassified from AOCI | AOCI Attributable to Parent | ||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
| Amounts reclassified from AOCI | (16,892) | 16,067 |
| Amounts reclassified from AOCI | Fixed maturities, available-for-sale | ||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
| Net unrealized investment gains (losses) | (11,944) | (6,837) |
| Amounts reclassified from AOCI | Currency/Interest rate | Cash flow hedges | ||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||
| Net unrealized investment gains (losses) | $ (4,948) | $ 22,904 |
Equity (Net Unrealized Investment Gains (Losses) in AOCI on AFS Fixed Maturity Securities with Allowance for Credit Losses and All Other Investments) (Details) $ in Thousands |
3 Months Ended |
|---|---|
|
Mar. 31, 2025
USD ($)
| |
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
| Begining Balance | $ 4,701,980 |
| Ending Balance | 5,468,127 |
| Net Unrealized Investment Gains (Losses) on Available-for-Sale Fixed Maturity Securities on which an allowance for credit losses has been recognized | |
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
| Begining Balance | 893 |
| Net investment gains (losses) on investments arising during the period | 2,710 |
| Reclassification adjustment for (gains) losses included in net income | 310 |
| Reclassification due to allowance for credit losses recorded during the period | 6 |
| Impact of net unrealized investment (gains) losses | 0 |
| Ending Balance | 3,919 |
| Net Unrealized Investment Gains (Losses) on All Other Investments | |
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
| Begining Balance | (1,847,178) |
| Net investment gains (losses) on investments arising during the period | 325,258 |
| Reclassification adjustment for (gains) losses included in net income | 16,582 |
| Reclassification due to allowance for credit losses recorded during the period | (6) |
| Impact of net unrealized investment (gains) losses | 0 |
| Ending Balance | (1,505,344) |
| Other Costs | |
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
| Begining Balance | (583,709) |
| Net investment gains (losses) on investments arising during the period | 0 |
| Reclassification adjustment for (gains) losses included in net income | 0 |
| Reclassification due to allowance for credit losses recorded during the period | 0 |
| Impact of net unrealized investment (gains) losses | 167,546 |
| Ending Balance | (416,163) |
| Future Policy Benefits and Policyholders’ Account Balances and other liabilities | |
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
| Begining Balance | 920,455 |
| Net investment gains (losses) on investments arising during the period | 0 |
| Reclassification adjustment for (gains) losses included in net income | 0 |
| Reclassification due to allowance for credit losses recorded during the period | 0 |
| Impact of net unrealized investment (gains) losses | (239,370) |
| Ending Balance | 681,085 |
| Income Tax Benefit (Expense) | |
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
| Begining Balance | 316,837 |
| Net investment gains (losses) on investments arising during the period | (68,696) |
| Reclassification adjustment for (gains) losses included in net income | (3,538) |
| Reclassification due to allowance for credit losses recorded during the period | 0 |
| Impact of net unrealized investment (gains) losses | 15,058 |
| Ending Balance | 259,661 |
| Accumulated Other Comprehensive Income (Loss) Related To Net Unrealized Investment Gains (Losses) | |
| AOCI Attributable to Parent, Net of Tax [Roll Forward] | |
| Begining Balance | (1,192,702) |
| Net investment gains (losses) on investments arising during the period | 259,272 |
| Reclassification adjustment for (gains) losses included in net income | 13,354 |
| Reclassification due to allowance for credit losses recorded during the period | 0 |
| Impact of net unrealized investment (gains) losses | (56,766) |
| Ending Balance | $ (976,842) |
Equity - Narrative (Details) |
Mar. 31, 2025 |
|---|---|
| Certain Subsidiaries | |
| Subsidiary or Equity Method Investee [Line Items] | |
| Subsidiary, ownership percentage | 100.00% |
Related Party Transactions (Narrative) (Details) |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|
|
Feb. 28, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
Nov. 30, 2024
entity
|
Jun. 30, 2024
USD ($)
|
May 31, 2023
USD ($)
|
Mar. 31, 2025
USD ($)
policy
|
Mar. 31, 2024
USD ($)
|
Dec. 31, 2024
USD ($)
|
|
| Related Party Transaction [Line Items] | ||||||||
| Commissions and fees | $ 398,346,000 | $ 2,909,205,000 | ||||||
| Payments to Fund Policy Loans | 60,078,000 | 64,385,000 | ||||||
| Policy loans | $ 1,541,480,000 | 1,556,658,000 | $ 1,541,480,000 | |||||
| Net investment income | 734,796,000 | 505,320,000 | ||||||
| Other invested assets | 1,582,094,000 | 2,040,612,000 | 1,582,094,000 | |||||
| Fee income from revenue sharing agreement | 52,080,000 | 56,632,000 | ||||||
| Commercial Mortgage Loans | 7,759,323,000 | 8,054,419,000 | 7,759,323,000 | |||||
| Accrued investment income | 466,394,000 | 502,312,000 | 466,394,000 | |||||
| Prudential Insurance | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Contributed Capital | $ 220,000,000 | 416,000,000 | ||||||
| Return of Capital | $ 550,000,000 | |||||||
| Dividends | 0 | 0 | ||||||
| PGF | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Investment Income, Interest | 102,000,000 | 128,000,000 | ||||||
| Prudential Insurance | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Stock option program plan expense | 100,000 | 200,000 | ||||||
| Deferred compensation program expense | 2,500,000 | 3,300,000 | ||||||
| Pension plan expense | 3,000,000 | 3,000,000 | ||||||
| Welfare plan expense | $ 5,000,000 | 4,000,000 | ||||||
| Defined contribution plan, employer matching contribution, percent (up to) | 4.00% | |||||||
| Defined contribution plan, cost recognized | $ 2,000,000 | 2,000,000 | ||||||
| Number of Corporate Owned Life Insurance policies sold | policy | 5 | |||||||
| Prudential Insurance and Prudential Financial | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Life Insurance, Corporate or Bank Owned, amount | 4,657,000,000 | $ 4,644,000,000 | 4,657,000,000 | |||||
| Fees related to Life Insurance, Corporate or Bank Owned, amount | 14,000,000 | 13,000,000 | ||||||
| Prudential Financial | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Company's share of corporate expenses | $ 29,000,000 | 36,000,000 | ||||||
| Number of Corporate Owned Life Insurance policies sold | policy | 1 | |||||||
| Payments to Fund Policy Loans | $ 900,000,000 | |||||||
| Policy loans | 897,000,000 | $ 894,000,000 | 897,000,000 | |||||
| Interest Income on Policy Loans | 10,000,000 | 10,000,000 | ||||||
| Affiliated Entity | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Related Party Transaction, Number Of Other Affiliated Entities | entity | 3 | |||||||
| Net investment income | 0 | 2,000,000 | ||||||
| Accrued interest receivable related to long-term notes | 1,000,000 | 2,000,000 | 1,000,000 | |||||
| Revenues related to long-term notes receivable | 2,000,000 | 1,000,000 | ||||||
| Accrued investment income | 0 | 0 | 0 | |||||
| Line of credit facility, maximum borrowing capacity | 7,000,000,000 | |||||||
| Long-term debt to affiliates | 0 | 0 | 0 | |||||
| Interest expense related to loans payable, Related Party | 6,000,000 | 4,000,000 | ||||||
| Affiliated Entity | Total commercial mortgage loans | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Commercial Mortgage Loans | 0 | 0 | 0 | |||||
| Affiliated Entity | PAD | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Commissions and fees | 145,000,000 | 178,000,000 | ||||||
| Affiliated Entity | PGIM | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Net investment income | 21,000,000 | 15,000,000 | ||||||
| Affiliated Entity | ASTISI and PGIM Investments | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Fee income from revenue sharing agreement | 63,000,000 | 69,000,000 | ||||||
| Affiliated Entity | PGIM Investments | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Fee income from revenue sharing agreement | $ 12,000,000 | 11,000,000 | ||||||
| Affiliated Entity | Prudential Advisors | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Selling expenses - Percentage return to Related Party | 98.00% | |||||||
| Selling Expense | $ 113,000,000 | |||||||
| Prudential Financial Joint Ventures | ||||||||
| Related Party Transaction [Line Items] | ||||||||
| Net investment income | 44,000,000 | $ 9,000,000 | ||||||
| Other invested assets | $ 1,100,000,000 | $ 1,513,000,000 | $ 1,100,000,000 | |||||
Related Party Transactions (Affiliated Notes Receivable) (Details) - Affiliated Entity - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
|
| Related Party Transaction [Line Items] | ||
| Total notes receivable - affiliated | $ 567,031 | $ 520,462 |
| U.S. Dollar fixed rate notes | ||
| Related Party Transaction [Line Items] | ||
| Total notes receivable - affiliated | $ 567,031 | $ 520,462 |
| U.S. Dollar fixed rate notes | Minimum | ||
| Related Party Transaction [Line Items] | ||
| Interest Rates | 0.00% | |
| U.S. Dollar fixed rate notes | Maximum | ||
| Related Party Transaction [Line Items] | ||
| Interest Rates | 9.46% |
Related Party Transactions (Affiliated Asset Transfers) (Details) - USD ($) $ in Thousands |
3 Months Ended | |||||
|---|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
[1] | Dec. 31, 2024 |
|||
| Related Party Transaction [Line Items] | ||||||
| Additional Paid in Capital | $ 4,923,299 | |||||
| Realized investment gains (losses), net | $ (106,374) | $ (2,805) | ||||
| Affiliated Entity | PARU - January 2024 - Transfer in - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 1,598,161 | |||||
| Book Value | 1,598,161 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PARU - January 2024 - Transfer in - Fixed Maturities 1 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 778,745 | |||||
| Book Value | 778,745 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PURC - January 2024 - Transfer in - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 2,155,560 | |||||
| Book Value | 2,155,560 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | GUL Re - January 2024 - Transfer in - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 1,685,582 | |||||
| Book Value | 1,685,582 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | GUL Re - January 2024 - Transfer in - Fixed Maturities 1 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 4,976 | |||||
| Book Value | 4,976 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PURE - January 2024 - Transfer out - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 1,598,161 | |||||
| Book Value | 1,598,161 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PURE - January 2024 - Transfer out - Fixed Maturities 1 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 778,745 | |||||
| Book Value | 778,745 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PURE - January 2024 - Transfer out - Fixed Maturities 2 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 2,155,560 | |||||
| Book Value | 2,155,560 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PURE - January 2024 - Transfer out - Fixed Maturities 3 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 1,685,582 | |||||
| Book Value | 1,685,582 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PURE - January 2024 - Transfer out - Fixed Maturities 4 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 4,976 | |||||
| Book Value | 4,976 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Ironbound - January 2024 - Purchase - Other Invested Assets | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 60,414 | |||||
| Book Value | 60,414 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Windhill CLO 1, Ltd. - February 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 18,428 | |||||
| Book Value | 18,858 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (430) | |||||
| Affiliated Entity | Windhill CLO 2, Ltd - February 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 19,652 | |||||
| Book Value | 20,057 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (405) | |||||
| Affiliated Entity | PAR Term - February 2024 - Purchase - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 43,084 | |||||
| Book Value | 43,084 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Windhill CLO 1, Ltd. - March 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 10,148 | |||||
| Book Value | 10,387 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (239) | |||||
| Affiliated Entity | Windhill CLO 2, Ltd. - March 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 14,763 | |||||
| Book Value | 15,091 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (328) | |||||
| Affiliated Entity | Prudential Insurance - March 2024 - Purchase - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 198,804 | |||||
| Book Value | 206,285 | |||||
| Additional Paid in Capital | 5,910 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PAR U - March 2024 - Transfer in - Other Invested Assets | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 188,500 | |||||
| Book Value | 188,500 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PURE - March 2024 - Transfer out - Other Invested Assets | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 188,500 | |||||
| Book Value | 188,500 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Windhill CLO 1, Ltd. - April 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 2,261 | |||||
| Book Value | 2,300 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (39) | |||||
| Affiliated Entity | Windhill CLO 2, Ltd. - May 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 14,034 | |||||
| Book Value | 14,415 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (381) | |||||
| Affiliated Entity | Windhill CLO 1, Ltd. - June 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 2,045 | |||||
| Book Value | 2,100 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (55) | |||||
| Affiliated Entity | Windhill CLO 2, Ltd. - June 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 23,342 | |||||
| Book Value | 23,743 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (401) | |||||
| Affiliated Entity | PAR U - June 2024 - Transfer in - Other Invested Assets | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 326 | |||||
| Book Value | 326 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PURE - June 2024 - Transfer out - Other Invested Assets | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 326 | |||||
| Book Value | 326 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PAR U - June 2024 - Purchase - Commercial Mortgage and Othe Loans | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 12,555 | |||||
| Book Value | 12,555 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Windhill CLO 2, Ltd. - July 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 53,462 | |||||
| Book Value | 54,628 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (1,166) | |||||
| Affiliated Entity | Windhill CLO 2, Ltd. - July 2024 - Sale - Fixed Maturities1 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 6,579 | |||||
| Book Value | 6,695 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (116) | |||||
| Affiliated Entity | Windhill CLO 1, Ltd. - July 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 2,136 | |||||
| Book Value | 2,200 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (64) | |||||
| Affiliated Entity | PAR U - July 2024 - Purchase - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 17,402 | |||||
| Book Value | 17,402 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Prudential Insurance - July 2024 - Purchase - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 22,655 | |||||
| Book Value | 23,433 | |||||
| Additional Paid in Capital | 614 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PAR U - July 2024 - Purchase - Fixed Maturities1 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 1,239 | |||||
| Book Value | 1,239 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PAR U - July 2024 - Purchase - Derivatives | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 2,975 | |||||
| Book Value | 2,975 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Windhill CLO 2, Ltd. - August 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 21,929 | |||||
| Book Value | 22,500 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (571) | |||||
| Affiliated Entity | Windhill CLO 1, Ltd. - August 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 13,650 | |||||
| Book Value | 14,100 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (450) | |||||
| Affiliated Entity | PAR U - August 2024 - Purchase - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 46,742 | |||||
| Book Value | 46,742 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PAR U - August 2024 - Purchase - Fixed Maturities1 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 4,793 | |||||
| Book Value | 4,793 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Prudential Insurance - August 2024 - Purchase - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 35,872 | |||||
| Book Value | 35,085 | |||||
| Additional Paid in Capital | (621) | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Windhill CLO 2, Ltd. - September 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 57,613 | |||||
| Book Value | 57,613 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Windhill CLO 2, Ltd. - September 2024 - Sale - Fixed Maturities1 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 24,575 | |||||
| Book Value | 24,911 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (336) | |||||
| Affiliated Entity | Prudential Insurance - September 2024 - Purchase - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 44,773 | |||||
| Book Value | 43,632 | |||||
| Additional Paid in Capital | (901) | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Hirakata - October 2024 - Purchase - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 21,229 | |||||
| Book Value | 21,229 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Hirakata - October 2024 - Purchase - Fixed Maturities1 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 3,901 | |||||
| Book Value | 3,901 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | PAR U - October 2024 - Transfer in - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 6,615,438 | |||||
| Book Value | 6,615,438 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Windhill CLO 3, Ltd. - October 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 232,036 | |||||
| Book Value | 235,610 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (3,574) | |||||
| Affiliated Entity | Windhill CLO 2, Ltd. - October 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 5,824 | |||||
| Book Value | 5,899 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (75) | |||||
| Affiliated Entity | Windhill CLO 2, Ltd. - October 2024 - Sale - Fixed Maturities1 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 14,690 | |||||
| Book Value | 14,959 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (269) | |||||
| Affiliated Entity | Windhill CLO 1, Ltd. - October 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 3,038 | |||||
| Book Value | 3,100 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (62) | |||||
| Affiliated Entity | PAR U - October 2024 - Transfer in - Equities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 6,120 | |||||
| Book Value | 6,120 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Windhill CLO 3, Ltd. - November 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 17,409 | |||||
| Book Value | 17,518 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (109) | |||||
| Affiliated Entity | Windhill CLO 3, Ltd. - December 2024 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 38,020 | |||||
| Book Value | 38,537 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (517) | |||||
| Affiliated Entity | Windhill CLO 3, Ltd. - December 2024 - Sale - Short-term Investments1 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 2,882 | |||||
| Book Value | 2,905 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (23) | |||||
| Affiliated Entity | Prudential Insurance - December 2024 - Contributed Capital - Equities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 415,696 | |||||
| Book Value | 416,265 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Windhill CLO 2, Ltd. - January 2025 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 2,738 | |||||
| Book Value | 2,800 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (62) | |||||
| Affiliated Entity | Windhill CLO 3, Ltd. - January 2025 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 17,046 | |||||
| Book Value | 17,363 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (317) | |||||
| Affiliated Entity | Windhill CLO 1, Ltd. - January 2025 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 2,152 | |||||
| Book Value | 2,200 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (48) | |||||
| Affiliated Entity | PAR U - February 2025 - Purchase - Derivatives | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 417,169 | |||||
| Book Value | 417,169 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Windhill CLO 2, Ltd. - February 2025 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 7,482 | |||||
| Book Value | 7,600 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (118) | |||||
| Affiliated Entity | Windhill CLO 3, Ltd. - February 2025 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 17,172 | |||||
| Book Value | 17,410 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (238) | |||||
| Affiliated Entity | Windhill CLO 1, Ltd. - February 2025 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 9,784 | |||||
| Book Value | 9,900 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (116) | |||||
| Affiliated Entity | Prudential Insurance - February 2025 - Purchase - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 100,033 | |||||
| Book Value | 101,147 | |||||
| Additional Paid in Capital | 880 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Prudential Insurance - March 2025 - Purchase - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 226,726 | |||||
| Book Value | 260,396 | |||||
| Additional Paid in Capital | 26,599 | |||||
| Realized investment gains (losses), net | 0 | |||||
| Affiliated Entity | Windhill CLO 3, Ltd. - March 2025 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 9,019 | |||||
| Book Value | 9,144 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (125) | |||||
| Affiliated Entity | Windhill CLO 1, Ltd. - March 2025 - Sale - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 8,469 | |||||
| Book Value | 8,500 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (31) | |||||
| Affiliated Entity | Windhill CLO 1, Ltd. - March 2025 - Sale - Fixed Maturities1 | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 10,184 | |||||
| Book Value | 10,301 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | (117) | |||||
| Affiliated Entity | Windhill CLO 1, Ltd. - March 2025 - Purchase - Fixed Maturities | ||||||
| Related Party Transaction [Line Items] | ||||||
| Fair Value | 921 | |||||
| Book Value | 921 | |||||
| Additional Paid in Capital | 0 | |||||
| Realized investment gains (losses), net | $ 0 | |||||
| ||||||
Commitments and Contingent Liabilities (Details) - Fair Value Guarantee [Member] - USD ($) $ in Thousands |
Mar. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Commitments and Contingent Liabilities [Line Items] | ||
| Guaranteed value of third-parties assets | $ 3,959,550 | $ 3,958,847 |
| Fair value of collateral supporting these assets | 3,616,006 | 3,543,500 |
| Asset (liability) associated with guarantee, carried at fair value | $ (12,503) | $ 111 |
Commitments and Contingent Liabilities (Narrative) (Details) - USD ($) $ in Millions |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
Jul. 31, 2017 |
|
| Commitments and Contingent Liabilities [Line Items] | ||||
| Litigation and regulatory matters loss contingency, range of possible loss, maximum (less than) | $ 100.0 | |||
| Indonesia | CT Corp Joint Venture | ||||
| Commitments and Contingent Liabilities [Line Items] | ||||
| Joint Venture with CT Corp, Ownership Percentage | 49.00% | |||
| Commitments | Total commercial mortgage loans | ||||
| Commitments and Contingent Liabilities [Line Items] | ||||
| Total outstanding mortgage loan commitments | 230.0 | $ 230.0 | ||
| Allowance for credit losses | 0.2 | 0.3 | ||
| Change in allowance for credit loss expense (reversal) | 0.1 | $ 0.1 | ||
| Commitments | Investments | ||||
| Commitments and Contingent Liabilities [Line Items] | ||||
| Commitments to purchase investment (excluding commercial mortgage loans) | 1,634.0 | 1,359.0 | ||
| Purchase Commitment | ||||
| Commitments and Contingent Liabilities [Line Items] | ||||
| Change in allowance for credit loss expense (reversal) | 0.0 | $ 0.0 | ||
| Other Guarantees | ||||
| Commitments and Contingent Liabilities [Line Items] | ||||
| Accrued liabilities | $ 32.0 | $ 32.0 | ||
Revision to Prior Year Information (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
||||||||||
| REVENUES | |||||||||||
| Other income (loss) | $ 176,441 | $ 214,995 | [1] | ||||||||
| Realized investment gains (losses), net | (106,374) | (2,805) | [1] | ||||||||
| Change in value of market risk benefits, net of related hedging gains (losses) | (326,071) | 103,996 | [1] | ||||||||
| TOTAL REVENUES | 1,052,678 | 3,879,525 | |||||||||
| BENEFITS AND EXPENSES | |||||||||||
| Interest credited to policyholders’ account balances | 293,762 | 258,350 | [1] | ||||||||
| Amortization of deferred policy acquisition costs | 160,223 | (129,157) | [1] | ||||||||
| General, administrative and other expenses | 294,480 | 297,814 | [1] | ||||||||
| TOTAL BENEFITS AND EXPENSES | 898,383 | 4,521,410 | |||||||||
| INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF OPERATING JOINT VENTURE | (641,885) | ||||||||||
| Income tax expense (benefit) | 19,677 | (67,647) | [1] | ||||||||
| NET INCOME (LOSS) ATTRIBUTABLE TO PRUCO LIFE INSURANCE COMPANY | 129,569 | (575,576) | |||||||||
| Gain (loss) from changes in non-performance risk on market risk benefits | (238,921) | ||||||||||
| Total | 421,910 | (521,760) | |||||||||
| Less: Income tax expense (benefit) related to other comprehensive income (loss) | (109,279) | ||||||||||
| Other comprehensive income (loss), net of tax | 332,968 | (412,481) | |||||||||
| Comprehensive income (loss) | 467,494 | (986,876) | |||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
| Begining Balance | 4,701,980 | ||||||||||
| Comprehensive income (loss): | |||||||||||
| Net Income (Loss) | 134,526 | (574,395) | [2] | ||||||||
| Other comprehensive income (loss), net of tax | 332,968 | (412,481) | |||||||||
| Total comprehensive income (loss) | 467,494 | (986,876) | |||||||||
| Ending Balance | 5,468,127 | ||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net Income (Loss) | 134,526 | (574,395) | [2] | ||||||||
| Interest credited to policyholders’ account balances | 293,762 | 258,350 | [2] | ||||||||
| Realized investment (gains) losses, net | 106,374 | 2,805 | [1] | ||||||||
| Change in value of market risk benefits, net of related hedging (gains) losses | 326,071 | (103,996) | [1] | ||||||||
| Change in: | |||||||||||
| Reinsurance related-balances | [3] | (248,674) | 496,373 | [2] | |||||||
| Deferred policy acquisition costs | [3] | (197,401) | (194,547) | [2] | |||||||
| Income taxes | 20,891 | (68,453) | [2] | ||||||||
| Derivatives, net | (714,931) | 125,100 | [2] | ||||||||
| Other, net | [3] | (150,083) | (52,194) | [2] | |||||||
| Cash flows from (used in) operating activities | 41,311 | 690,625 | |||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||
| Ceded policyholders’ account deposits | (592,077) | (301,733) | [2] | ||||||||
| Policyholders’ account withdrawals | (1,048,147) | (978,866) | [2] | ||||||||
| Other, net | [3] | 86,696 | (78,207) | [2] | |||||||
| Cash flows from (used in) financing activities | 3,213,526 | 2,739,124 | |||||||||
| Scenario, Adjustment | |||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Interest credited to policyholders’ account balances | 258,350 | ||||||||||
| Retained Earnings | |||||||||||
| BENEFITS AND EXPENSES | |||||||||||
| Comprehensive income (loss) | 129,569 | (575,576) | |||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
| Begining Balance | 272,519 | (551,471) | |||||||||
| Comprehensive income (loss): | |||||||||||
| Net Income (Loss) | 129,569 | (575,576) | [4] | ||||||||
| Total comprehensive income (loss) | 129,569 | (575,576) | |||||||||
| Ending Balance | 402,088 | (1,127,047) | [4] | ||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net Income (Loss) | 129,569 | (575,576) | [4] | ||||||||
| AOCI | |||||||||||
| BENEFITS AND EXPENSES | |||||||||||
| Other comprehensive income (loss), net of tax | 332,968 | (412,481) | [4] | ||||||||
| Comprehensive income (loss) | 332,968 | (412,481) | |||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
| Begining Balance | (601,877) | (30,961) | |||||||||
| Comprehensive income (loss): | |||||||||||
| Other comprehensive income (loss), net of tax | 332,968 | (412,481) | [4] | ||||||||
| Total comprehensive income (loss) | 332,968 | (412,481) | |||||||||
| Ending Balance | (268,909) | (443,442) | [4] | ||||||||
| Total Equity | |||||||||||
| BENEFITS AND EXPENSES | |||||||||||
| Other comprehensive income (loss), net of tax | 332,968 | (412,481) | [4] | ||||||||
| Comprehensive income (loss) | 467,494 | (986,876) | |||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
| Begining Balance | 4,701,980 | 4,502,864 | |||||||||
| Comprehensive income (loss): | |||||||||||
| Net Income (Loss) | 134,526 | (574,395) | [4] | ||||||||
| Other comprehensive income (loss), net of tax | 332,968 | (412,481) | [4] | ||||||||
| Total comprehensive income (loss) | 467,494 | (986,876) | |||||||||
| Ending Balance | 5,468,127 | 3,547,020 | [4] | ||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net Income (Loss) | $ 134,526 | (574,395) | [4] | ||||||||
| Previously Reported | |||||||||||
| REVENUES | |||||||||||
| Other income (loss) | 213,485 | ||||||||||
| Realized investment gains (losses), net | 23,000 | ||||||||||
| Change in value of market risk benefits, net of related hedging gains (losses) | 91,591 | ||||||||||
| TOTAL REVENUES | 3,891,415 | ||||||||||
| BENEFITS AND EXPENSES | |||||||||||
| Interest credited to policyholders’ account balances | 224,550 | ||||||||||
| Amortization of deferred policy acquisition costs | (131,015) | ||||||||||
| General, administrative and other expenses | 308,178 | ||||||||||
| TOTAL BENEFITS AND EXPENSES | 4,496,116 | ||||||||||
| INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF OPERATING JOINT VENTURE | (604,701) | ||||||||||
| Income tax expense (benefit) | (63,617) | ||||||||||
| NET INCOME (LOSS) ATTRIBUTABLE TO PRUCO LIFE INSURANCE COMPANY | (542,422) | ||||||||||
| Gain (loss) from changes in non-performance risk on market risk benefits | (238,974) | ||||||||||
| Total | (521,813) | ||||||||||
| Less: Income tax expense (benefit) related to other comprehensive income (loss) | (109,291) | ||||||||||
| Other comprehensive income (loss), net of tax | (412,522) | ||||||||||
| Comprehensive income (loss) | (953,763) | ||||||||||
| Comprehensive income (loss): | |||||||||||
| Net Income (Loss) | (541,241) | ||||||||||
| Other comprehensive income (loss), net of tax | (412,522) | ||||||||||
| Total comprehensive income (loss) | (953,763) | ||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net Income (Loss) | (541,241) | ||||||||||
| Interest credited to policyholders’ account balances | 224,550 | ||||||||||
| Realized investment (gains) losses, net | (23,000) | ||||||||||
| Change in value of market risk benefits, net of related hedging (gains) losses | (91,591) | ||||||||||
| Change in: | |||||||||||
| Reinsurance related-balances | 497,883 | ||||||||||
| Deferred policy acquisition costs | (186,041) | ||||||||||
| Income taxes | (64,423) | ||||||||||
| Derivatives, net | (23,220) | ||||||||||
| Other, net | 96,126 | ||||||||||
| Cash flows from (used in) operating activities | 690,625 | ||||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||
| Ceded policyholders’ account deposits | (356,405) | ||||||||||
| Policyholders’ account withdrawals | (1,027,050) | ||||||||||
| Other, net | 24,649 | ||||||||||
| Cash flows from (used in) financing activities | 2,739,124 | ||||||||||
| Previously Reported | Retained Earnings | |||||||||||
| BENEFITS AND EXPENSES | |||||||||||
| Comprehensive income (loss) | (542,422) | ||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
| Begining Balance | (532,951) | ||||||||||
| Comprehensive income (loss): | |||||||||||
| Net Income (Loss) | (542,422) | ||||||||||
| Total comprehensive income (loss) | (542,422) | ||||||||||
| Ending Balance | (1,075,373) | ||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net Income (Loss) | (542,422) | ||||||||||
| Previously Reported | AOCI | |||||||||||
| BENEFITS AND EXPENSES | |||||||||||
| Other comprehensive income (loss), net of tax | (412,522) | ||||||||||
| Comprehensive income (loss) | (412,522) | ||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
| Begining Balance | (30,920) | ||||||||||
| Comprehensive income (loss): | |||||||||||
| Other comprehensive income (loss), net of tax | (412,522) | ||||||||||
| Total comprehensive income (loss) | (412,522) | ||||||||||
| Ending Balance | (443,442) | ||||||||||
| Previously Reported | Total Equity | |||||||||||
| BENEFITS AND EXPENSES | |||||||||||
| Other comprehensive income (loss), net of tax | (412,522) | ||||||||||
| Comprehensive income (loss) | (953,763) | ||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
| Begining Balance | 4,521,425 | ||||||||||
| Comprehensive income (loss): | |||||||||||
| Net Income (Loss) | (541,241) | ||||||||||
| Other comprehensive income (loss), net of tax | (412,522) | ||||||||||
| Total comprehensive income (loss) | (953,763) | ||||||||||
| Ending Balance | 3,598,694 | ||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net Income (Loss) | (541,241) | ||||||||||
| Adjustments | |||||||||||
| REVENUES | |||||||||||
| Other income (loss) | 1,510 | ||||||||||
| Realized investment gains (losses), net | (25,805) | ||||||||||
| Change in value of market risk benefits, net of related hedging gains (losses) | 12,405 | ||||||||||
| TOTAL REVENUES | (11,890) | ||||||||||
| BENEFITS AND EXPENSES | |||||||||||
| Interest credited to policyholders’ account balances | 33,800 | ||||||||||
| Amortization of deferred policy acquisition costs | 1,858 | ||||||||||
| General, administrative and other expenses | (10,364) | ||||||||||
| TOTAL BENEFITS AND EXPENSES | 25,294 | ||||||||||
| INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF OPERATING JOINT VENTURE | (37,184) | ||||||||||
| Income tax expense (benefit) | (4,030) | ||||||||||
| NET INCOME (LOSS) ATTRIBUTABLE TO PRUCO LIFE INSURANCE COMPANY | (33,154) | ||||||||||
| Gain (loss) from changes in non-performance risk on market risk benefits | 53 | ||||||||||
| Total | 53 | ||||||||||
| Less: Income tax expense (benefit) related to other comprehensive income (loss) | 12 | ||||||||||
| Other comprehensive income (loss), net of tax | 41 | ||||||||||
| Comprehensive income (loss) | (33,113) | ||||||||||
| Comprehensive income (loss): | |||||||||||
| Net Income (Loss) | (33,154) | ||||||||||
| Other comprehensive income (loss), net of tax | 41 | ||||||||||
| Total comprehensive income (loss) | (33,113) | ||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net Income (Loss) | (33,154) | ||||||||||
| Interest credited to policyholders’ account balances | 33,800 | ||||||||||
| Realized investment (gains) losses, net | 25,805 | ||||||||||
| Change in value of market risk benefits, net of related hedging (gains) losses | (12,405) | ||||||||||
| Change in: | |||||||||||
| Reinsurance related-balances | (1,510) | ||||||||||
| Deferred policy acquisition costs | (8,506) | ||||||||||
| Income taxes | (4,030) | ||||||||||
| Derivatives, net | 148,320 | ||||||||||
| Other, net | (148,320) | ||||||||||
| Cash flows from (used in) operating activities | 0 | ||||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||
| Ceded policyholders’ account deposits | 54,672 | ||||||||||
| Policyholders’ account withdrawals | 48,184 | ||||||||||
| Other, net | (102,856) | ||||||||||
| Cash flows from (used in) financing activities | 0 | ||||||||||
| Adjustments | Retained Earnings | |||||||||||
| BENEFITS AND EXPENSES | |||||||||||
| Comprehensive income (loss) | (33,154) | ||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
| Begining Balance | (18,520) | ||||||||||
| Comprehensive income (loss): | |||||||||||
| Net Income (Loss) | (33,154) | ||||||||||
| Total comprehensive income (loss) | (33,154) | ||||||||||
| Ending Balance | (51,674) | ||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net Income (Loss) | (33,154) | ||||||||||
| Adjustments | AOCI | |||||||||||
| BENEFITS AND EXPENSES | |||||||||||
| Other comprehensive income (loss), net of tax | 41 | ||||||||||
| Comprehensive income (loss) | 41 | ||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
| Begining Balance | (41) | ||||||||||
| Comprehensive income (loss): | |||||||||||
| Other comprehensive income (loss), net of tax | 41 | ||||||||||
| Total comprehensive income (loss) | 41 | ||||||||||
| Ending Balance | 0 | ||||||||||
| Adjustments | Total Equity | |||||||||||
| BENEFITS AND EXPENSES | |||||||||||
| Other comprehensive income (loss), net of tax | 41 | ||||||||||
| Comprehensive income (loss) | (33,113) | ||||||||||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
| Begining Balance | (18,561) | ||||||||||
| Comprehensive income (loss): | |||||||||||
| Net Income (Loss) | (33,154) | ||||||||||
| Other comprehensive income (loss), net of tax | 41 | ||||||||||
| Total comprehensive income (loss) | (33,113) | ||||||||||
| Ending Balance | (51,674) | ||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||
| Net Income (Loss) | $ (33,154) | ||||||||||
| |||||||||||